<!DOCTYPE html><html lang="en"><head><script src="https://cdnjs.cloudflare.com/ajax/libs/js-polyfills/0.1.42/polyfill.min.js"></script><link href="https://www.hindawi.com/static/themes/hindawi/base.css" rel="stylesheet"/><meta charSet="utf-8" class="next-head"/><meta name="viewport" content="width=device-width, initial-scale=1" class="next-head"/><title class="next-head">Neurogenesis and Increase in Differentiated Neural Cell Survival via Phosphorylation of Akt1 after Fluoxetine Treatment of Stem Cells</title><link rel="canonical" href="https://www.hindawi.com/journals/bmri/2013/582526/" class="next-head"/><link rel="shortcut icon" type="image/x-icon" href="https://preprod-admin.w2o.hindawi.com/themes/custom/hindawi_extended/favicon.ico" class="next-head"/><meta name="title" content="Neurogenesis and Increase in Differentiated Neural Cell Survival via Phosphorylation of Akt1 after Fluoxetine Treatment of Stem Cells"/><meta rel="canonical" href="https://www.hindawi.com/journals/bmri/2013/582526/"/><meta name="description" content="Fluoxetine (FLX) is a selective serotonin reuptake inhibitor (SSRI). Its action is possibly through an increase in neural cell survival. The mechanism of improved survival rate of neurons by FLX may relate to the overexpression of some kinases such as Akt protein. Akt1 (a serine/threonine kinase) plays a key role in the modulation of cell proliferation and survival. Our study evaluated the effects of FLX on mesenchymal stem cell (MSC) fate and Akt1 phosphorylation levels in MSCs. Evaluation tests included reverse transcriptase polymerase chain reaction, western blot, and immunocytochemistry assays. Nestin, MAP-2, and &lt;i&gt;&amp;#x3b2;&lt;/i&gt;-tubulin were detected after neurogenesis as neural markers. Ten &lt;i&gt;&amp;#x3bc;&lt;/i&gt;M of FLX upregulated phosphorylation of Akt1 protein in induced hEnSC significantly. Also FLX did increase viability of these MSCs. Continuous FLX treatment after neurogenesis elevated the survival rate of differentiated neural cells probably by enhanced induction of Akt1 phosphorylation. This study addresses a novel role of FLX in neurogenesis and differentiated neural cell survival that may contribute to explaining the therapeutic action of fluoxetine in regenerative pharmacology."/><meta property="og:url" content="https://www.hindawi.com/journals/bmri/2013/582526/"/><meta property="og:type" content="website"/><meta property="og:image" content="https://images.hindawi.com/journals/bmri/bmri.banner.jpg"/><meta property="og:image:type" content="image/jpeg"/><meta property="og:image:width" content="600"/><meta property="og:image:height" content="315"/><meta property="og:title" content="Neurogenesis and Increase in Differentiated Neural Cell Survival via Phosphorylation of Akt1 after Fluoxetine Treatment of Stem Cells"/><meta name="twitter:site" content="website"/><meta name="twitter:card" content="summary_large_image"/><meta name="twitter:image" content="https://images.hindawi.com/journals/bmri/bmri.banner.jpg"/><meta name="twitter:title" content="Neurogenesis and Increase in Differentiated Neural Cell Survival via Phosphorylation of Akt1 after Fluoxetine Treatment of Stem Cells"/><meta property="og:description" content="Fluoxetine (FLX) is a selective serotonin reuptake inhibitor (SSRI). Its action is possibly through an increase in neural cell survival. The mechanism of improved survival rate of neurons by FLX may relate to the overexpression of some kinases such as Akt protein. Akt1 (a serine/threonine kinase) plays a key role in the modulation of cell proliferation and survival. Our study evaluated the effects of FLX on mesenchymal stem cell (MSC) fate and Akt1 phosphorylation levels in MSCs. Evaluation tests included reverse transcriptase polymerase chain reaction, western blot, and immunocytochemistry assays. Nestin, MAP-2, and &lt;i&gt;&amp;#x3b2;&lt;/i&gt;-tubulin were detected after neurogenesis as neural markers. Ten &lt;i&gt;&amp;#x3bc;&lt;/i&gt;M of FLX upregulated phosphorylation of Akt1 protein in induced hEnSC significantly. Also FLX did increase viability of these MSCs. Continuous FLX treatment after neurogenesis elevated the survival rate of differentiated neural cells probably by enhanced induction of Akt1 phosphorylation. This study addresses a novel role of FLX in neurogenesis and differentiated neural cell survival that may contribute to explaining the therapeutic action of fluoxetine in regenerative pharmacology."/><meta name="twitter:description" content="Fluoxetine (FLX) is a selective serotonin reuptake inhibitor (SSRI). Its action is possibly through an increase in neural cell survival. The mechanism of improved survival rate of neurons by FLX may relate to the overexpression of some kinases such as Akt protein. Akt1 (a serine/threonine kinase) plays a key role in the modulation of cell proliferation and survival. Our study evaluated the effects of FLX on mesenchymal stem cell (MSC) fate and Akt1 phosphorylation levels in MSCs. Evaluation tests included reverse transcriptase polymerase chain reaction, western blot, and immunocytochemistry assays. Nestin, MAP-2, and &lt;i&gt;&amp;#x3b2;&lt;/i&gt;-tubulin were detected after neurogenesis as neural markers. Ten &lt;i&gt;&amp;#x3bc;&lt;/i&gt;M of FLX upregulated phosphorylation of Akt1 protein in induced hEnSC significantly. Also FLX did increase viability of these MSCs. Continuous FLX treatment after neurogenesis elevated the survival rate of differentiated neural cells probably by enhanced induction of Akt1 phosphorylation. This study addresses a novel role of FLX in neurogenesis and differentiated neural cell survival that may contribute to explaining the therapeutic action of fluoxetine in regenerative pharmacology."/><meta name="citation_title" content="Neurogenesis and Increase in Differentiated Neural Cell Survival via Phosphorylation of Akt1 after Fluoxetine Treatment of Stem Cells"/><meta name="citation_author" content="Rahmani, Anahita"/><meta name="citation_author" content="Kheradmand, Danial"/><meta name="citation_author" content="Keyhanvar, Peyman"/><meta name="citation_author" content="Shoae-Hassani, Alireza"/><meta name="citation_author" content="Darbandi-Azar, Amir"/><meta name="citation_journal_title" content="BioMed Research International"/><meta name="citation_publisher" content="Hindawi"/><meta name="citation_volume" content="2013"/><meta name="citation_year" content="2013"/><meta name="citation_date" content="2013/08/18"/><meta name="citation_online_date" content="2013/08/18"/><meta name="citation_doi" content="https://doi.org/10.1155/2013/582526"/><meta name="citation_issn" content="2314-6133"/><meta name="citation_abstract" content="Fluoxetine (FLX) is a selective serotonin reuptake inhibitor (SSRI). Its action is possibly through an increase in neural cell survival. The mechanism of improved survival rate of neurons by FLX may relate to the overexpression of some kinases such as Akt protein. Akt1 (a serine/threonine kinase) plays a key role in the modulation of cell proliferation and survival. Our study evaluated the effects of FLX on mesenchymal stem cell (MSC) fate and Akt1 phosphorylation levels in MSCs. Evaluation tests included reverse transcriptase polymerase chain reaction, western blot, and immunocytochemistry assays. Nestin, MAP-2, and &lt;i&gt;&amp;#x3b2;&lt;/i&gt;-tubulin were detected after neurogenesis as neural markers. Ten &lt;i&gt;&amp;#x3bc;&lt;/i&gt;M of FLX upregulated phosphorylation of Akt1 protein in induced hEnSC significantly. Also FLX did increase viability of these MSCs. Continuous FLX treatment after neurogenesis elevated the survival rate of differentiated neural cells probably by enhanced induction of Akt1 phosphorylation. This study addresses a novel role of FLX in neurogenesis and differentiated neural cell survival that may contribute to explaining the therapeutic action of fluoxetine in regenerative pharmacology."/><meta name="citation_fulltext_html_url" content="https://www.hindawi.com/journals/bmri/2013/582526/"/><meta name="citation_pdf_url" content="https://downloads.hindawi.com/journals/bmri/2013/582526.pdf"/><meta name="citation_xml_url" content="https://downloads.hindawi.com/journals/bmri/2013/582526.xml"/><meta name="dc.creator" content="Rahmani, Anahita"/><meta name="dc.creator" content="Kheradmand, Danial"/><meta name="dc.creator" content="Keyhanvar, Peyman"/><meta name="dc.creator" content="Shoae-Hassani, Alireza"/><meta name="dc.creator" content="Darbandi-Azar, Amir"/><meta name="dc.title" content="Neurogenesis and Increase in Differentiated Neural Cell Survival via Phosphorylation of Akt1 after Fluoxetine Treatment of Stem Cells"/><meta name="dc.description" content="Fluoxetine (FLX) is a selective serotonin reuptake inhibitor (SSRI). Its action is possibly through an increase in neural cell survival. The mechanism of improved survival rate of neurons by FLX may relate to the overexpression of some kinases such as Akt protein. Akt1 (a serine/threonine kinase) plays a key role in the modulation of cell proliferation and survival. Our study evaluated the effects of FLX on mesenchymal stem cell (MSC) fate and Akt1 phosphorylation levels in MSCs. Evaluation tests included reverse transcriptase polymerase chain reaction, western blot, and immunocytochemistry assays. Nestin, MAP-2, and &lt;i&gt;&amp;#x3b2;&lt;/i&gt;-tubulin were detected after neurogenesis as neural markers. Ten &lt;i&gt;&amp;#x3bc;&lt;/i&gt;M of FLX upregulated phosphorylation of Akt1 protein in induced hEnSC significantly. Also FLX did increase viability of these MSCs. Continuous FLX treatment after neurogenesis elevated the survival rate of differentiated neural cells probably by enhanced induction of Akt1 phosphorylation. This study addresses a novel role of FLX in neurogenesis and differentiated neural cell survival that may contribute to explaining the therapeutic action of fluoxetine in regenerative pharmacology."/><meta name="dc.publisher" content="Hindawi"/><meta name="dc.format" content="text/html"/><meta name="dc.language" content="en"/><meta name="dc.identifier" content="https://doi.org/10.1155/2013/582526"/><meta name="dc.type" content="Research Article"/><meta name="dc.date" content="2013/08/18"/><meta name="dcterms.issued" content="2013/08/18"/><meta name="prism.publicationDate" content="2013/08/18"/><meta name="prism.volume" content="2013"/><meta name="prism.section" content="Research Article"/><meta name="prism.doi" content="https://doi.org/10.1155/2013/582526"/><meta name="prism.issn" content="2314-6133"/><meta name="dc.source" content="BioMed Research International"/><meta name="prism.publicationName" content="BioMed Research International"/><meta name="authors" content="Anahita Rahmani | Danial Kheradmand | ... | Amir Darbandi-Azar"/><meta name="Author" content="Hindawi"/><meta name="robots" content="index"/><meta name="google-site-verification" content="AxEuDsL7vXGOxRe53-uFhOk2ODN0bbXMeuBy6Pfq4ww"/><script src="https://cdn.cookielaw.org/scripttemplates/otSDKStub.js" type="text/javascript" charset="UTF-8" data-domain-script="fbafd62a-0a4e-4f7b-a04d-56f57fa3d716"></script><link href="https://static-01.hindawi.com/next_assets/cpr9K8AjZYaP4CWVbtn5c/static/lib/basictable.css" rel="stylesheet" media="none" class="next-head"/><link rel="stylesheet" href="https://static-01.hindawi.com/next_assets/cpr9K8AjZYaP4CWVbtn5c/static/lib/owl.carousel.min.css" media="none" class="next-head"/><link rel="stylesheet" href="https://static-01.hindawi.com/next_assets/cpr9K8AjZYaP4CWVbtn5c/static/lib/owl.theme.default.min.css" media="none" class="next-head"/><script src="https://static-01.hindawi.com/next_assets/cpr9K8AjZYaP4CWVbtn5c/static/lib/jquery.js" class="next-head"></script><link rel="preload" type="text/css" href="https://cdn.bibblio.org/rcm/4.24/bib-related-content.min.css" as="style" class="next-head"/><link rel="preload" type="text/css" href="https://cdn.bibblio.org/rcm/4.24/bib-related-content.min.css" as="style" class="next-head"/><script class="next-head">
        (function(w,d,s,l,i){w[l]=w[l]||[];
            w[l].push({'gtm.start': new Date().getTime(),event:'gtm.js', });
            var f=d.getElementsByTagName(s)[0],j=d.createElement(s),dl=l!='dataLayer'?'&l='+l:'';
            j.async=true;j.src='//www.googletagmanager.com/gtm.js?id='+i+dl
            ;
            f.parentNode.insertBefore(j,f);
        })(window,document,'script','dataLayer','GTM-MQ4MGW');</script><link rel="preload" href="https://static-01.hindawi.com/next_assets/cpr9K8AjZYaP4CWVbtn5c/_next/static/cpr9K8AjZYaP4CWVbtn5c/pages/journal_article.js" as="script"/><link rel="preload" href="https://static-01.hindawi.com/next_assets/cpr9K8AjZYaP4CWVbtn5c/_next/static/cpr9K8AjZYaP4CWVbtn5c/pages/_app.js" as="script"/><link rel="preload" href="https://static-01.hindawi.com/next_assets/cpr9K8AjZYaP4CWVbtn5c/_next/static/runtime/webpack-8ed9452df514b4d17d80.js" as="script"/><link rel="preload" href="https://static-01.hindawi.com/next_assets/cpr9K8AjZYaP4CWVbtn5c/_next/static/chunks/common.833c76e043bbff9f1f05.js" as="script"/><link rel="preload" href="https://static-01.hindawi.com/next_assets/cpr9K8AjZYaP4CWVbtn5c/_next/static/chunks/vendors~static/cpr9K8AjZYaP4CWVbtn5c/pages/_error.js~static/cpr9K8AjZYaP4CWVbtn5c/pages/basic_page.j~be281a1b.25833a967f60c50378e5.js" as="script"/><link rel="preload" href="https://static-01.hindawi.com/next_assets/cpr9K8AjZYaP4CWVbtn5c/_next/static/runtime/main-87fc3e527b54e364ead2.js" as="script"/><link rel="preload" href="https://static-01.hindawi.com/next_assets/cpr9K8AjZYaP4CWVbtn5c/_next/static/chunks/vendors~static/cpr9K8AjZYaP4CWVbtn5c/pages/_app.js~static/cpr9K8AjZYaP4CWVbtn5c/pages/login.js~stati~9d879864.8fb864f66b07cdcdf10f.js" as="script"/><link rel="preload" href="https://static-01.hindawi.com/next_assets/cpr9K8AjZYaP4CWVbtn5c/_next/static/chunks/vendors~static/cpr9K8AjZYaP4CWVbtn5c/pages/_app.js~static/cpr9K8AjZYaP4CWVbtn5c/pages/content_alerts~fb8dc725.93e0b4fc708693fdbfaa.js" as="script"/><link rel="stylesheet" href="https://static-01.hindawi.com/next_assets/cpr9K8AjZYaP4CWVbtn5c/_next/static/css/common.19957fe3.chunk.css"/><link rel="stylesheet" href="https://static-01.hindawi.com/next_assets/cpr9K8AjZYaP4CWVbtn5c/_next/static/css/static/cpr9K8AjZYaP4CWVbtn5c/pages/journal_article.js.bf2397b9.chunk.css"/><style data-styled="NQpXC gnduKR jzXSTA bNmdOy epRoim bUhGXt gjctdt jGJLow kAzjOl ivbKJD fopjOz hbVEoI khbeDd gvAGTV kNoiZu diutvq bqeMOy bMdQcY ldSkVQ cmzomn fJLQxX kuxTps prcY bJcSpM elhyhe fTkdCR jCfZqq EwsTm mkXor dULvrJ dfaOeH jOLhQl iiusBg TsaZF cqhPZs gaRePw dEfJbW eBepOs fSPaCp bVEEaH etauus ctePXh gCIfTO OGgkt dUABlg jUTgTa eujois cQgXqt ewCAZX kdvWPs hAFFGk lkWWFY ehYbwJ legory epgILe kCfRMJ bjwAQR byflLi jXeALb UVThf dDyxFF fkVFlF dzZrgS jLUVhb dVCLgr bBmZJZ ewHMLz bbzREB jknsZc eSvjPB jntdRu iySbrx bCmGAV TdHTO bmMPie fClRDD iomKnj fexZtq eGVCps mBGSe bkiEfx ztvYg cUsFHx duuwge lcOiDF gsmOCv kPshFw kRoxOt jZOxOO eHMFfo XkrFe iQSObO irNWJI dMuGGA kfDwZY evMkvU fYrLtk fjviok hgKieC cIribm khHUcu exFqMv dbAANp eyHfWh cBTaXT becpDt kbSZJl jzTMLK gbrQxi hRnXob hymroZ cbcyj hmDWcT isgRZA ihmyEq itFKcQ cGuwDn jrsDZP gWTCXQ jGPvPL etzuBr gWgCNb WHkfb ibWUzs kdRRST cHatnS kxdGAZ jHPgUP fXBKFa hNPrIr bnbfTS cYsVdk inBNwS dkutRV hlGpbO filPdg ecHxGW gCiATD eEFYIL dsXEHZ iXKuYd" data-styled-version="4.4.1">
/* sc-component-id: sc-bdVaJa */
.EwsTm{height:200vh;width:100%;position:fixed;z-index:1;background:rgba(255,255,255,0.8);} .EwsTm.isHide{display:none;} @media (min-width:768px) and (max-width:991px){} @media (min-width:992px){.EwsTm{display:none;}}
/* sc-component-id: sc-htpNat */
.bUhGXt{color:black;-webkit-text-decoration:none;text-decoration:none;border-radius:5px;font-size:16px;} .bUhGXt:focus-visible{outline-width:3px;outline-color:#8fc9ff;outline-style:solid;}
/* sc-component-id: sc-bxivhb */
.ivbKJD{display:inline-block;}
/* sc-component-id: sc-ifAKCX */
.fopjOz{display:-webkit-inline-box;display:-webkit-inline-flex;display:-ms-inline-flexbox;display:inline-flex;-webkit-flex:wrap;-ms-flex:wrap;flex:wrap;-webkit-align-items:center;-webkit-box-align:center;-ms-flex-align:center;align-items:center;list-style-type:none;margin:0;padding:0;} .fopjOz li{padding:0 10px;} .fopjOz li a{padding:0;} .fopjOz a{-webkit-transition:border .25s ease-in-out 0s;transition:border .25s ease-in-out 0s;border-bottom:2px solid #fff;border-radius:0;} .fopjOz a:hover{border-bottom:2px solid #9b9b9b;padding-bottom:4px;} .fopjOz .active{border-bottom:2px solid #57a61e;}
/* sc-component-id: sc-EHOje */
.jOLhQl{vertical-align:middle;height:24px;}.iiusBg{vertical-align:middle;height:16px;}.TsaZF{vertical-align:middle;height:40px;}
/* sc-component-id: sc-bZQynM */
.bNmdOy{max-width:1440px;margin:0 auto;width:100%;}
/* sc-component-id: sc-htoDjs */
.khbeDd{vertical-align:middle;font-size:24px;}.gvAGTV{vertical-align:middle;font-size:9px;}.kNoiZu{vertical-align:middle;font-size:16px;}.diutvq{vertical-align:middle;font-size:22px;}.bqeMOy{vertical-align:middle;font-size:20px;}.bMdQcY{vertical-align:middle;font-size:11px;}
/* sc-component-id: sc-fjdhpX */
.jzXSTA{position:fixed;top:0;left:0;right:0;z-index:1000;background:#fff;height:70px;font-size:16px;font-weight:500;border-bottom:1px solid #e3e3e3;-webkit-transition:all 0.5s;transition:all 0.5s;} @media (max-width:991px){.jzXSTA{border-bottom:1px solid #e3e3e3;}} @media (max-width:767px){.jzXSTA{margin-bottom:70px;height:60px;}} .jzXSTA .header__padding{padding:0 20px;box-sizing:border-box;} @media (max-width:991px){.jzXSTA .header__padding{padding:0 0 0 20px;}} .jzXSTA .menu{position:fixed;top:60px;right:0;width:100%;background:white;} @media (max-width:991px){.jzXSTA .menu{z-index:2;}} @media (min-width:768px){.jzXSTA .menu{width:500px;top:70px;}} @media (min-width:991.5px){.jzXSTA .menu{display:none;}} .jzXSTA .menu ul{list-style-type:none;text-align:center;padding:0;margin:0;} @media (min-width:768px){.jzXSTA .menu ul{padding:0;border-left:1px solid #e3e3e3;}} .jzXSTA .menu ul li a{color:#4a4a4a;padding:10px;-webkit-text-decoration:none;text-decoration:none;display:block;border-bottom:1px solid #e3e3e3;} .jzXSTA .menu .button_wrap{width:90%;margin:10px auto;border-radius:5px;border-style:solid;border-width:1px;} @media (min-width:768px){.jzXSTA .menu .button_wrap{display:none;}} .jzXSTA .menu .button__publishing{background-color:#6ba439;color:#fff;border-color:#6ba439;} .jzXSTA .menu .button__login{display:none;background-color:#fff;color:#4D8A17;border-color:#e3e3e3;} .jzXSTA.headerUp{-webkit-transform:translateY(-100%);-ms-transform:translateY(-100%);transform:translateY(-100%);}
/* sc-component-id: sc-jzJRlG */
.jGJLow{-webkit-box-pack:end;-webkit-justify-content:flex-end;-ms-flex-pack:end;justify-content:flex-end;} .jGJLow a{padding:10px;} .jGJLow nav{-webkit-align-self:center;-ms-flex-item-align:center;align-self:center;} @media (max-width:991px){.jGJLow nav{display:none;}} .jGJLow nav ul{margin-right:16px;} .jGJLow nav ul li a{color:#4a4a4a;padding:10px 0px 4px;margin:0 6px;} @media (max-width:991px){.jGJLow .icon-themeable{border-left:1px solid #e3e3e3;padding:23px 20px;}} @media (max-width:767px){.jGJLow .icon-themeable{padding:18px 20px;}} @media (max-width:767.5px){.jGJLow.mobileButtonFlex{-ms-flex:0 0 51%;-webkit-flex:0 0 51%;-ms-flex:0 0 51%;flex:0 0 51%;max-width:51%;}}
/* sc-component-id: sc-cSHVUG */
.ldSkVQ{display:none;padding:0;background-color:#fff;border:none;height:59px;} @media (min-width:768px){.ldSkVQ{height:69px;}} .ldSkVQ img{box-sizing:content-box;width:28px;padding:17px 20px;} @media (min-width:768px){.ldSkVQ img{padding:22px 20px;}} @media (max-width:991px){.ldSkVQ{display:inline-block;}}
/* sc-component-id: sc-kAzzGY */
.epRoim a{display:inline-block;padding:15px 0;} @media (max-width:767px){.epRoim a{padding:10px 0;}} @media (max-width:767.5px){.epRoim.mobileLogoFlex{-ms-flex:0 0 49%;-webkit-flex:0 0 49%;-ms-flex:0 0 49%;flex:0 0 49%;max-width:49%;}}
/* sc-component-id: sc-chPdSV */
.hbVEoI{border:none;height:50px;background-color:#fff;margin:10px 0 0 17px;position:relative;} @media (max-width:991.5px){.hbVEoI{margin:0 3px 0 16px;padding:0;height:69px;}} @media (max-width:767.5px){.hbVEoI{height:59px;}} .hbVEoI img{box-sizing:content-box;} .hbVEoI .icon__cross{width:24px;height:24px;} @media (min-width:768px){.hbVEoI .icon__cross{padding:23px 20px;}} @media (min-width:992px){.hbVEoI .icon__cross{padding:0px;}}
/* sc-component-id: sc-ckVGcZ */
.gjctdt{vertical-align:middle;height:39px;} @media (max-width:401px){.gjctdt{max-width:100%;}}
/* sc-component-id: sc-jKJlTe */
.inBNwS{background-color:#0d2934;font-size:16px;position:relative;z-index:3;} @media (max-width:991px){.inBNwS{z-index:0;}}
/* sc-component-id: sc-eNQAEJ */
.dkutRV{border-bottom :1px solid;border-color:#828282;padding:29px 40px 30px 40px;} @media (min-width:992px){.dkutRV{padding:40px 40px 40px 35px;}} .dkutRV .primary__footer .mobile{display:block;} .dkutRV .primary__footer .desktop{display:none;} @media (min-width:992px){.dkutRV .primary__footer{-webkit-box-pack:justify;-webkit-justify-content:space-between;-ms-flex-pack:justify;justify-content:space-between;}.dkutRV .primary__footer .mobile{display:none;}.dkutRV .primary__footer .desktop{display:block;}} @media (min-width:992px){.dkutRV .col5{-webkit-flex:0 0 18%;-ms-flex:0 0 18%;flex:0 0 18%;max-width:18%;}} .dkutRV address{font-style:inherit;line-height:1.5;font-size:16px;display:none;border-right:1px solid #EBEBEB;} @media (max-width:767px){.dkutRV address{border-bottom:1px solid #E3E3E3;padding-bottom:20px;}} @media (min-width:992px){.dkutRV address{display:-webkit-box;display:-webkit-flex;display:-ms-flexbox;display:flex;-webkit-flex-direction:column;-ms-flex-direction:column;flex-direction:column;-webkit-box-pack:center;-webkit-justify-content:center;-ms-flex-pack:center;justify-content:center;margin-right:50px;}} @media (min-width:1200px){.dkutRV address{margin-right:70px;}} .dkutRV address p{margin:0;font-size:14px;} @media (max-width:767px){.dkutRV address p{text-align:center;}} @media (min-width:1200px){.dkutRV address p{font-size:16px;}} .dkutRV nav ul{list-style:none;padding:0;line-height:2;font-size:16px;margin:18px 0 0 0;} .dkutRV nav ul:first-child{margin:0;} @media (min-width:992px){.dkutRV nav ul{margin:0;}} .dkutRV nav ul li{line-height:22px;padding:5px;} .dkutRV nav ul li a{color:#d8d8d8;font-weight:500;display:block;font-size:16px;} .dkutRV nav ul li img{padding:2.5px 0 0 10px;box-sizing:content-box;-webkit-transform:rotate(180deg);-ms-transform:rotate(180deg);transform:rotate(180deg);}
/* sc-component-id: sc-hMqMXs */
.hlGpbO{padding-top:6px;color:#FFFFFF;font-weight:500;margin-bottom:29px;} @media (min-width:992px){.hlGpbO{-webkit-flex:0 0 25%;-ms-flex:0 0 25%;flex:0 0 25%;max-width:-webkit-fit-content;max-width:-moz-fit-content;max-width:fit-content;}}
/* sc-component-id: sc-kEYyzF */
.ecHxGW{margin-right:20px;} .ecHxGW:last-child{margin-right:0;}
/* sc-component-id: sc-kkGfuU */
.filPdg{margin-top:15px;}
/* sc-component-id: sc-iAyFgw */
.gCiATD{line-height:30px;font-size:11px;padding:10px 20px;text-align:center;} .gCiATD .textright{text-align:right;font-weight:500;} @media (max-width:767px){.gCiATD .textright{text-align:center;}} @media (min-width:992px){.gCiATD .textright{font-weight:100;}} .gCiATD a{font-size:13px;color:#fff;}
/* sc-component-id: sc-hSdWYo */
.etauus{display:inline-block;background-color:#fff;color:#4D8A17;border-color:#E3E3E3;width:auto;border-radius:5px;font-size:16px;border-width:1px;border-style:solid;} .etauus:focus-visible{outline-width:3px;outline-color:#8fc9ff;outline-style:solid;}
/* sc-component-id: sc-eHgmQL */
.fTkdCR{font-size:22px;color:#000;} @media (min-width:767.5px){.fTkdCR{font-size:24px;}} @media (min-width:991.5px){.fTkdCR{font-size:25px;}} .fTkdCR:after{content:'';display:inline-block;margin-top:0.2em;margin-left:0.5em;}
/* sc-component-id: sc-iRbamj */
.jZOxOO{font-size:30px;font-weight:500;-webkit-letter-spacing:1px;-moz-letter-spacing:1px;-ms-letter-spacing:1px;letter-spacing:1px;line-height:1;margin-top:0;} @media (min-width:767.5px){.jZOxOO{font-size:40px;}} @media (min-width:991.5px){.jZOxOO{font-size:40px;}} .jZOxOO sup,.jZOxOO sub{vertical-align:baseline;position:relative;top:-10px;} .jZOxOO sub{top:10px;}
/* sc-component-id: sc-Rmtcm */
.hNPrIr{font-size:20px;font-weight:500;margin-top:0;margin-bottom:15px;}
/* sc-component-id: sc-bRBYWo */
.fXBKFa{display:inline-block;} @media (max-width:991.5px){.fXBKFa{width:100%;}} @media (min-width:991.5px){.fXBKFa.hide{display:none !important;}}
/* sc-component-id: sc-hzDkRC */
.bnbfTS{display:-webkit-inline-box;display:-webkit-inline-flex;display:-ms-inline-flexbox;display:inline-flex;-webkit-flex:wrap;-ms-flex:wrap;flex:wrap;-webkit-align-items:center;-webkit-box-align:center;-ms-flex-align:center;align-items:center;list-style-type:none;margin:0;width:100%;padding:0 !important;border-top:1px solid #fff;} .bnbfTS li{width:100%;text-align:center;box-sizing:border-box;padding:17px 0px;min-height:48px;} .bnbfTS li a{display:block;} .bnbfTS .iconBorder{border-right:1px solid #fff;} .bnbfTS img{width:23px;} .bnbfTS img.socialLinkedin{width:28px;} .bnbfTS .wechat-container{position:relative;} .bnbfTS .wechat-container .addthis_inline_share_toolbox{position:absolute;top:0;left:0;width:100%;height:100%;opacity:0 !important;}
/* sc-component-id: sc-jtRfpW */
.OGgkt{background-color:#6BA439;color:#fff;padding:20px;line-height:22px !important;border-radius:0;border-top:1px solid #fff;display:-webkit-box;display:-webkit-flex;display:-ms-flexbox;display:flex;-webkit-box-pack:justify;-webkit-justify-content:space-between;-ms-flex-pack:justify;justify-content:space-between;min-height:60px;} .OGgkt img{display:-webkit-inline-box;display:-webkit-inline-flex;display:-ms-inline-flexbox;display:inline-flex;-webkit-align-self:center;-ms-flex-item-align:center;align-self:center;} .OGgkt span{display:-webkit-box;display:-webkit-flex;display:-ms-flexbox;display:flex;-webkit-align-self:center;-ms-flex-item-align:center;align-self:center;} .OGgkt span.text{padding-left:20px;font-weight:500;} @media (max-width:360px){.OGgkt span.text{padding-left:5px;font-size:14px;}} @media (min-width:320px) and (max-width:767.5px){.OGgkt span.text{padding-left:20px;}}.dUABlg{background-color:#F2F2F2;color:#4A4A4A;padding:20px;line-height:22px !important;border-radius:0;border-top:1px solid #E3E3E3;display:-webkit-box;display:-webkit-flex;display:-ms-flexbox;display:flex;-webkit-box-pack:justify;-webkit-justify-content:space-between;-ms-flex-pack:justify;justify-content:space-between;min-height:60px;} .dUABlg img{display:-webkit-inline-box;display:-webkit-inline-flex;display:-ms-inline-flexbox;display:inline-flex;-webkit-align-self:center;-ms-flex-item-align:center;align-self:center;} .dUABlg span{display:-webkit-box;display:-webkit-flex;display:-ms-flexbox;display:flex;-webkit-align-self:center;-ms-flex-item-align:center;align-self:center;} .dUABlg span.text{padding-left:20px;font-weight:500;} @media (max-width:360px){.dUABlg span.text{padding-left:5px;font-size:14px;}} @media (min-width:320px) and (max-width:767.5px){.dUABlg span.text{padding-left:20px;}}
/* sc-component-id: sc-kTUwUJ */
.eujois{width:20px;}
/* sc-component-id: sc-dqBHgY */
.cQgXqt{width:20px;height:16px;color:#6ba439;}
/* sc-component-id: sc-cbkKFq */
.kuxTps{-webkit-transition:-webkit-transform 0.5s;-webkit-transition:transform 0.5s;transition:transform 0.5s;position:fixed;top:60px;} @media (min-width:767.5px){.kuxTps{position:fixed;top:70px;}} @media (min-width:991.5px){.kuxTps{position:fixed;top:70px;}}.prcY{-webkit-transition:-webkit-transform 0.5s;-webkit-transition:transform 0.5s;transition:transform 0.5s;top:0px;} @media (min-width:767.5px){.prcY{top:0px;}} @media (min-width:991.5px){.prcY{position:fixed;top:241px;}}
/* sc-component-id: sc-hGoxap */
.dEfJbW{position:relative;background:#007d8d;} @media (max-width:991px){.dEfJbW{z-index:2;}} @media (min-width:767.5px) and (max-width:991.5px){.dEfJbW{width:50%;}} @media (min-width:991.5px){.dEfJbW{display:-webkit-box;display:-webkit-flex;display:-ms-flexbox;display:flex;-webkit-box-pack:end;-webkit-justify-content:flex-end;-ms-flex-pack:end;justify-content:flex-end;border-top:1px solid white;}} .dEfJbW.isHide{display:none;} @media (min-width:991.5px){.dEfJbW.isHide{display:-webkit-box;display:-webkit-flex;display:-ms-flexbox;display:flex;}} .dEfJbW .submit__button{display:-webkit-box;display:-webkit-flex;display:-ms-flexbox;display:flex;box-shadow:0 2px 4px rgba(0,0,0,.5);padding:0 20px;min-height:45px;} .dEfJbW .submit__button span.text{font-size:16px;} .dEfJbW .submit__button img{width:20px;} @media (min-width:767.5px){.dEfJbW .submit__button{min-height:58px;}.dEfJbW .submit__button img{width:22px;}} @media (min-width:991.5px){.dEfJbW .submit__button{display:none;}}
/* sc-component-id: sc-fjmCvl */
.fSPaCp{display:-webkit-box;display:-webkit-flex;display:-ms-flexbox;display:flex;width:100%;font-size:16px;font-weight:500;color:#fff;background-color:#007d8d;line-height:20px;padding:10px 20px;border:0;border-radius:0;border-top:1px solid #fff;-webkit-box-pack:justify;-webkit-justify-content:space-between;-ms-flex-pack:justify;justify-content:space-between;margin:0;} @media (min-width:767.5px){.fSPaCp{padding:16px 20px;}} @media (min-width:991.5px){.fSPaCp{border-top:none;border-right:1px solid #fff;padding:14.5px 15px;font-size:14px;}} @media (min-width:1200px){.fSPaCp{padding:14.5px 20px;font-size:16px;}} .fSPaCp .icon__inactive{-webkit-transform:rotateZ(-90deg);-ms-transform:rotateZ(-90deg);transform:rotateZ(-90deg);line-height:20px;} @media (min-width:991.5px){.fSPaCp .icon__inactive{-webkit-transform:rotateZ(0);-ms-transform:rotateZ(0);transform:rotateZ(0);}} .fSPaCp.button__active{background:#fff;color:#4A4A4A;} @media (min-width:767.5px) and (max-width:991.5px){.fSPaCp.button__active{border-right:1px solid #007f8f;}} .fSPaCp .icon__active{-webkit-transform:rotateZ(-90deg);-ms-transform:rotateZ(-90deg);transform:rotateZ(-90deg);line-height:20px;} @media (min-width:991.5px){.fSPaCp .icon__active{-webkit-transform:rotate(0);-ms-transform:rotate(0);transform:rotate(0);}} .fSPaCp .icon__hidden{display:none;}.bVEEaH{display:-webkit-box;display:-webkit-flex;display:-ms-flexbox;display:flex;width:100%;font-size:16px;font-weight:500;color:#fff;background-color:#007d8d;line-height:20px;padding:10px 20px;border:0;border-radius:0;border-top:1px solid #fff;-webkit-box-pack:justify;-webkit-justify-content:space-between;-ms-flex-pack:justify;justify-content:space-between;margin:0;} @media (min-width:767.5px){.bVEEaH{padding:16px 20px;}} @media (min-width:991.5px){.bVEEaH{border-top:none;border-right:0;padding:14.5px 15px;font-size:14px;}} @media (min-width:1200px){.bVEEaH{padding:14.5px 20px;font-size:16px;}} .bVEEaH .icon__inactive{-webkit-transform:rotateZ(-90deg);-ms-transform:rotateZ(-90deg);transform:rotateZ(-90deg);line-height:20px;} @media (min-width:991.5px){.bVEEaH .icon__inactive{-webkit-transform:rotateZ(0);-ms-transform:rotateZ(0);transform:rotateZ(0);}} .bVEEaH.button__active{background:#fff;color:#4A4A4A;} @media (min-width:767.5px) and (max-width:991.5px){.bVEEaH.button__active{border-right:1px solid #007f8f;}} .bVEEaH .icon__active{-webkit-transform:rotateZ(-90deg);-ms-transform:rotateZ(-90deg);transform:rotateZ(-90deg);line-height:20px;} @media (min-width:991.5px){.bVEEaH .icon__active{-webkit-transform:rotate(0);-ms-transform:rotate(0);transform:rotate(0);}} .bVEEaH .icon__hidden{display:none;}
/* sc-component-id: sc-TFwJa */
.gCIfTO{display:-webkit-box;display:-webkit-flex;display:-ms-flexbox;display:flex;width:100%;font-size:16px;font-weight:500;color:#fff;background-color:#007d8d;line-height:20px;padding:10px 20px;border:0;border-radius:0;border-top:1px solid #fff;-webkit-box-pack:justify;-webkit-justify-content:space-between;-ms-flex-pack:justify;justify-content:space-between;} @media (min-width:767.5px){.gCIfTO{padding:16px 20px;}} @media (min-width:991.5px){.gCIfTO{-webkit-transition:all 0.25s;transition:all 0.25s;border-top:none;border-right:1px solid #fff;border-left:0;padding:14.5px 30px 14.5px 20px;width:calc(100% / 6);font-size:14px;}.gCIfTO:hover{background:#fff;color:#4A4A4A;}} @media (min-width:1200px){.gCIfTO{font-size:16px;}}
/* sc-component-id: sc-bHwgHz */
.ctePXh{width:18px;margin-right:-4px;} @media (min-width:991.5px){.ctePXh{width:7px;font-size:7px;}} @media (min-width:1200px){.ctePXh{width:18px;}}
/* sc-component-id: sc-krDsej */
.ewCAZX{position:absolute;top:0;width:calc(100% - 20px);right:0;bottom:0;background:#fff;-webkit-transition:-webkit-transform 0.5s;-webkit-transition:transform 0.5s;transition:transform 0.5s;min-height:290px;box-shadow:0 2px 4px rgba(0,0,0,0.5);} .ewCAZX.hide__submenu{-webkit-transform:translateX(100%);-ms-transform:translateX(100%);transform:translateX(100%);} @media (min-width:767.5px){.ewCAZX.hide__submenu{-webkit-transform:translateX(-200%);-ms-transform:translateX(-200%);transform:translateX(-200%);}} @media (min-width:767.5px){.ewCAZX{left:100%;width:100%;padding-top:20px;z-index:-1;min-height:375px;}} @media (min-width:991.5px){.ewCAZX{display:none;}}
/* sc-component-id: sc-dTdPqK */
.lkWWFY{-webkit-transition:-webkit-transform 0.5s;-webkit-transition:transform 0.5s;transition:transform 0.5s;display:none;} @media (min-width:991.5px){.lkWWFY.hide__submenu{-webkit-transform:translateY(-300%);-ms-transform:translateY(-300%);transform:translateY(-300%);}} @media (min-width:991.5px){.lkWWFY{display:-webkit-box;display:-webkit-flex;display:-ms-flexbox;display:flex;height:186px;top:49px;left:0;position:absolute;right:0;background:#fff;z-index:-1;box-shadow:0 4px 6px rgba(0,0,0,0.21);}}
/* sc-component-id: sc-itybZL */
.kdvWPs{font-weight:700;border:0;color:#4A4A4A;padding:10px 0;background-color:#fff;font-size:16px;line-height:20px;} .kdvWPs:focus-visible{outline-width:3px;outline-color:#8fc9ff;outline-style:solid;} @media (min-width:767.5px){.kdvWPs{display:none;}}
/* sc-component-id: sc-fzsDOv */
.hAFFGk{margin:0px 10px 2px 20px;-webkit-transform:rotate(90deg);-ms-transform:rotate(90deg);transform:rotate(90deg);display:inline-block;}
/* sc-component-id: sc-gPWkxV */
.legory{width:50%;}
/* sc-component-id: sc-jVODtj */
.epgILe{color:#007B8B;width:50%;font-size:16px;line-height:26px;margin:auto;padding:0 6%;}
/* sc-component-id: sc-kUaPvJ */
.ehYbwJ{display:-webkit-box;display:-webkit-flex;display:-ms-flexbox;display:flex;width:50%;padding:24.5px 2% 0;-webkit-order:0;-ms-flex-order:0;order:0;} @media (min-width:1024px){.ehYbwJ{padding:24.5px 3% 0;}}
/* sc-component-id: sc-giadOv */
.eBepOs{display:-webkit-box;display:-webkit-flex;display:-ms-flexbox;display:flex;width:100%;} @media (min-width:991.5px){.eBepOs{width:calc(100% / 6);}.eBepOs:first-child{border-left:none;}}
/* sc-component-id: sc-fONwsr */
.kCfRMJ{background-color:#D8D8D8;position:absolute;left:50%;display:inline-block;height:121px;width:2px;top:33px;}
/* sc-component-id: sc-LKuAh */
.lcOiDF{padding:0;margin:10px 0 25px 0;}
/* sc-component-id: sc-iBEsjs */
.kPshFw{display:-webkit-box;display:-webkit-flex;display:-ms-flexbox;display:flex;border:none;font-size:12px;font-weight:500;margin-top:7px;padding:0;color:#4D8A17;-webkit-text-decoration:none;text-decoration:none;cursor:pointer;} .kPshFw:hover{-webkit-text-decoration:underline;text-decoration:underline;} @media (min-width:767.5px){.kPshFw{margin-top:10px;}}
/* sc-component-id: sc-hzNEM */
.gsmOCv{overflow-y:hidden;height:auto;max-height:100%;-webkit-transition:all .5s;transition:all .5s;background-color:#F2F2F2;padding:0 16px;} .gsmOCv.isHide{max-height:0;-webkit-transition:all .5s;transition:all .5s;} .gsmOCv p{font-size:14px;line-height:22px;} .gsmOCv sup{margin-top:-5px;}
/* sc-component-id: sc-chbbiW */
.mBGSe{padding:0;}
/* sc-component-id: sc-kZmsYB */
.bkiEfx{font-size:14px;font-weight:700;line-height:16px;-webkit-letter-spacing:0.58px;-moz-letter-spacing:0.58px;-ms-letter-spacing:0.58px;letter-spacing:0.58px;margin:23px 0 0px !important;} @media (min-width:767.5px){.bkiEfx{margin:34px 0 0px !important;}} @media (min-width:991.5px){.bkiEfx{margin:-4px 0 0 !important;}}
/* sc-component-id: sc-RcBXQ */
.ztvYg{font-size:14px;line-height:22px;} .ztvYg a{color:#4D8A17;-webkit-text-decoration:none;text-decoration:none;cursor:pointer;} .ztvYg a:hover{-webkit-text-decoration:underline;text-decoration:underline;}
/* sc-component-id: sc-iSDuPN */
@font-face{font-family:'STIXGeneral-Bold';src:url('https://static-01.hindawi.com/next_assets/cpr9K8AjZYaP4CWVbtn5c/_next/static/node_modules/hindawi-ui/fonts/STIXGeneral-Bold.otf');font-weight:normal;font-style:normal;} .kRoxOt{font-weight:700;font-family:STIXGeneral-Bold;margin:19px 0 22px;font-size:25px;line-height:28px;-webkit-letter-spacing:normal;-moz-letter-spacing:normal;-ms-letter-spacing:normal;letter-spacing:normal;} @media (min-width:767.5px){.kRoxOt{font-size:25px;margin:20px 0 23px;}} @media (min-width:991.5px){.kRoxOt{font-size:30px;line-height:34px;margin:19px 0 22px;}} .kRoxOt p{margin:0;}
/* sc-component-id: sc-fZwumE */
.cUsFHx{padding:0 3px;}
/* sc-component-id: sc-fQejPQ */
.duuwge{font-size:14px;} .duuwge:hover{-webkit-text-decoration:underline;text-decoration:underline;}
/* sc-component-id: sc-jtRlXQ */
@font-face{font-family:'STIXGeneral-Regular';src:url('https://static-01.hindawi.com/next_assets/cpr9K8AjZYaP4CWVbtn5c/_next/static/node_modules/hindawi-ui/fonts/STIXGeneral-Regular.otf');font-weight:normal;font-style:normal;} @font-face{src:url('https://static-01.hindawi.com/next_assets/cpr9K8AjZYaP4CWVbtn5c/_next/static/node_modules/hindawi-ui/fonts/STIXGeneral-Regular.otf');font-weight:normal;font-style:normal;} @font-face{font-family:'STIXGeneral-Regular';src:url('https://static-01.hindawi.com/next_assets/cpr9K8AjZYaP4CWVbtn5c/_next/static/node_modules/hindawi-ui/fonts/STIXGeneral-Regular.otf');font-weight:normal;font-style:normal;} .exFqMv{font-family:STIXGeneral-Regular;text-align:justify;} .exFqMv a{word-break:break-all;} .exFqMv h4:first-of-type{border-top:0px solid #E3E3E3;padding-top:0;} .exFqMv h4{font-size:20px;font-family:"IBM Plex Sans",sans-serif;border-top:1px solid #E3E3E3;padding-top:23px;margin-top:15px;margin-bottom:-3px;} .exFqMv h4#abstract{margin-top:-7px;margin-bottom:-3px;} @media (min-width:767.5){.exFqMv h4#abstract{margin-top:-6px;}} @media (min-width:991.5px){.exFqMv h4#abstract{margin-top:34px;}} .exFqMv h4.references,.exFqMv h4.copyright{border-top:1px solid #E3E3E3;padding-top:23px;} .exFqMv h4.references{margin-bottom:-8px;} .exFqMv h5,.exFqMv h6{margin:22px 0;font-size:16px;word-break:break-word;} .exFqMv h6{margin:25px 0;text-align:left;} .exFqMv p{font-size:16px;word-break:break-word;} .exFqMv .floats-partial-section{border:1px solid #E3E3E3;margin:25px auto;} @media (max-width:767px){.exFqMv .floats-partial-section{margin:0 auto;overflow-x:hidden;}} .exFqMv .floats-partial-section .floats-partial-content{padding:19px 0px 19px 0px;height:254px;width:96%;overflow:hidden;margin:0 auto;position:relative;cursor:pointer;} .exFqMv .floats-partial-section .floats-partial-content table{margin:0 auto;} .exFqMv .floats-partial-section .floats-partial-content .table-group{width:-webkit-fit-content;width:-moz-fit-content;width:fit-content;} .exFqMv .floats-partial-section .floats-partial-content .table-group table{width:-webkit-fit-content;width:-moz-fit-content;width:fit-content;} .exFqMv .floats-partial-section .floats-partial-content .table-group table object{z-index:-1;position:relative;} .exFqMv .floats-partial-section .floats-partial-content .table-group table td{padding:4px 7px;} .exFqMv .floats-partial-section .floats-partial-content .table-group table td.align_left{text-align:left;} .exFqMv .floats-partial-section .floats-partial-content .table-group table td.align_center{text-align:center;} @media (min-width:768px){.exFqMv .floats-partial-section .floats-partial-content{padding:22px 0px 0 0px;height:197px;}} @media (min-width:992px){.exFqMv .floats-partial-section .floats-partial-content{padding:23px 0px 13px 0px;height:215px;}} .exFqMv .floats-partial-section .floats-partial-content:after{content:"";height:20%;position:absolute;bottom:0;right:0;left:0;background:-moz-linear-gradient(left,rgba(255,255,255,.7) 0%,rgba(255,255,255,.7) 56%,rgba(255,255,255,.7) 100%);background:-webkit-gradient(linear,left top,right top,color-stop(0%,rgba(255,255,255,.7)),color-stop(56%,rgba(255,255,255,.7)),color-stop(100%,rgba(255,255,255,.7)));background:-webkit-linear-gradient(rgba(255,255,255,0) 0%,rgba(255,255,255,0.5) 30%,rgba(255,255,255,0.7) 56%,rgba(255,255,255,0.9) 75%,rgba(255,255,255,1) 100%);background:-o-linear-gradient(left,rgba(255,255,255,.7) 0%,rgba(255,255,255,.7) 56%,rgba(255,255,255,.7) 100%);background:-ms-linear-gradient(left,rgba(255,255,255,.7) 0%,rgba(255,255,255,.7) 56%,rgba(255,255,255,.7) 100%);background:linear-gradient(left,rgba(255,255,255,.7) 0%,rgba(255,255,255,.7) 56%,rgba(255,255,255,.7) 100%);-webkit-filter:progid:DXImageTransform.Microsoft.gradient( startColorstr='#00ffffff',endColorstr='#ffffff',GradientType=1 );filter:progid:DXImageTransform.Microsoft.gradient( startColorstr='#00ffffff',endColorstr='#ffffff',GradientType=1 );} .exFqMv .floats-partial-section .floats-partial-footer{background-color:#F2F2F2;border-top:1px solid #E3E3E3;} .exFqMv .floats-partial-section .floats-partial-footer .floats-partial-caption{display:-webkit-box;display:-webkit-flex;display:-ms-flexbox;display:flex;-webkit-box-pack:end;-webkit-justify-content:flex-end;-ms-flex-pack:end;justify-content:flex-end;} .exFqMv .floats-partial-section .floats-partial-footer .floats-partial-caption .minimize_btn{-webkit-flex:1;-ms-flex:1;flex:1;background:url('data:image/svg+xml;base64,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') no-repeat 6px;background-position:center;margin-top:10px;min-width:55px;} @media (min-width:768px){.exFqMv .floats-partial-section .floats-partial-footer .floats-partial-caption .minimize_btn{display:none;}} .exFqMv .floats-partial-section .floats-partial-footer .floats-partial-caption .expand_btn{-webkit-flex:1;-ms-flex:1;flex:1;background:url('data:image/svg+xml;base64,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') no-repeat 6px;background-position:center;margin-top:10px;min-width:55px;display:none;} @media (min-width:768px){.exFqMv .floats-partial-section .floats-partial-footer .floats-partial-caption .expand_btn{display:none;}} .exFqMv .floats-partial-section .floats-partial-footer .floats-partial-caption .caption-text{-webkit-flex:9;-ms-flex:9;flex:9;text-align:left;padding:21px 37px 10px 0px;font-size:16px;font-weight:700;} @media (min-width:768px){.exFqMv .floats-partial-section .floats-partial-footer .floats-partial-caption .caption-text{padding:19px 18px 10px 18px;}} @media (min-width:992px){.exFqMv .floats-partial-section .floats-partial-footer .floats-partial-caption .caption-text{padding:19px 21px 10px 21px;}} .exFqMv .floats-partial-section .floats-partial-footer .floats-partial-caption .caption-partial-url{-webkit-flex:1;-ms-flex:1;flex:1;background:url('data:image/svg+xml;base64,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') no-repeat 6px;background-position:center;padding:16px 0 16px 0;min-width:62px;max-width:62px;} @media (min-width:768px){.exFqMv .floats-partial-section .floats-partial-footer .floats-partial-caption .caption-partial-url{padding:16px 0 17px 0;min-width:52px;max-width:52px;}} @media (min-width:992px){.exFqMv .floats-partial-section .floats-partial-footer .floats-partial-caption .caption-partial-url{padding:15px 0 17px 0;min-width:60px;max-width:60px;}} .exFqMv .floats-partial-section .floats-partial-footer .floats-partial-caption .caption-partial-url:hover{-webkit-text-decoration:none;text-decoration:none;} .exFqMv .floats-partial-section .floats-partial-footer .floats-partial-caption-text{font-size:14px;padding:0px 18px 17px 22px;} @media (min-width:768px){.exFqMv .floats-partial-section .floats-partial-footer .floats-partial-caption-text{padding:0px 15px 15px 18px;}} @media (min-width:992px){.exFqMv .floats-partial-section .floats-partial-footer .floats-partial-caption-text{padding:0px 18px 19px 21px;}} .exFqMv .floats-partial-section .floats-partial-footer .floats-partial-caption-text figcaption{margin:0;padding:0;} .exFqMv .floats-partial-section .floats-partial-footer .floats-partial-caption-text svg{max-width:100%;} .exFqMv ol{font-size:16px;padding-left:32px;font-family:STIXGeneral-Regular;line-height:24px;margin:15px 0;} .exFqMv ol li{margin:10px 0;padding-left:10px;word-break:normal;} .exFqMv ol li a{word-break:break-all;} .exFqMv ol li .reflinks{display:block;} .exFqMv ol li .reflinks a{color:#4D8A17;-webkit-text-decoration:none;text-decoration:none;cursor:pointer;} .exFqMv ol li .reflinks a:hover{-webkit-text-decoration:underline;text-decoration:underline;} .exFqMv ol li .reflinks .sep{color:#000000;} .exFqMv .table-wrapper{width:auto;overflow-x:auto;} .exFqMv .table-wrapper::-webkit-scrollbar{-webkit-appearance:none;width:5px;height:5px;} .exFqMv .table-wrapper::-webkit-scrollbar-thumb{border-radius:5px;background-color:rgba(0,0,0,.5);-webkit-box-shadow:0 0 1px rgba(255,255,255,.5);} @media (min-width:768px){.exFqMv .table-wrapper{overflow-x:auto;width:auto;-webkit-break-word:word-break;break-word:word-break;margin:0 auto;}} @media (min-width:992px){.exFqMv .table-wrapper{width:auto;}} @media (min-width:1324px){.exFqMv .table-wrapper{width:auto;}} @media (min-width:320px){.exFqMv{margin-bottom:33px;padding:0;}} @media (min-width:992px){.exFqMv{padding:0;margin-bottom:100px;}} @media (min-width:1325px){.exFqMv{margin-bottom:100px;}} .exFqMv .owl-stage{display:-webkit-box;display:-webkit-flex;display:-ms-flexbox;display:flex;} .exFqMv .floats-partial-middle--thumbs{display:-webkit-box;display:-webkit-flex;display:-ms-flexbox;display:flex;} .exFqMv .floats-partial-middle--thumbs .partial-carousel-dot svg{fill:#4D8A17;} .exFqMv .floats-partial-middle--thumbs .partial-carousel-dot strong{color:#4D8A17;font-weight:500;} .exFqMv .floats-partial-middle--thumbs .partial-carousel-dot.active strong{color:#007B8B;} .exFqMv .floats-partial-middle--thumbs .partial-carousel-dot.active svg{fill:#007B8B;} .exFqMv .floats-partial-middle--thumbs .partial-carousel-dot .nowrap{white-space:nowrap;} .exFqMv .partial-carousel-dot{text-align:center;cursor:pointer;border:0;width:100px;padding-bottom:20px;background-color:#fff;display:table-cell;} .exFqMv .partial-carousel-dot:focus-visible{outline-offset:-3px;} .exFqMv .partial-carousel-dot strong{font-size:11px;padding-top:12px;} @media (min-width:767.5px){.exFqMv .partial-carousel-dot strong{font-size:16px;}} .exFqMv .partial-carousel-dot img{width:90px;height:90px;border:1px solid #979797;margin:10px 0;} .exFqMv .partial-carousel-wrapper .floats-partial-middle{border-top:1px solid #e3e3e3;display:block;margin-bottom:50px;padding-top:1px;} @media (min-width:767.5px){.exFqMv .partial-carousel-wrapper .floats-partial-middle{display:-webkit-box;display:-webkit-flex;display:-ms-flexbox;display:flex;margin-bottom:0;}} .exFqMv .partial-carousel--single-image{overflow:hidden;text-align:center;} .exFqMv .partial-carousel--single-image img{width:100%;max-height:239px;height:auto;} @media (min-width:767.5px){.exFqMv .partial-carousel--single-image img{max-height:357px;}} @media (min-width:991.5px){.exFqMv .partial-carousel--single-image img{max-height:417px;}} .exFqMv .partial-carousel--single-image strong{font-size:11px;padding-top:12px;} @media (min-width:767.5px){.exFqMv .partial-carousel--single-image strong{font-size:16px;}} .exFqMv .owl-nav,.exFqMv .owl-dots{display:none;} .exFqMv .partial-carousel-wrapper .owl-loaded{position:relative;height:auto;max-height:287px;} @media (min-width:767.6px){.exFqMv .partial-carousel-wrapper .owl-loaded{max-height:414px;}} @media (min-width:767.5px){.exFqMv .partial-carousel-wrapper .owl-loaded{max-height:477px;}} .exFqMv .partial-carousel-wrapper .floats-partial-content,.exFqMv .owl-stage-outer,.exFqMv .owl-stage{max-height:287px;height:auto;} @media (min-width:767.6px){.exFqMv .partial-carousel-wrapper .floats-partial-content,.exFqMv .owl-stage-outer,.exFqMv .owl-stage{max-height:414px;}} @media (min-width:767.5px){.exFqMv .partial-carousel-wrapper .floats-partial-content,.exFqMv .owl-stage-outer,.exFqMv .owl-stage{max-height:477px;}} .exFqMv .partial-carousel-wrapper .floats-partial-content::after,.exFqMv .owl-stage-outer::after,.exFqMv .owl-stage::after{background:transparent;} .exFqMv .partial-carousel-wrapper .floats-partial-middle--thumbs{width:100%;overflow-x:auto;-webkit-align-items:self-start;-webkit-box-align:self-start;-ms-flex-align:self-start;align-items:self-start;} @media (min-width:767.5px){.exFqMv .partial-carousel-wrapper .floats-partial-middle--thumbs{width:calc(100% - 110px);}} .exFqMv .partial-carousel-wrapper .floats-partial-middle--nav{width:100%;position:relative;} @media (min-width:767.5px){.exFqMv .partial-carousel-wrapper .floats-partial-middle--nav{width:20%;}} .exFqMv .floats-partial-middle{position:relative;} .exFqMv .partial-carousel-wrapper .carousel-prev{background:url('data:image/svg+xml;base64,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') no-repeat 17.5px;height:50px;width:61px;display:inline-block;border:0;border-right:1px solid #E3E3E3;padding:0;cursor:pointer;background-position-y:54.35%;} @media (min-width:767.5px){.exFqMv .partial-carousel-wrapper .carousel-prev{width:51px;background-position-x:8px;}} @media (min-width:991.5px){.exFqMv .partial-carousel-wrapper .carousel-prev{width:59px;background-position-x:16px;}} .exFqMv .partial-carousel-wrapper .carousel-next{background:url('data:image/svg+xml;base64,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') no-repeat 18.5px;height:52px;width:61px;display:inline-block;padding:0px;cursor:pointer;border:0;} @media (min-width:767.5px){.exFqMv .partial-carousel-wrapper .carousel-next{width:51px;}} @media (min-width:991.5px){.exFqMv .partial-carousel-wrapper .carousel-next{width:59px;}} .exFqMv .partial-carousel-wrapper .partial-carousel-next-prev{position:absolute;right:0;bottom:-50px;height:50px;} @media (min-width:767.5px){.exFqMv .partial-carousel-wrapper .partial-carousel-next-prev{bottom:0;}} .exFqMv .partial-carousel-wrapper .floats-partial-content{padding:12px;} .exFqMv .partial-carousel-wrapper .floats-partial-section .floats-partial-footer .floats-partial-caption .caption-partial-url{border-left:none;} .exFqMv .partial-other-wrapper[data-section*="tab"] .floats-partial-content{display:none;} .exFqMv .partial-other-wrapper[data-section*="tab"] .floats-partial-footer{background-image:url(https://w2o-xhtml-parsed-preprod.s3-eu-west-1.amazonaws.com/table_thumb.svg);background-repeat:no-repeat;background-position:17px 17px;background-size:100px 70px;border-top:none;min-height:110px;position:relative;} .exFqMv .partial-other-wrapper[data-section*="tab"] .floats-partial-footer .table-thumb-overlay{cursor:pointer;position:absolute;left:17px;top:17px;height:70px;width:100px;} .exFqMv .partial-other-wrapper[data-section*="tab"] .floats-partial-footer .caption-text{padding-left:137px;padding-right:0px;position:relative;} .exFqMv .partial-other-wrapper[data-section*="tab"] .floats-partial-footer .caption-text .caption-text-overlay{cursor:pointer;position:absolute;top:20px;left:135px;height:20px;width:60px;} .exFqMv .partial-other-wrapper[data-section*="tab"] .floats-partial-footer .floats-partial-caption-text{color:black;display:block !important;-webkit-text-decoration:none;text-decoration:none;width:auto;margin-left:140px;margin-right:20px;padding:0px 0px 15px 0px;width:-webkit-fit-content;width:-moz-fit-content;width:fit-content;} .exFqMv .partial-other-wrapper[data-section*="tab"] .floats-partial-footer .minimize_btn{display:none !important;} .exFqMv .partial-other-wrapper[data-section*="tab"] .floats-partial-footer .expand_btn{display:none !important;} @media (max-width:567px){.exFqMv .partial-other-wrapper[data-section*="tab"] .floats-partial-footer{background-size:60px 45px;}.exFqMv .partial-other-wrapper[data-section*="tab"] .floats-partial-footer .table-thumb-overlay{height:45px;width:60px;}.exFqMv .partial-other-wrapper[data-section*="tab"] .floats-partial-footer .caption-text{padding:30px 0px 15px 95px;}.exFqMv .partial-other-wrapper[data-section*="tab"] .floats-partial-footer .caption-text .caption-text-overlay{top:30px;left:95px;}.exFqMv .partial-other-wrapper[data-section*="tab"] .floats-partial-footer .floats-partial-caption-text{margin:0px 20px;}} .exFqMv .owl-item{overflow-y:hidden;margin-bottom:0;display:-webkit-box;display:-webkit-flex;display:-ms-flexbox;display:flex;-webkit-align-items:center;-webkit-box-align:center;-ms-flex-align:center;align-items:center;-webkit-box-pack:center;-webkit-justify-content:center;-ms-flex-pack:center;justify-content:center;} .exFqMv .supplementary--docs{display:-ms-flexbox;display:-webkit-box;display:-webkit-flex;display:-ms-flexbox;display:flex;-ms-flex-wrap:wrap;-webkit-flex-wrap:wrap;-ms-flex-wrap:wrap;flex-wrap:wrap;padding-left:2em;} @media (min-width:767.5px){.exFqMv .supplementary--docs{padding-left:1em;}} .exFqMv .supplementary--docs li{-ms-flex:0 0 100%;-webkit-flex:0 0 100%;-ms-flex:0 0 100%;flex:0 0 100%;max-width:100%;} @media (min-width:991.5px){.exFqMv .supplementary--docs li{-ms-flex:0 0 50%;-webkit-flex:0 0 50%;-ms-flex:0 0 50%;flex:0 0 50%;max-width:50%;}} .exFqMv .supplementary--docs li a::after{content:'';background :url(data:image/svg+xml;base64,PD94bWwgdmVyc2lvbj0iMS4wIiBlbmNvZGluZz0iVVRGLTgiPz4KPHN2ZyB3aWR0aD0iMjBweCIgaGVpZ2h0PSIyMnB4IiB2aWV3Qm94PSIwIDAgMjAgMjIiIHZlcnNpb249IjEuMSIgeG1sbnM9Imh0dHA6Ly93d3cudzMub3JnLzIwMDAvc3ZnIiB4bWxuczp4bGluaz0iaHR0cDovL3d3dy53My5vcmcvMTk5OS94bGluayI+CiAgICA8IS0tIEdlbmVyYXRvcjogU2tldGNoIDUzLjIgKDcyNjQzKSAtIGh0dHBzOi8vc2tldGNoYXBwLmNvbSAtLT4KICAgIDx0aXRsZT5jaGV2cm9uLWRvd24gY29weSAzPC90aXRsZT4KICAgIDxkZXNjPkNyZWF0ZWQgd2l0aCBTa2V0Y2guPC9kZXNjPgogICAgPGRlZnM+CiAgICAgICAgPHBhdGggZD0iTTExLDEzLjU4NTc4NjQgTDExLDIgQzExLDEuNDQ3NzE1MjUgMTEuNDQ3NzE1MywxIDEyLDEgQzEyLjU1MjI4NDcsMSAxMywxLjQ0NzcxNTI1IDEzLDIgTDEzLDEzLjU4NTc4NjQgTDE1LjI5Mjg5MzIsMTEuMjkyODkzMiBDMTUuNjgzNDE3NSwxMC45MDIzNjg5IDE2LjMxNjU4MjUsMTAuOTAyMzY4OSAxNi43MDcxMDY4LDExLjI5Mjg5MzIgQzE3LjA5NzYzMTEsMTEuNjgzNDE3NSAxNy4wOTc2MzExLDEyLjMxNjU4MjUgMTYuNzA3MTA2OCwxMi43MDcxMDY4IEwxMi43MDcxMDY4LDE2LjcwNzEwNjggQzEyLjMxNjU4MjUsMTcuMDk3NjMxMSAxMS42ODM0MTc1LDE3LjA5NzYzMTEgMTEuMjkyODkzMiwxNi43MDcxMDY4IEw3LjI5Mjg5MzIyLDEyLjcwNzEwNjggQzYuOTAyMzY4OTMsMTIuMzE2NTgyNSA2LjkwMjM2ODkzLDExLjY4MzQxNzUgNy4yOTI4OTMyMiwxMS4yOTI4OTMyIEM3LjY4MzQxNzUxLDEwLjkwMjM2ODkgOC4zMTY1ODI0OSwxMC45MDIzNjg5IDguNzA3MTA2NzgsMTEuMjkyODkzMiBMMTEsMTMuNTg1Nzg2NCBaIE0yLDE3IEMyLDE2LjQ0NzcxNTMgMi40NDc3MTUyNSwxNiAzLDE2IEMzLjU1MjI4NDc1LDE2IDQsMTYuNDQ3NzE1MyA0LDE3IEw0LDIwIEM0LDIwLjU1MjI4NDcgNC40NDc3MTUyNSwyMSA1LDIxIEwxOSwyMSBDMTkuNTUyMjg0NywyMSAyMCwyMC41NTIyODQ3IDIwLDIwIEwyMCwxNyBDMjAsMTYuNDQ3NzE1MyAyMC40NDc3MTUzLDE2IDIxLDE2IEMyMS41NTIyODQ3LDE2IDIyLDE2LjQ0NzcxNTMgMjIsMTcgTDIyLDIwIEMyMiwyMS42NTY4NTQyIDIwLjY1Njg1NDIsMjMgMTksMjMgTDUsMjMgQzMuMzQzMTQ1NzUsMjMgMiwyMS42NTY4NTQyIDIsMjAgTDIsMTcgWiIgaWQ9InBhdGgtMSI+PC9wYXRoPgogICAgPC9kZWZzPgogICAgPGcgaWQ9IlN5bWJvbHMiIHN0cm9rZT0ibm9uZSIgc3Ryb2tlLXdpZHRoPSIxIiBmaWxsPSJub25lIiBmaWxsLXJ1bGU9ImV2ZW5vZGQiPgogICAgICAgIDxnIGlkPSJTaWRlYmFycy9EZXNrdG9wL0FydGljbGUtU2lkZWJhciIgdHJhbnNmb3JtPSJ0cmFuc2xhdGUoLTI5MS4wMDAwMDAsIC0xMzQuMDAwMDAwKSI+CiAgICAgICAgICAgIDxnIGlkPSJEb3dubG9hZC1yZWZlcmVuY2UiIHRyYW5zZm9ybT0idHJhbnNsYXRlKDAuMDAwMDAwLCAxMTIuMDAwMDAwKSI+CiAgICAgICAgICAgICAgICA8ZyBpZD0iVHlwZS1hbmQtaWNvbnMiIHRyYW5zZm9ybT0idHJhbnNsYXRlKDIwLjAwMDAwMCwgMjEuMDAwMDAwKSI+CiAgICAgICAgICAgICAgICAgICAgPGcgaWQ9Ikljb25zL0Rvd25sb2FkIiB0cmFuc2Zvcm09InRyYW5zbGF0ZSgyNjkuMDAwMDAwLCAwLjAwMDAwMCkiPgogICAgICAgICAgICAgICAgICAgICAgICA8ZyBpZD0iZG93bmxvYWQiPgogICAgICAgICAgICAgICAgICAgICAgICAgICAgPG1hc2sgaWQ9Im1hc2stMiIgZmlsbD0id2hpdGUiPgogICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgIDx1c2UgeGxpbms6aHJlZj0iI3BhdGgtMSI+PC91c2U+CiAgICAgICAgICAgICAgICAgICAgICAgICAgICA8L21hc2s+CiAgICAgICAgICAgICAgICAgICAgICAgICAgICA8dXNlIGlkPSJDb21iaW5lZC1TaGFwZSIgZmlsbD0iIzAwMDAwMCIgZmlsbC1ydWxlPSJub256ZXJvIiB4bGluazpocmVmPSIjcGF0aC0xIj48L3VzZT4KICAgICAgICAgICAgICAgICAgICAgICAgICAgIDxnIGlkPSJDT0xPUi8tUHJpbWFyeS1HcmVlbiIgbWFzaz0idXJsKCNtYXNrLTIpIiBmaWxsPSIjOGVkMTU0IiBmaWxsLXJ1bGU9ImV2ZW5vZGQiPgogICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgIDxyZWN0IGlkPSJSZWN0YW5nbGUiIHg9IjAiIHk9IjAiIHdpZHRoPSIyNCIgaGVpZ2h0PSIyNCI+PC9yZWN0PgogICAgICAgICAgICAgICAgICAgICAgICAgICAgPC9nPgogICAgICAgICAgICAgICAgICAgICAgICA8L2c+CiAgICAgICAgICAgICAgICAgICAgPC9nPgogICAgICAgICAgICAgICAgPC9nPgogICAgICAgICAgICA8L2c+CiAgICAgICAgPC9nPgogICAgPC9nPgo8L3N2Zz4=) no-repeat 5px;padding-right:35px;background-size:14px;} .exFqMv .dataset-section .supplementary--dpis-desc{padding-left:19px;} .exFqMv .dataset-section .supplementary--dpis-desc p{margin:10px 0;} .exFqMv .table-group.fixed-width,.exFqMv .table-group.sidewaystable{min-width:auto;} .exFqMv .noliststyle{padding-left:1em;} .exFqMv .noliststyle li{padding-left:0;} .exFqMv .xml-content > hr{display:none;} .exFqMv sup,.exFqMv sub{vertical-align:baseline;position:relative;top:5px;} .exFqMv sup{top:-5px;} @media (min-width:767.5px){.exFqMv a{position:relative;}} .exFqMv a div.tooltip{cursor:auto;position:absolute;width:280px;background:#fff;border:1px solid #adadad;padding:20px;margin:0;display:none;z-index:2;color:#000;} @media (min-width:767.5px){.exFqMv a div.tooltip{width:400px;}} @media (min-width:991.5px){.exFqMv a div.tooltip{width:572px;}} .exFqMv a div.tooltip .cross{position:absolute;right:10px;top:10px;display:block;height:14px;width:14px;cursor:pointer;} .exFqMv a div.tooltip ol{margin:0;padding:0 0 10px 20px;} .exFqMv a div.tooltip ol li{text-align:left;margin:0;} .exFqMv a div.tooltip.left{left:20px;} @media (min-width:767.5px){.exFqMv a div.tooltip.left{left:-20px;}} @media (min-width:991.5px){.exFqMv a div.tooltip.left{left:-100px;}} .exFqMv a div.tooltip.right{right:20px;} @media (min-width:767.5px){.exFqMv a div.tooltip.right{right:-20px;}} @media (min-width:991.5px){.exFqMv a div.tooltip.right{right:-100px;}} .exFqMv a div.tooltip a.seeRef{padding-left:30px;} .exFqMv .gloss-abbr tr td:first-child{white-space:nowrap;} .exFqMv table.algorithm td{word-break:keep-all;} .exFqMv h4#copyright + p a{word-break:break-word;}
/* sc-component-id: sc-bGbJRg */
.dVCLgr{width:100%;} @media (min-width:991.5px){.dVCLgr{width:19%;}} @media (min-width:1280px){.dVCLgr{width:24%;max-width:350px;}} .dVCLgr p{border:1px solid #E3E3E3;}
/* sc-component-id: sc-bEjcJn */
.jLUVhb{-webkit-flex:1 0 30%;-ms-flex:1 0 30%;flex:1 0 30%;list-style:none;padding:0;-webkit-transition:-webkit-transform 0.5s;-webkit-transition:transform 0.5s;transition:transform 0.5s;} @media (min-width:320px) and (max-width:991.5px){.jLUVhb{position:fixed;width:100%;z-index:2;margin:0;margin-top:50px;top:169px;max-height:calc(100vh - 165px);overflow-y:auto;}} @media (min-width:767.5px) and (max-width:991.5px){.jLUVhb{top:179px;}} @media (min-width:991.5px) and (max-width:1200px){.jLUVhb{max-width:354px;-webkit-flex:1 0 20%;-ms-flex:1 0 20%;flex:1 0 20%;}} @media (min-width:1200px){.jLUVhb{-webkit-flex:1 0 25%;-ms-flex:1 0 25%;flex:1 0 25%;max-width:354px;}} .jLUVhb p{margin:0;padding:10px 0;font-size:16px;font-weight:700;line-height:24px;display:none;} @media (min-width:991.5px){.jLUVhb p{display:block;padding:10px 20px;border:1px solid #E3E3E3;border-bottom:0;}} .jLUVhb.links__hidden{display:none;} @media (min-width:991.5px){.jLUVhb.links__hidden{display:block;}} .jLUVhb.translate{-webkit-transform :translateY(-120px);-ms-transform :translateY(-120px);transform :translateY(-120px);} @media (min-width:768px){.jLUVhb.translate{-webkit-transform:translateY(-130px);-ms-transform:translateY(-130px);transform:translateY(-130px);}} @media (min-width:991.5px){.jLUVhb.translate{-webkit-transform:none;-ms-transform:none;transform:none;}.jLUVhb.translate #leftSectionMenu{-webkit-transform:translateY(-130px);-ms-transform:translateY(-130px);transform:translateY(-130px);}}
/* sc-component-id: sc-ePZHVD */
.ewHMLz{color:#4A4A4A;}
/* sc-component-id: sc-likbZx */
.bBmZJZ{font-size:16px;font-weight:500;line-height:20px;color:#4A4A4A;border:1px solid #E3E3E3;border-bottom:0;background-color:#f2f2f2;display:list-item;} @media (min-width:991px){.bBmZJZ{-webkit-transition:background-color 0.25s ease-in-out 0s;transition:background-color 0.25s ease-in-out 0s;}.bBmZJZ:hover{background-color :#D8D8D8;-webkit-transition:background-color 0.25s ease-in-out 0s;transition:background-color 0.25s ease-in-out 0s;}} .bBmZJZ:last-child{border-bottom:1px solid #E3E3E3;} .bBmZJZ a{display:block;padding:10px 20px;}
/* sc-component-id: sc-eKZiaR */
.dzZrgS{position:fixed;width:100%;height:50px;color:#4D8A17;background-color:#F2F2F2;border:none;font-size:16px;line-height:18px;font-weight:500;z-index:2;top:170px;-webkit-transition:-webkit-transform 0.5s;-webkit-transition:transform 0.5s;transition:transform 0.5s;text-align:left;border-top:1px solid #FFFFFF;} @media (min-width:320px) and (max-width:991.5px){.dzZrgS{padding-left:15px;border-bottom:4px solid #FFFFFF;}.dzZrgS.is-open{border-bottom:4px solid #F2F2F2;}} @media (min-width:767.5px){.dzZrgS{top:179px;}} @media (min-width:991.5px){.dzZrgS{display:none;}} .dzZrgS .icon__dots{cursor:pointer;-webkit-transform:rotate(90deg) translateY(8px);-ms-transform:rotate(90deg) translateY(8px);transform:rotate(90deg) translateY(8px);margin-right:15px;} @media (min-width:991.5px){.dzZrgS .icon__dots{padding-right:20px;margin-bottom:2px;-webkit-transform:none;-ms-transform:none;transform:none;}} .dzZrgS.translate{-webkit-transform :translateY(-120px);-ms-transform :translateY(-120px);transform :translateY(-120px);top:170px;} @media(min-width:991.5px){.dzZrgS.translate{-webkit-transform :translateY(-130px) rotate(90deg);-ms-transform :translateY(-130px) rotate(90deg);transform :translateY(-130px) rotate(90deg);}}
/* sc-component-id: sc-jrIrqw */
.eHMFfo{padding:0;margin:20px 0;} .eHMFfo span{font-size:14px;} .eHMFfo span.isHide{display:none;} .eHMFfo span i{font-style:italic;} .eHMFfo span i.isHide{display:none;}
/* sc-component-id: sc-hjRWVT */
.irNWJI{width:16px;margin:0 2px 2px;}
/* sc-component-id: sc-iybRtq */
.iQSObO{width:16px;margin-bottom:2px;}
/* sc-component-id: sc-iQtOjA */
.kfDwZY{display:-webkit-box;display:-webkit-flex;display:-ms-flexbox;display:flex;border:none;font-size:12px;font-weight:500;margin-top:7px;padding:0;color:#4D8A17;-webkit-text-decoration:none;text-decoration:none;cursor:pointer;} .kfDwZY:hover{-webkit-text-decoration:underline;text-decoration:underline;} @media (min-width:767.5px){.kfDwZY{margin-top:5px;}}
/* sc-component-id: sc-fHxwqH */
.dMuGGA{overflow-y:hidden;height:auto;max-height:100%;-webkit-transition:all .5s;transition:all .5s;} .dMuGGA.isHide{max-height:0;-webkit-transition:all .5s;transition:all .5s;} .dMuGGA p:first-child{margin-top:15px;} .dMuGGA p{font-size:14px;line-height:23px;display:block;} .dMuGGA sup{margin-top:-5px;}
/* sc-component-id: sc-cEvuZC */
.XkrFe{border:none;border-top:1px solid #E3E3E3;height:2px;margin:15px 0;} .XkrFe.hr__author{margin-bottom:12px;}
/* sc-component-id: sc-cBdUnI */
@media (min-width:320px) and (max-width:991.5px){.hRnXob{display:none;}} @media (min-width:991.5px){.hRnXob{z-index:1;}}
/* sc-component-id: sc-exkUMo */
.hymroZ{background-color:#6ba339;color:#ffffff;display:none;} .hymroZ span.text{padding-left:20px;} @media (min-width:991px){.hymroZ{-webkit-transition:background-color 0.25s ease-in-out 0s;transition:background-color 0.25s ease-in-out 0s;}.hymroZ:hover{background-color :#D8D8D8;-webkit-transition:background-color 0.25s ease-in-out 0s;transition:background-color 0.25s ease-in-out 0s;}}
/* sc-component-id: sc-kcDeIU */
.cbcyj{background-color:#f2f2f2;color:#4a4a4a;display:none;} .cbcyj span.text{padding-left:20px;} @media (min-width:991.5px) and (max-width:1279.5px){.cbcyj{display:none !important;}} @media (min-width:991px){.cbcyj{-webkit-transition:background-color 0.25s ease-in-out 0s;transition:background-color 0.25s ease-in-out 0s;}.cbcyj:hover{background-color :#D8D8D8;-webkit-transition:background-color 0.25s ease-in-out 0s;transition:background-color 0.25s ease-in-out 0s;}} @media (min-width:991.5px){.cbcyj.hide{display:none !important;}}
/* sc-component-id: sc-BngTV */
.hmDWcT{background-color:#f2f2f2;color:#4a4a4a;display:none;} .hmDWcT span.text{padding-left:20px;} @media (min-width:1279.5px){.hmDWcT{display:none !important;}} @media (min-width:991px){.hmDWcT{-webkit-transition:background-color 0.25s ease-in-out 0s;transition:background-color 0.25s ease-in-out 0s;}.hmDWcT:hover{background-color :#5D9230;-webkit-transition:background-color 0.25s ease-in-out 0s;transition:background-color 0.25s ease-in-out 0s;}} @media (min-width:991.5px){.hmDWcT.hide{display:none !important;}}
/* sc-component-id: sc-hBbWxd */
.kdRRST{background-color:#f2f2f2;border-top:1px solid #ffffff;display:-webkit-box;display:-webkit-flex;display:-ms-flexbox;display:flex;font-size:14px;-webkit-box-pack:justify;-webkit-justify-content:space-between;-ms-flex-pack:justify;justify-content:space-between;padding:20px 55px 20px 25px;} @media (max-width:1279.5px){.kdRRST{padding-right:20px;}} @media (max-width:991.5px){.kdRRST{display:none;}}
/* sc-component-id: sc-dyGzUR */
.cHatnS div{display:-webkit-box;display:-webkit-flex;display:-ms-flexbox;display:flex;-webkit-flex-direction:column;-ms-flex-direction:column;flex-direction:column;} .cHatnS div:last-of-type{padding-top:20px;} .cHatnS span{color:#4F4F4F;font-size:20px;font-weight:700;line-height:26px;}
/* sc-component-id: sc-drKuOJ */
.kxdGAZ{-webkit-align-items:center;-webkit-box-align:center;-ms-flex-align:center;align-items:center;display:-webkit-box;display:-webkit-flex;display:-ms-flexbox;display:flex;-webkit-flex-direction:column-reverse;-ms-flex-direction:column-reverse;flex-direction:column-reverse;height:100%;-webkit-box-pack:end;-webkit-justify-content:flex-end;-ms-flex-pack:end;justify-content:flex-end;} .kxdGAZ span{padding-top:15px;}
/* sc-component-id: sc-cTjmhe */
@media (min-width:991.5px){.ihmyEq{width:100%;z-index:1;}}
/* sc-component-id: sc-cugefK */
.itFKcQ{background-color:#F2F2F2;color:#4A4A4A;border-top:1px solid #FFFFFF;font-size:16px;font-weight:500;padding:20px;display:-webkit-box;display:-webkit-flex;display:-ms-flexbox;display:flex;-webkit-align-items:center;-webkit-box-align:center;-ms-flex-align:center;align-items:center;cursor:pointer;-webkit-box-pack:justify;-webkit-justify-content:space-between;-ms-flex-pack:justify;justify-content:space-between;} @media (min-width:991px){.itFKcQ{-webkit-transition:background-color 0.25s ease-in-out 0s;transition:background-color 0.25s ease-in-out 0s;}.itFKcQ:hover{background-color :#D8D8D8;-webkit-transition:background-color 0.25s ease-in-out 0s;transition:background-color 0.25s ease-in-out 0s;}} @media (min-width:991.5px){.itFKcQ.hide{display:none !important;}} .itFKcQ.active .icon-themeable{-webkit-transform:rotate(180deg);-ms-transform:rotate(180deg);transform:rotate(180deg);}
/* sc-component-id: sc-fnwBNb */
.etzuBr{display:none;}
/* sc-component-id: sc-iNhVCk */
.gWgCNb{background-color:#f2f2f2;border-radius:0;border-top:1px solid #e3e3e3;font-size:16px;color:#4a4a4a;font-weight:500;padding:11px 20px;display:-webkit-box;display:-webkit-flex;display:-ms-flexbox;display:flex;-webkit-align-items:center;-webkit-box-align:center;-ms-flex-align:center;align-items:center;} @media (min-width:991px){.gWgCNb{-webkit-transition:background-color 0.25s ease-in-out 0s;transition:background-color 0.25s ease-in-out 0s;}.gWgCNb:hover{background-color :#D8D8D8;-webkit-transition:background-color 0.25s ease-in-out 0s;transition:background-color 0.25s ease-in-out 0s;}}
/* sc-component-id: sc-eAKXzc */
.WHkfb{-webkit-flex:1 0 90%;-ms-flex:1 0 90%;flex:1 0 90%;padding-left:50px;} @media (min-width:767.5px){.WHkfb{padding-left:93px;}} @media (min-width:991.5px){.WHkfb{padding-left:50px;}}
/* sc-component-id: sc-bfYoXt */
.cGuwDn{width:20px;height:24px;}
/* sc-component-id: sc-gbOuXE */
.jGPvPL{width:22px;height:21px;padding:2px;}
/* sc-component-id: sc-dRFtgE */
.jrsDZP{-webkit-flex:1 0 80%;-ms-flex:1 0 80%;flex:1 0 80%;padding-left:26px;} @media (min-width:767.5px){.jrsDZP{padding-left:69px;}} @media (min-width:991.5px){.jrsDZP{padding-left:20px;}} @media (min-width:991.5px) and (max-width:1279.5px){.jrsDZP{display:none;}}
/* sc-component-id: sc-gkFcWv */
.gWTCXQ{display:none;} @media (min-width:991.5px){.gWTCXQ{padding-left:20px;max-width:100px;display:inline;}} @media (min-width:1279.5px){.gWTCXQ{display:none;}}
/* sc-component-id: sc-hUfwpO */
.jHPgUP{width:100%;border-left:1px solid #f2f2f2;border-right:1px solid #f2f2f2;border-bottom:none;cursor:pointer;} .jHPgUP li{background-color:#f2f2f2;} @media (min-width:991px){.jHPgUP li{-webkit-transition:background-color 0.25s ease-in-out 0s;transition:background-color 0.25s ease-in-out 0s;}.jHPgUP li:hover{background-color :#ffffff;-webkit-transition:background-color 0.25s ease-in-out 0s;transition:background-color 0.25s ease-in-out 0s;}} .jHPgUP h3{display:none;}
/* sc-component-id: sc-imABML */
.ibWUzs{background-color:#f2f2f2;color:#4a4a4a;display:block;border-top:1px solid #ffffff;border-radius:0;font-size:16px;font-weight:500;padding:20px;display:-webkit-box;display:-webkit-flex;display:-ms-flexbox;display:flex;-webkit-align-items:center;-webkit-box-align:center;-ms-flex-align:center;align-items:center;cursor:pointer;-webkit-box-pack:justify;-webkit-justify-content:space-between;-ms-flex-pack:justify;justify-content:space-between;} .ibWUzs .right__icon{padding:0;height:16px;width:20px;} @media (min-width:991px){.ibWUzs{-webkit-transition:background-color 0.25s ease-in-out 0s;transition:background-color 0.25s ease-in-out 0s;}.ibWUzs:hover{background-color :#D8D8D8;-webkit-transition:background-color 0.25s ease-in-out 0s;transition:background-color 0.25s ease-in-out 0s;}} @media (min-width:991.5px){.ibWUzs.hide{display:none !important;}}
/* sc-component-id: sc-cjHlYL */
.mkXor{display:-webkit-box;display:-webkit-flex;display:-ms-flexbox;display:flex;width:25%;float:right;margin-top:-49px;} @media (max-width:374px){.mkXor{width:26.5%;}} @media (min-width:992px){.mkXor{display:none;}}
/* sc-component-id: sc-dRaagA */
.dULvrJ{background-color:#6ba339;color:white;-webkit-flex:1 0 25%;-ms-flex:1 0 25%;flex:1 0 25%;z-index:100;padding:14px 16px 10px 19px;border-radius:0px;border-bottom:1px solid #ffffff;} @media (min-width:320px) and (max-width:767px){.dULvrJ{border-bottom:none;padding:16px 16px 14px 16px;font-size:14px;}.dULvrJ .article_toolbar_icon{display:none;}}
/* sc-component-id: sc-fEUNkw */
.dfaOeH{margin-right:16px;width:24px;height:24px;}
/* sc-component-id: sc-dREXXX */
.cqhPZs{width:16px;height:auto;float:right;} @media (min-width:767.5px){.cqhPZs{width:24px;height:24px;}}
/* sc-component-id: sc-nrwXf */
.byflLi{font-size:14px;padding:16px 20px 24px;} @media (max-width:991px){.byflLi{display:none;}}
/* sc-component-id: sc-eitiEO */
.jXeALb{font-size:14px;} .jXeALb:hover{-webkit-text-decoration:underline;text-decoration:underline;}
/* sc-component-id: sc-bhlBdH */
.UVThf{font-size:14px;font-weight:bold;}
/* sc-component-id: sc-kDhYZr */
.iySbrx{margin:35px 0 0;display:none;} @media(max-width:767px){.iySbrx.mobile_tabs{display:-webkit-box;display:-webkit-flex;display:-ms-flexbox;display:flex;}.iySbrx.row2{margin:15px 0 0;}} @media(min-width:768px){.iySbrx.desktop_tabs{display:-webkit-box;display:-webkit-flex;display:-ms-flexbox;display:flex;}} @media (min-width:991.5px){.iySbrx{margin:0;}}
/* sc-component-id: sc-sPYgB */
.bCmGAV{width:15px;border-bottom:1px solid #E0E0E0;} @media(max-width:767px){.bCmGAV.row2_edge_left{-webkit-flex-basis:10%;-ms-flex-preferred-size:10%;flex-basis:10%;}.bCmGAV.row2_edge_right{-webkit-flex-basis:30%;-ms-flex-preferred-size:30%;flex-basis:30%;}}
/* sc-component-id: sc-dHIava */
.TdHTO{display:-webkit-box;display:-webkit-flex;display:-ms-flexbox;display:flex;-webkit-box-pack:center;-webkit-justify-content:center;-ms-flex-pack:center;justify-content:center;-webkit-align-items:center;-webkit-box-align:center;-ms-flex-align:center;align-items:center;padding:0 10px;width:190px;min-height:40px;-webkit-flex:auto;-ms-flex:auto;flex:auto;border:1px solid #E0E0E0;border-radius:0;border-right:0;border-bottom:0;color:#4D8A17;-webkit-text-decoration:none;text-decoration:none;cursor:pointer;color:#4D8A17 !important;} .TdHTO:hover{-webkit-text-decoration:underline;text-decoration:underline;} @media(min-width:768px){.TdHTO{width:215px;}} .TdHTO:last-of-type{border-right:1px solid #E0E0E0;border-top:1px solid #E0E0E0;}.bmMPie{display:-webkit-box;display:-webkit-flex;display:-ms-flexbox;display:flex;-webkit-box-pack:center;-webkit-justify-content:center;-ms-flex-pack:center;justify-content:center;-webkit-align-items:center;-webkit-box-align:center;-ms-flex-align:center;align-items:center;padding:0 10px;width:190px;min-height:40px;-webkit-flex:auto;-ms-flex:auto;flex:auto;border:1px solid #E0E0E0;border-radius:0;border-right:0;color:#4D8A17;-webkit-text-decoration:none;text-decoration:none;cursor:pointer;color:#4A4A4A !important;} .bmMPie:hover{-webkit-text-decoration:underline;text-decoration:underline;} @media(min-width:768px){.bmMPie{width:215px;}} .bmMPie:last-of-type{border-right:1px solid #E0E0E0;border-top:1px solid #E0E0E0;}
/* sc-component-id: sc-bSbAYC */
.fClRDD{border-width:1px;border-style:solid;border-color:#007B8B;background:rgba(0,123,139,0.05);padding:25px 20px;display:-webkit-box;display:-webkit-flex;display:-ms-flexbox;display:flex;margin-top:30px;}
/* sc-component-id: sc-guztPN */
.fexZtq{display:block;margin-left:15px;} @media(min-width:768px){.fexZtq{margin-left:30px;}} .fexZtq br{content:"";display:block;margin-bottom:16px;}
/* sc-component-id: sc-cFlXAS */
.iomKnj{font-family:STIXGeneral;font-size:30px;width:37px;height:37px;-webkit-flex:1 0 37px;-ms-flex:1 0 37px;flex:1 0 37px;border-radius:50%;background:#3396A3;color:#FFFFFF;display:-webkit-box;display:-webkit-flex;display:-ms-flexbox;display:flex;-webkit-box-pack:center;-webkit-justify-content:center;-ms-flex-pack:center;justify-content:center;-webkit-align-items:center;-webkit-box-align:center;-ms-flex-align:center;align-items:center;font-weight:bold;} @media(min-width:768px){.iomKnj{font-size:40px;width:48px;height:48px;-webkit-flex:1 0 48px;-ms-flex:1 0 48px;flex:1 0 48px;}}
/* sc-component-id: sc-OxbzP */
.eEFYIL{width:100%;height:auto;background-color:#4A4A4A;font-family:'IBM Plex Sans',sans-serif;font-size:14px;font-weight:500;color:#fff;padding:15px 20px;line-height:20px;position:fixed;bottom:0px;z-index:3;display:-webkit-box;display:-webkit-flex;display:-ms-flexbox;display:flex;-webkit-box-pack:justify;-webkit-justify-content:space-between;-ms-flex-pack:justify;justify-content:space-between;-webkit-transition:-webkit-transform .25s;-webkit-transition:transform .25s;transition:transform .25s;} .eEFYIL a{color:#7ED321;} .eEFYIL p{display:inline;margin:0;} .eEFYIL.hideBanner{-webkit-transform:translateY(100%);-ms-transform:translateY(100%);transform:translateY(100%);}
/* sc-component-id: sc-bYnzgO */
.dsXEHZ{background:transparent;border:none;height:20px;width:20px;margin-left:20px;padding:0;cursor:pointer;}
/* sc-component-id: sc-cPuPxo */
.iXKuYd{min-width:20px;height:20px;}
/* sc-component-id: baseContent__Main-sc-134g3di-2 */
.cmzomn{margin-top:140px;} @media (min-width:767.5px){.cmzomn{margin-top:85px;}} @media (min-width:991.5px){.cmzomn{margin-top:70px;min-height:calc(100vh - 334px);}}
/* sc-component-id: threeColumn__ThreeColumnWrapper-sc-1bf4078-0 */
.dDyxFF{width:100%;} @media only screen and (min-width:992px){.dDyxFF{display:-webkit-box;display:-webkit-flex;display:-ms-flexbox;display:flex;-webkit-flex-flow:row wrap;-ms-flex-flow:row wrap;flex-flow:row wrap;padding:0 20px;max-width:1440px;margin:0 auto;}} @media (min-width:991.5px) and (max-width:1100.5px){.dDyxFF .partenership__collabText{font-size:12px;}} @media (min-width:1100.5px) and (max-width:1200.5px){.dDyxFF .partenership__collabText{font-size:14px;}} @media (min-width:991.5px) and (max-width:1071.5px){.dDyxFF .partenership__logoWrapper img{margin-left:20px;margin-bottom:10px;}.dDyxFF .partenership__logoWrapper img:last-child{margin-left:0;margin-bottom:0;}} @media (max-width:1150px){.dDyxFF .journal-metrics-container{display:none;}.dDyxFF .journal_report_link-border-helper{display:none;}}
/* sc-component-id: threeColumn__LeftWrapper-sc-1bf4078-1 */
@media only screen and (min-width:992px){.fkVFlF{width:20%;}} @media only screen and (min-width:1280px){.fkVFlF{width:25%;}}
/* sc-component-id: threeColumn__RightWrapper-sc-1bf4078-2 */
.jzTMLK{-webkit-transition:-webkit-transform 0.5s;-webkit-transition:transform 0.5s;transition:transform 0.5s;} @media only screen and (min-width:992px){.jzTMLK{width:20%;margin-bottom:60px;}.jzTMLK.translate{-webkit-transform:translateY(-130px);-ms-transform:translateY(-130px);transform:translateY(-130px);}} @media only screen and (min-width:1280px){.jzTMLK{width:25%;}}
/* sc-component-id: threeColumn__ContentWrapper-sc-1bf4078-3 */
.bbzREB{margin:0 20px;overflow:hidden;} @media only screen and (min-width:992px){.bbzREB{width:calc(60% - 40px);}} @media only screen and (min-width:1280px){.bbzREB{width:calc(50% - 40px);}}
/* sc-component-id: threeColumn__Content-sc-1bf4078-4 */
.jknsZc{margin:0 auto;overflow:hidden;} @media only screen and (min-width:768px){.jknsZc{max-width:688px;}} @media only screen and (min-width:992px){.jknsZc{max-width:100%;}} @media only screen and (min-width:1075px){.jknsZc{max-width:572px;}}
/* sc-component-id: article__BaseStyle-sc-10qhnp8-0 */
.gnduKR{width:100%;margin-top:170px;} @media (min-width:767.5px){.gnduKR{margin-top:179px;}} @media (min-width:991.5px){.gnduKR{margin-top:180px;min-height:840px;}}
/* sc-component-id: article__StickyStyle-sc-10qhnp8-1 */
.fJLQxX{width:100%;max-width:1440px;z-index:3;-webkit-transition:all 0.5s;transition:all 0.5s;} .fJLQxX.translate{-webkit-transform:translateY(-120px);-ms-transform:translateY(-120px);transform:translateY(-120px);} @media (min-width:767.5px){.fJLQxX.translate{-webkit-transform:translateY(-130px);-ms-transform:translateY(-130px);transform:translateY(-130px);}} @media (min-width:991.5px){.fJLQxX.translate{-webkit-transform:translateY(-130px);-ms-transform:translateY(-130px);transform:translateY(-130px);}}
/* sc-component-id: article__SubtitleStyled-sc-10qhnp8-2 */
.elhyhe{background-color:#007b8b;opacity:0.8;color:#fff;margin-bottom:0;margin-top:0;padding:17px 0 17px 20px;line-height:23px;height:60px;-webkit-align-items:center;-webkit-box-align:center;-ms-flex-align:center;align-items:center;display:-webkit-box;display:-webkit-flex;display:-ms-flexbox;display:flex;font-size:20px;font-weight:500;} @media (min-width:767.5px){.elhyhe{line-height:26px;}} @media (min-width:991.5px){.elhyhe{line-height:50px;padding:5px 0 5px 20px;height:60px;}}
/* sc-component-id: article__JournalMenuTitle-sc-10qhnp8-3 */
.jCfZqq{display:-webkit-box;display:-webkit-flex;display:-ms-flexbox;display:flex;-webkit-align-items:center;-webkit-box-align:center;-ms-flex-align:center;align-items:center;font-size:16px;font-weight:500;line-height:20px;height:50px;width:100%;background-color:#007b8b;color:#fff;text-align:left;padding-left:14px;padding-right:0;border:0;border-top:1px solid #fff;} .jCfZqq span{font-size:24px;padding-right:14px;} @media (min-width:991.5px){.jCfZqq{display:none;}}
/* sc-component-id: article__WhiteWrapper-sc-10qhnp8-5 */
.bJcSpM{background-color:#fff;display:block;position:relative;} .bJcSpM h1,.bJcSpM h2{color:#fff;} .bJcSpM h2{font-size:20px;} @media (min-width:767.5px){.bJcSpM h2{font-size:25px;}} .bJcSpM h1{font-size:20px;} @media (min-width:767.5px){.bJcSpM h1{font-size:24px;}} @media (min-width:991.5px){.bJcSpM h1{font-size:40px;}}
/* sc-component-id: articleContent__ArticleContentsWrapper-sc-2yl9jy-0 */
.eSvjPB{display:-webkit-box;display:-webkit-flex;display:-ms-flexbox;display:flex;width:100%;} .eSvjPB .author__editor--hr{display:block;}
/* sc-component-id: articleContent__ArticleContentsSectionsWrapper-sc-2yl9jy-1 */
.jntdRu{width:100%;} @media (max-width:991.5px){.jntdRu{margin-top:52px;}} .jntdRu p{margin:12px 0;line-height:20px;} .jntdRu .articlecontent__alignment{width:100%;min-width:306px;padding-left:7px;padding-right:7px;} @media (min-width:346px){.jntdRu .articlecontent__alignment{padding-left:20px;padding-right:20px;}} @media (min-width:767.5px){.jntdRu .articlecontent__alignment{width:543px;margin:auto;padding-left:0px;padding-right:0px;}} @media (min-width:991.5px){.jntdRu .articlecontent__alignment{max-width:612px;width:75%;margin:inherit;margin-left:50px;padding-left:20px;padding-right:20px;}} @media (min-width:1100px){.jntdRu .articlecontent__alignment{margin-left:118px;}} .jntdRu .article__title{padding-bottom:12px;} @media (min-width:767.5px){.jntdRu .article__title{padding-bottom:15px;}} .jntdRu .article__summary{padding-bottom:65px;} @media (min-width:991.5px){.jntdRu .article__summary{padding-bottom:75px;}} @media (min-width:767.5px){.jntdRu #vjs_video_3 button{-webkit-transform:none;-ms-transform:none;transform:none;left:40%;margin-top:0;}} .jntdRu .video-js .vjs-big-play-button{top:calc(50% - 22.5px);left:calc(50% - 50px);} .jntdRu .video-js{margin:20px 0;} .jntdRu a{color:#4D8A17;-webkit-text-decoration:none;text-decoration:none;cursor:pointer;} .jntdRu a:hover{-webkit-text-decoration:underline;text-decoration:underline;}
/* sc-component-id: articleContent__ArticleWrapper-sc-2yl9jy-2 */
.eGVCps{background-position:0px 0px;background-origin:content-box;background-size:99%;margin-top:50px;}
/* sc-component-id: articleContent__EditorWrapper-sc-2yl9jy-3 */
.evMkvU{padding:0;}
/* sc-component-id: articleContent__PublicationTimeLineWrapper-sc-2yl9jy-4 */
.fjviok{display:-webkit-box;display:-webkit-flex;display:-ms-flexbox;display:flex;-webkit-flex-wrap:wrap;-ms-flex-wrap:wrap;flex-wrap:wrap;margin:15px 0 30px;border-bottom:1px solid #E3E3E3;} @media (min-width:767.5px){.fjviok{border-top:1px solid #E3E3E3;margin:20px 0 30px;}}
/* sc-component-id: articleContent__PublcationCol-sc-2yl9jy-5 */
.hgKieC{-webkit-flex-basis:0;-ms-flex-preferred-size:0;flex-basis:0;-webkit-box-flex:1;-webkit-flex-grow:1;-ms-flex-positive:1;flex-grow:1;max-width:100%;border-right:1px solid #E3E3E3;padding:5px 0 15px;} @media (min-width:767.5px){.hgKieC{padding:5px 0;}} .hgKieC.notPublished{display:none;} @media (min-width:767.5px){.hgKieC.notPublished{display:block;}} @media (max-width:767.5px){.hgKieC.isPublished{display:-webkit-box;display:-webkit-flex;display:-ms-flexbox;display:flex;}.hgKieC.isPublished span:first-child::after{content:':';padding-right:3px;}} .hgKieC:last-child{border-right:none;}
/* sc-component-id: articleContent__PublicationField-sc-2yl9jy-6 */
.cIribm{display:block;text-align:center;font-size:14px;font-weight:700;}
/* sc-component-id: articleContent__PublicationValue-sc-2yl9jy-7 */
.khHUcu{display:block;text-align:center;font-size:14px;}
/* sc-component-id: articleContent__TextWrapper-sc-2yl9jy-8 */
.fYrLtk{margin:-7px 0 -5px;font-size:14px;}
/* sc-component-id: biblio__Wrapper-sc-1nou1lz-0 */
.eyHfWh{position:relative;} .eyHfWh.hide{display:none;} .eyHfWh hr{position:absolute;left:0;right:0;top:-30px;border-top:1px solid #E3E3E3;border-bottom:0;}.cBTaXT.hide{display:none;} .cBTaXT hr{display:none;}
/* sc-component-id: biblio__BiblioWrapper-sc-1nou1lz-1 */
@font-face{font-family:'STIXGeneral-Bold';src:url('https://static-01.hindawi.com/next_assets/cpr9K8AjZYaP4CWVbtn5c/_next/static/_/hindawi-ui/fonts/STIXGeneral-Regular.otf');} .kbSZJl{padding:0 20px 20px;} .kbSZJl .bib__image{display:none;} .kbSZJl .bib__title{font-size:20px;} .kbSZJl .bib__name{font-size:18px;font-family:'STIXGeneral-Bold',serif !important;color:rgb(74,74,74);font-weight:700;} .kbSZJl .bib--split .bib__link .bib__info,.kbSZJl .bib--split .bib__link.bib__link--image .bib__info,.kbSZJl [class*='bib--txt'] .bib__link .bib__info,.kbSZJl [class*='bib--txt'] .bib__link.bib__link--image .bib__info{padding:10px 0 !important;} .kbSZJl .bib__author{font-size:14px;line-height:22px;color:rgb(132,132,132);margin-top:3px;margin-bottom:0px;margin-right:20px;opacity:1;font-family:'IBM Plex Sans',sans-serif;font-weight:500;} .kbSZJl #biblio_sidebar .bib__link{border-top:1px solid rgb(227,227,227) !important;padding-top:5px !important;padding-bottom:5px !important;} .kbSZJl #biblio_sidebar .bib__link:first-child{border-top:0 !important;padding-top:0 !important;} .kbSZJl #biblio_sidebar .bib__link:first-child .bib__info{padding-top:0 !important;} .kbSZJl #biblio_widget .bib--split .bib__link .bib__info,.kbSZJl #biblio_widget .bib--split .bib__link.bib__link--image .bib__info{padding:10px 15px 10px 0 !important;} @media (min-width:767.5px){.kbSZJl{padding:0 40px 20px;}} @media (min-width:991.5px){.kbSZJl{padding:0 20px;}}
/* sc-component-id: biblio__H4-sc-1nou1lz-2 */
.becpDt{font-size:20px;font-family:'IBM Plex Sans';color:#000;font-weight:600;margin-top:34px;margin-bottom:18px;padding:0 20px;}
/* sc-component-id: journal_article__ArticleStickyTopToolbar-sc-12fk6zy-0 */
.gbrQxi{display:none;} @media (min-width:991.5px){.gbrQxi{display:block;}.gbrQxi .article_top_toolbar{top:110px;z-index:-100;}.gbrQxi .article_top_toolbar .pdf_desktop{display:-webkit-box;display:-webkit-flex;display:-ms-flexbox;display:flex;}.gbrQxi .article_top_toolbar .ref_desktop{display:-webkit-box;display:-webkit-flex;display:-ms-flexbox;display:flex;}} .gbrQxi .article_toolbar_views{margin-top:-58px;display:block;text-align:right;}
/* sc-component-id: journal_article__ArticleStickyBottomToolbar-sc-12fk6zy-1 */
@media (min-width:991.5px){.isgRZA .article_bottom_toolbar{top:292px;z-index:-10;}}
/* sc-component-id: journal_article__BreadCrumbStyle-sc-12fk6zy-2 */
@media (min-width:991.5px){.bjwAQR{padding:16px 20px 24px;height:60px;}}
/* sc-component-id: journal_article__ArticleBaseStyle-sc-12fk6zy-3 */
.NQpXC .content,.NQpXC .contentWrapper{overflow:visible;}
/* sc-component-id: journal_article__BiblioIntegratorSidebar-sc-12fk6zy-4 */
.cYsVdk{max-width:350px;} @media (max-width:991.5px){.cYsVdk{display:none !important;}}
/* sc-component-id: journal_article__BiblioIntegratorWidget-sc-12fk6zy-5 */
.dbAANp{background-color:#f5f5f5;padding:15px 20px 24px 20px;margin-top:2px;margin-bottom:20px;} @media (min-width:991.5px){.dbAANp{margin-top:-64px;margin-bottom:40px;}} .dbAANp .hrTitleRef{padding:0;margin-top:0;font-family:'IBM Plex Sans',sans-serif;} .dbAANp #biblio_widget{padding:0;}</style></head><body style="margin:0;box-sizing:border-box"><div id="__next"><div class="static_page"><div class="page no__focus__outline"><header class="sc-fjdhpX jzXSTA"><div class="sc-bZQynM bNmdOy E_HUmlU2Hj3PpkDmWzKPd header__padding"><div class="sc-kAzzGY epRoim mobileLogoFlex _1fpqArXPCxgnlv2rXZC2sl _1SoDWGr_FVsil9klRfjnhb"><a class="sc-htpNat bUhGXt link" href="/" aria-label="Home"><img alt="logo" src="https://preprod-admin.w2o.hindawi.com/themes/custom/hindawi_extended/logo.svg" class="sc-ckVGcZ gjctdt"/></a></div><div class="sc-jzJRlG jGJLow mobileButtonFlex _2v1j-tLx3hx0tgKcpPzH6B _3wm8FgzqRuRWouJG31YgKx E_HUmlU2Hj3PpkDmWzKPd"><nav class="sc-bxivhb ivbKJD"><ul class="sc-ifAKCX fopjOz sc-kpOJdX kAzjOl"><li class="navigation__link"><a class="sc-htpNat bUhGXt link link" href="/journals/" aria-label="Journals">Journals</a></li><li class="navigation__link"><a class="sc-htpNat bUhGXt link link" href="/publish-research/" aria-label="Publish with us">Publish with us</a></li><li class="navigation__link"><a class="sc-htpNat bUhGXt link link" href="/publishing-partnerships/" aria-label="Publishing partnerships">Publishing partnerships</a></li><li class="navigation__link"><a class="sc-htpNat bUhGXt link link" href="/about/" aria-label="About us">About us</a></li><li class="navigation__link"><a class="sc-htpNat bUhGXt link link" href="/blog/" aria-label="Blog">Blog</a></li></ul></nav><button class="sc-chPdSV hbVEoI icon__search" aria-label="Search"><span class="sc-htoDjs khbeDd icon__search icon-colored _3hSk3ArgsWMFh5QJIGblNr icon-themeable" title="" font-size="24"></span></button><button aria-label="Hamburger Menu" class="sc-cSHVUG ldSkVQ"><span class="sc-htoDjs khbeDd hamburger icon-colored _20YUA8q5mREEBfJm8VsdXV icon-themeable" title="" font-size="24"></span></button></div></div></header><div class="sc-bZQynM bNmdOy"></div><main class="baseContent__Main-sc-134g3di-2 cmzomn  article__BaseStyle-sc-10qhnp8-0 gnduKR DADtd11SJ4KyWZ2l6zAnr base_style journal_article__ArticleBaseStyle-sc-12fk6zy-3 NQpXC"><div class="sc-bZQynM bNmdOy width_wrapper"><div id="journal__navigation" class="sc-cbkKFq kuxTps article__StickyStyle-sc-10qhnp8-1 fJLQxX"><a class="sc-htpNat bUhGXt link article__WhiteWrapper-sc-10qhnp8-5 bJcSpM" href="/journals/bmri/" aria-label=""><h2 class="sc-eHgmQL fTkdCR article__SubtitleStyled-sc-10qhnp8-2 elhyhe _1ZrXcsbATVL_kHOpFAan9k">BioMed Research International</h2></a><button class="article__JournalMenuTitle-sc-10qhnp8-3 jCfZqq journalNavCheck" id="journalMenuTitle"><span>+</span>Journal Menu</button><div class="sc-bdVaJa EwsTm isHide" id="fadeOut"></div><div class="sc-cjHlYL mkXor"><a class="sc-htpNat bUhGXt link sc-dRaagA dULvrJ article-toolbar-link" href="https://downloads.hindawi.com/journals/bmri/2013/582526.pdf" aria-label="" download=""><img alt=" " class="sc-EHOje jOLhQl sc-fEUNkw dfaOeH article_toolbar_icon" title="" role="presentation" src="https://static-01.hindawi.com/next_assets/cpr9K8AjZYaP4CWVbtn5c/_next/static/node_modules/hindawi-ui/src/icon/svg/pdf.svg" height="24"/>PDF<img alt=" " class="sc-EHOje jOLhQl sc-dREXXX cqhPZs" title="" role="presentation" src="data:image/svg+xml;base64,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" height="24"/></a></div><nav id="journal__nav" class="sc-hGoxap dEfJbW article__JournalNavigationStyle-sc-10qhnp8-4 gaRePw isHide journalNavCheck"><div class="sc-giadOv eBepOs journalNavCheck"><button class="sc-hSdWYo etauus sc-fjmCvl fSPaCp journalNavCheck" color="">Journal overview<span class="sc-htoDjs gvAGTV sc-bHwgHz ctePXh journalNavCheck icon__inactive icon-white _1CwL9R82TPl2HxDleeYGDR icon-themeable" title="" font-size="9"></span><span class="sc-htoDjs gvAGTV sc-bHwgHz ctePXh journalNavCheck icon__active icon-colored icon__hidden _1CwL9R82TPl2HxDleeYGDR icon-themeable" title="" font-size="9"></span></button></div><a class="sc-htpNat bUhGXt link sc-TFwJa gCIfTO" href="/journals/bmri/guidelines/" aria-label="For authors">For authors</a><a class="sc-htpNat bUhGXt link sc-TFwJa gCIfTO" href="/publish-research/reviewers/" aria-label="For reviewers">For reviewers</a><a class="sc-htpNat bUhGXt link sc-TFwJa gCIfTO" href="/publish-research/editors/" aria-label="For editors">For editors</a><a class="sc-htpNat bUhGXt link sc-TFwJa gCIfTO" href="/journals/bmri/contents/year/2022/" aria-label="Table of Contents">Table of Contents</a><div class="sc-giadOv eBepOs journalNavCheck"><button class="sc-hSdWYo etauus sc-fjmCvl bVEEaH journalNavCheck" color="">Special Issues<span class="sc-htoDjs gvAGTV sc-bHwgHz ctePXh journalNavCheck icon__inactive icon-white _1CwL9R82TPl2HxDleeYGDR icon-themeable" title="" font-size="9"></span><span class="sc-htoDjs gvAGTV sc-bHwgHz ctePXh journalNavCheck icon__active icon-colored icon__hidden _1CwL9R82TPl2HxDleeYGDR icon-themeable" title="" font-size="9"></span></button></div><a class="sc-htpNat bUhGXt link sc-jtRfpW OGgkt submit__button journalNavCheck" href="https://review.hindawi.com/submit?journal=bmri" aria-label="" target="" id=""><span><img alt=" " class="sc-EHOje jOLhQl sc-kTUwUJ jUTgTa" title="" role="presentation" src="data:image/svg+xml;base64,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" height="24"/><span class="text">Submit</span></span><span class="sc-htoDjs kNoiZu sc-dqBHgY cQgXqt fileArrow icon-colored undefined icon-themeable" title="" font-size="16"></span></a><div class="sc-krDsej ewCAZX hide__submenu journalSubmenuCheck" id="journalnav__submenu"><button class="sc-itybZL kdvWPs journalSubmenuCheck"><span class="sc-htoDjs gvAGTV sc-fzsDOv hAFFGk journalSubmenuCheck icon-colored _1CwL9R82TPl2HxDleeYGDR icon-themeable" title="" font-size="9"></span></button></div><div class="sc-dTdPqK lkWWFY hide__submenu journal__nav__desktop" id="journalnav__submenudesktop"><div order="0" class="sc-kUaPvJ ehYbwJ"><div class="sc-gPWkxV legory"></div><div class="sc-gPWkxV legory"></div></div><div class="sc-jVODtj epgILe"></div><span class="sc-fONwsr kCfRMJ"></span></div></nav></div><div class="sc-nrwXf byflLi breadcrumb__wrapper journal_article__BreadCrumbStyle-sc-12fk6zy-2 bjwAQR article"><a class="sc-htpNat bUhGXt link sc-eitiEO jXeALb breadCrumb" href="/journals/bmri/" aria-label="BioMed Research International">BioMed Research International</a> / <a class="sc-htpNat bUhGXt link sc-eitiEO jXeALb breadCrumb" href="/journals/bmri/contents/year/2013/" aria-label="2013">2013</a> / <span class="sc-bhlBdH UVThf">Article</span></div><div class="threeColumn__ThreeColumnWrapper-sc-1bf4078-0 dDyxFF threeColumnWrapper"><div class="threeColumn__LeftWrapper-sc-1bf4078-1 fkVFlF leftWrapper"><button type="button" class="sc-eKZiaR dzZrgS section__button  " id="sectionButton"><span class="sc-htoDjs diutvq icon__dots dots__detector icon-colored _3n-7Ho7DlfjMlZbrRr9Q4a icon-themeable" title="" font-size="22"></span>Article Sections</button><div class="sc-bEjcJn jLUVhb static_contents__section_links
           links__hidden "><div id="leftSectionMenu" class="sc-cbkKFq prcY sc-bGbJRg dVCLgr left_section_menu"><p>On this page</p><span class="sc-likbZx bBmZJZ grey" property="background-color" color="#D8D8D8"><a class="sc-htpNat bUhGXt link sc-ePZHVD ewHMLz" href="#abstract" aria-label="">Abstract</a></span><span class="sc-likbZx bBmZJZ grey" property="background-color" color="#D8D8D8"><a class="sc-htpNat bUhGXt link sc-ePZHVD ewHMLz" href="#introduction" aria-label="">Introduction</a></span><span class="sc-likbZx bBmZJZ grey" property="background-color" color="#D8D8D8"><a class="sc-htpNat bUhGXt link sc-ePZHVD ewHMLz" href="#materials-and-methods" aria-label="">Materials and Methods</a></span><span class="sc-likbZx bBmZJZ grey" property="background-color" color="#D8D8D8"><a class="sc-htpNat bUhGXt link sc-ePZHVD ewHMLz" href="#results" aria-label="">Results</a></span><span class="sc-likbZx bBmZJZ grey" property="background-color" color="#D8D8D8"><a class="sc-htpNat bUhGXt link sc-ePZHVD ewHMLz" href="#discussion" aria-label="">Discussion</a></span><span class="sc-likbZx bBmZJZ grey" property="background-color" color="#D8D8D8"><a class="sc-htpNat bUhGXt link sc-ePZHVD ewHMLz" href="#conclusion" aria-label="">Conclusion</a></span><span class="sc-likbZx bBmZJZ grey" property="background-color" color="#D8D8D8"><a class="sc-htpNat bUhGXt link sc-ePZHVD ewHMLz" href="#references" aria-label="">References</a></span><span class="sc-likbZx bBmZJZ grey" property="background-color" color="#D8D8D8"><a class="sc-htpNat bUhGXt link sc-ePZHVD ewHMLz" href="#copyright" aria-label="">Copyright</a></span></div></div></div><div class="threeColumn__ContentWrapper-sc-1bf4078-3 bbzREB contentWrapper"><div class="threeColumn__Content-sc-1bf4078-4 jknsZc content"><div class="articleContent__ArticleContentsWrapper-sc-2yl9jy-0 eSvjPB article_contents"><div class="articleContent__ArticleContentsSectionsWrapper-sc-2yl9jy-1 jntdRu article_contents__sections_wrapper"><div class="sc-kDhYZr iySbrx desktop_tabs"><div class="sc-sPYgB bCmGAV"></div><a class="sc-htpNat bUhGXt link link--active sc-dHIava TdHTO" href="/journals/bmri/2013/582526/" aria-label="Research Article">Research Article</a><a class="sc-htpNat bUhGXt link sc-dHIava bmMPie" href="/journals/bmri/2015/372630/" aria-label="Corrigendum">Corrigendum</a><div class="sc-sPYgB bCmGAV"></div></div><div class="sc-kDhYZr iySbrx mobile_tabs row1"><div class="sc-sPYgB bCmGAV row1_edge_left"></div><a class="sc-htpNat bUhGXt link link--active sc-dHIava TdHTO row1_link" href="/journals/bmri/2013/582526/" aria-label="Research Article">Research Article</a><a class="sc-htpNat bUhGXt link sc-dHIava bmMPie row1_link" href="/journals/bmri/2015/372630/" aria-label="Corrigendum">Corrigendum</a><div class="sc-sPYgB bCmGAV row1_edge_right"></div></div><div class="sc-bSbAYC fClRDD"><span class="sc-cFlXAS iomKnj">!</span><span class="sc-guztPN fexZtq alert__message">A <b>Corrigendum</b> for this article has been published.
  To view the article details, please click the Corrigendum tab above.</span></div><div class="articleContent__ArticleWrapper-sc-2yl9jy-2 eGVCps"><div class="sc-chbbiW mBGSe article_header_class"><p class="sc-kZmsYB bkiEfx article_type">Research Article | <!-- -->Open Access</p><div class="sc-RcBXQ ztvYg article_citation">Volume<!-- --> <!-- -->2013<!-- --> <span class="sc-fZwumE cUsFHx">|</span>Article ID<!-- --> <!-- -->582526<!-- --> <span class="sc-fZwumE cUsFHx">| </span><a class="sc-htpNat bUhGXt link sc-fQejPQ duuwge" href="https://doi.org/10.1155/2013/582526" aria-label="Doi-link">https://doi.org/10.1155/2013/582526</a></div><div class="sc-LKuAh lcOiDF article_full_citation"><div class="sc-hzNEM gsmOCv isHide"><p>Anahita Rahmani, Danial Kheradmand, Peyman Keyhanvar, Alireza Shoae-Hassani, Amir Darbandi-Azar<!-- -->,<!-- --> <!-- -->&quot;<span class="adjust-article-svg-size">Neurogenesis and Increase in Differentiated Neural Cell Survival via Phosphorylation of Akt1 after Fluoxetine Treatment of Stem Cells</span>&quot;,<!-- --> <i>BioMed Research International</i>,<!-- --> <!-- -->vol. <!-- -->2013<!-- -->,<!-- --> <!-- -->Article ID <!-- -->582526<!-- -->,<!-- --> <!-- -->9<!-- --> <!-- --> <!-- --> <!-- -->pages<!-- -->,<!-- --> <!-- -->2013<!-- -->.<!-- --> <!-- -->https://doi.org/10.1155/2013/582526</p></div><button class="sc-hSdWYo etauus sc-iBEsjs kPshFw" color="">Show citation</button></div><h1 class="sc-iRbamj jZOxOO sc-iSDuPN kRoxOt article_title adjust-article-svg-size heading-title">Neurogenesis and Increase in Differentiated Neural Cell Survival via Phosphorylation of Akt1 after Fluoxetine Treatment of Stem Cells</h1></div><div class="sc-jrIrqw eHMFfo article_authors"><hr class="sc-cEvuZC XkrFe hr__author"/><span class="">Anahita Rahmani<!-- -->,<sup>1</sup> </span><span class="">Danial Kheradmand<!-- -->,<sup>2</sup> </span><span class="">Peyman Keyhanvar<!-- -->,<sup>3<!-- -->,<!-- -->4</sup> </span><span class="">Alireza Shoae-Hassani<a class="sc-htpNat bUhGXt link" href="http://orcid.org/0000-0002-0655-1343" aria-label="Redirect to Doi" target="_blank"><img alt=" " class="sc-EHOje iiusBg sc-iybRtq iQSObO" title="" role="presentation" src="data:image/svg+xml;base64,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" height="16"/></a>,<sup>1</sup> <!-- --> and </span><span class=""><b>Amir Darbandi-Azar</b><a class="sc-htpNat bUhGXt link" href="mailto:" aria-label="Mail Option"><span class="sc-htoDjs kNoiZu sc-hjRWVT irNWJI icon-colored _2zt-1j0LmaF8UjTQAM413G icon-themeable" title="" font-size="16"></span></a><sup>4</sup></span><div class="sc-fHxwqH dMuGGA isHide"><p><sup>1</sup><span>Stem Cell and Tissue Engineering Department, Research Center for Science and Technology in Medicine (RCSTiM), Tehran University of Medical Sciences, Tehran, Iran</span></p><p><sup>2</sup><span>Faculty of Medicine, Islamic Azad University, Mashhad Branch, Mashhad 19988-96953, Iran</span></p><p><sup>3</sup><span>Medical Nanotechnology Department, School of Advanced Technologies in Medicine, Tehran University of Medical Sciences, Tehran, Iran</span></p><p><sup>4</sup><span>Rajaei Cardiovascular, Medical, and Research Centre, Iran University of Medical Sciences, P.O. Box 14185-615, Tehran, Iran</span></p></div><button class="sc-hSdWYo etauus sc-iQtOjA kfDwZY" color="">Show more</button></div><div class="articleContent__EditorWrapper-sc-2yl9jy-3 evMkvU"><div class="articleContent__TextWrapper-sc-2yl9jy-8 fYrLtk"><b>Academic Editor: </b>Paul Higgins</div><div class="articleContent__PublicationTimeLineWrapper-sc-2yl9jy-4 fjviok"><div class="articleContent__PublcationCol-sc-2yl9jy-5 hgKieC notPublished"><span class="articleContent__PublicationField-sc-2yl9jy-6 cIribm">Received</span><span class="articleContent__PublicationValue-sc-2yl9jy-7 khHUcu">10 Apr 2013</span></div><div class="articleContent__PublcationCol-sc-2yl9jy-5 hgKieC notPublished"><span class="articleContent__PublicationField-sc-2yl9jy-6 cIribm">Revised</span><span class="articleContent__PublicationValue-sc-2yl9jy-7 khHUcu">15 Jul 2013</span></div><div class="articleContent__PublcationCol-sc-2yl9jy-5 hgKieC notPublished"><span class="articleContent__PublicationField-sc-2yl9jy-6 cIribm">Accepted</span><span class="articleContent__PublicationValue-sc-2yl9jy-7 khHUcu">15 Jul 2013</span></div><div class="articleContent__PublcationCol-sc-2yl9jy-5 hgKieC isPublished"><span class="articleContent__PublicationField-sc-2yl9jy-6 cIribm">Published</span><span class="articleContent__PublicationValue-sc-2yl9jy-7 khHUcu">18 Aug 2013</span></div></div></div><article class="sc-jtRlXQ exFqMv article_body "><div><div class="xml-content"><h4 class="header" id="abstract">Abstract</h4><p>Fluoxetine (FLX) is a selective serotonin reuptake inhibitor (SSRI). Its action is possibly through an increase in neural cell survival. The mechanism of improved survival rate of neurons by FLX may relate to the overexpression of some kinases such as Akt protein. Akt1 (a serine/threonine kinase) plays a key role in the modulation of cell proliferation and survival. Our study evaluated the effects of FLX on mesenchymal stem cell (MSC) fate and Akt1 phosphorylation levels in MSCs. Evaluation tests included reverse transcriptase polymerase chain reaction, western blot, and immunocytochemistry assays. Nestin, MAP-2, and <i></i>-tubulin were detected after neurogenesis as neural markers. Ten <i></i>M of FLX upregulated phosphorylation of Akt1 protein in induced hEnSC significantly. Also FLX did increase viability of these MSCs. Continuous FLX treatment after neurogenesis elevated the survival rate of differentiated neural cells probably by enhanced induction of Akt1 phosphorylation. This study addresses a novel role of FLX in neurogenesis and differentiated neural cell survival that may contribute to explaining the therapeutic action of fluoxetine in regenerative pharmacology.</p><span class="end-abs"></span><h4 id="introduction">1. Introduction</h4><p>  Recent works in stem cell biology have opened up new ways in therapeutic strategies to replace lost cells with stem cells in injuries. Cell therapy will be an effective strategy for treating neurodegenerative diseases and spinal cord injuries [<a href="#B1">1</a>]. However the important part of the successful therapy depends on differentiation and promoting the survival of implanted cells. The survival rate of stem cells after differentiation and transplantation is important for the efficacy of cell therapy [<a href="#B2">2</a>]. Some factors are involved in the regulation of neurogenesis and their survival. Corticosteroids were the first hormones found to have a neurogenesis effect [<a href="#B3">3</a>]. Neurotransmitters and growth factors also can affect neurogenesis [<a href="#B4">4</a>]. Based on the fact that fluoxetine (FLX) improves brain function, researchers have explored the effect of antidepressants on the neurogenesis. FLX was the first selective serotonin reuptake inhibitor (SSRI) approved for the treatment of depression. On the molecular basis of its clinical efficacy, FLX increases serotonin synaptic availability [<a href="#B5">5</a>]. Increased neurogenesis started by antidepressants in some manner contributes to their therapeutic effects [<a href="#B6">6</a>]. These results provide some initial insights, but more work is needed to fully elucidate the SSRI actions on stem cell neurogenesis. </p><p>  To promote extended survival of transplanted stem cells, we must modulate the properties of the cells. This purpose might be accomplished by overexpressing Akt1 protein which is a general mediator of cell survival signal. Akt is a serine/threonine kinase that plays a key role in the modulation of cell proliferation and survival. It is wellknown for its antiapoptotic effects against a variety of situations including oxidative and osmotic stress, irradiation, and ischemic shock [<a href="#B7">7</a><a href="#B10">10</a>].</p><p>  This study aimed to investigate whether fluoxetine could induce neurogenesis in mesenchymal stem cells and to further examine the putative role of Akt1 and its phosphorylation in FLX-mediated effects.</p><h4 id="materials-and-methods">2. Materials and Methods</h4><h5 id="sec2.1">2.1. Isolation and Culture of Human Endometrial Stem Cells</h5><p>This study was carried out in accordance with the Tehran University of Medical Sciences Ethical Committee Law. There was a consent form for each donor that is included in the supplementary data. Here we were using human endometrial stem cell (hEnSC) as a source of mesenchymal stem cell. Stem cell was obtained from 30 donors between 25 and 35 years old in the gynecology department as described previously [<a href="#B11">11</a>]. Briefly, the biopsies from endometrium were dissected and then treated with collagenase (Sigma, USA) for 45min. Isolated cells were suspended in phosphate buffered saline (PBS, Sigma, USA) supplemented with 10% fetal bovine serum (FBS; Gibco, UK), 0.2mM EDTA (Sigma, USA), 100U/mL penicillin, and 0.1mg/mL streptomycin (Gibco, UK). The cells were layered on Ficoll Paque (Sigma, USA) and centrifuged at 400g for 35min at 4C. EnSCs were retrieved from the buffy coat layer, washed in PBS, and then kept in DMEM/F12 medium (Gibco, UK). In the passage two, the CD146<sup>+</sup>, CD105<sup>+</sup>, and CD90<sup>+</sup> cells were isolated from total cells [<a href="#B12">12</a>] by the fluorescent analyzer cell sorter (FACS). </p><h5 id="sec2.2">2.2. Mesenchymal Stem Cells Differentiation</h5><p>Human EnSCs were placed on collagen precoated plates with DMEM low-glucose medium. The cultures were kept in a humidified 10% CO<sub>2</sub> atmosphere at 37C for 10 days. The media were replaced with fresh media every 3d. Stem cells that have grown to 70% confluence were pretreated with 1<i></i>M dimethyl-sulfoxide (DMSO, Sigma, USA) and then were treated with fluoxetine (1, 2, 5, and 10<i></i>M, Sigma, USA). Treatment with 1<i></i>M retinoic acid (RA, Sigma, USA) and dH<sub>2</sub>O was done as positive and negative controls in order. Also hEnSCs cultured in FLX treated media containing 10<i></i>M phosphatidylinositol-3-kinase (PI3-K) inhibitor (LY294002, Promega, USA) served as control cells to determine the Akt role. After treatment for 10d, cells were subjected to examining the Akt1 phosphorylation by western blot and for specific markers of neural cells via reverse transcriptase PCR and immunocytochemistry assays. In each experiment, a nontreated group was tested.</p><h5 id="sec2.3">2.3. Reverse Transcriptase PCR Analysis for Neural Specific Markers</h5><p>For collection of total RNA from treated hEnSCs, we used an Isogen kit according to the manufacturers instructions (Nippon Gene, Tokyo, Japan). RNA quantity and purity were determined by spectrophotometry (Beckman DU-65). Standard reverse transcription was performed using the AMV kit (Takara Biomedicals, Ohtsu, Japan) with 1<i></i>g RNA and 0.5<i></i>g oligo-dT per reaction, according to the manufacturers instructions. Reaction mixtures included 2.5<i></i>L cDNA, 1x PCR buffer (AMS TM, Cinnagen, Iran), 200<i></i>M dNTPs, 0.5<i></i>M of each of forward and reverse primers (Table <a href="tab1/" target="_blank">1</a>), and 1U Taq DNA polymerase. Polymerase chain reactions were performed at 94C for 1min, 30 cycles 94C for 30s, 5563C for 30s, and 72C for 30s, and 72C for 10min. Amplified DNA fragments were electrophoresed on 1.5% agarose gel. The gels were stained with ethidium bromide (10<i></i>g/mL) and photographed on a UV transilluminator (Uvidoc, UK).</p><div class="floats-partial-section partial-other-wrapper" data-section="tab1"><div class="floats-partial-content fig-content-tab1"><table class="table-group" id="tab1"><tr><td><table class="table"><tr><td class="thead-hr" colspan="3"><hr /></td></tr><tr class="thead"><td align="left">Target genes</td><td align="center">Primer sequences</td><td align="center">Accession number</td></tr><tr><td class="thead-hr" colspan="3"><hr /></td></tr><tr><td align="left" rowspan="2">Nestin</td><td align="center">F: 5-GCCCTGACCACTCCAGTTTA-3</td><td align="center" rowspan="2">NM:051373</td></tr><tr><td align="center">R: 5-GGAGTCCTGGATTTCCTTCC-3</td></tr><tr><td align="left" rowspan="2">Map-2</td><td align="center">F: 5-CCATTTGCAACAGGAAGACAC-3</td><td align="center" rowspan="2">NM:002374.3</td></tr><tr><td align="center">R: 5-CAGCTCAAATGCTTTGCAACTAT-3</td></tr><tr><td align="left" rowspan="2"><i></i>-tubulin</td><td align="center">F: 5-ATGTACGAAGACGACGAGGAG-3</td><td align="center" rowspan="2">NM:BC:003021</td></tr><tr><td align="center">R: 5-GTATCCCCGAAAATATAAACACA-3</td></tr><tr><td align="left" rowspan="2"><i></i>-actin</td><td align="center">F: 5-AAGAGAGGCATCCTGACCCT-3</td></tr><tr><td align="center">R: 5-ACATGGCTGGGGTGTTGAAGC-3</td></tr><tr class="table-tr"><td colspan="3"><hr class="tbody-hr" /></td></tr></table></td></tr></table></div><div class="floats-partial-footer"><div class="floats-partial-caption"><span class="caption-text">Table 1</span><a aria-label="full view" class="caption-partial-url" href="tab1/" title="full view" target="_blank">&nbsp;</a></div><div class="floats-partial-caption-text">Primers used for specific neuronal genes expression.</div></div></div><h5 id="sec2.4">2.4. Neural Markers Immunostaining</h5><p> The hEnSCs treated with FLX and FLX + 10<i></i>M PI3-K inhibitor (LY294002, Promega, USA) were fixed by incubation in 9% paraformaldehyde for 20min and permeabilized with 0.5% Triton X-100 for 10min as described previously [<a href="#B1">1</a>]. The cells were then reacted with primary antibodies for Nestin (Sigma, USA), MAP-2 (Sigma, USA), <i></i>-tubulin-III (Chemicon, USA), and CD11b as a glial marker (Millipore, USA) at 4C for 12h, washed with PBS and reacted with the fluorescent isothiocyanate (FITC) conjugated secondary antibody (Sigma, USA) at room temperature for 2h. Finally, the cells were washed with PBS three times, and DAPI was used for DNA staining. </p><h5 id="sec2.5">2.5. Detection of Akt1 Phosphorylation via Western Blotting</h5><p>After FLX treatment, the cell lysates were collected and protein concentration was determined by using a protein assay kit (Bio-Rad, USA). Total cell extracts containing equal amounts of protein in sample buffer were subjected to WB analysis as described previously [<a href="#B13">13</a>]. Briefly, the samples were boiled for 5min and then separated by 12% sodium dodecyl sulfate polyacrylamide gel electrophoresis (SDS-PAGE). After that, the gel was transferred onto polyvinylidene difluoride (PVDF) membrane for blotting. The membrane was first blocked by incubation in bovine albumin at room temperature for 2h and then incubated with anti-Akt1 antibody (Cell Signaling Technology, USA) and anti-phospho-Akt1 antibody (Cell Signaling Technology, USA) for 2h at room temperature, washed for 3 times with tris buffer containing Tween-20 and incubated at room temperature with HRP conjugated secondary antibody for 2h. The membrane was washed 5 times with tris buffer, and then specific bands were quantified using a ChemiImager System (Alpha Innotech Corporation). Anti-<i></i> actin antibody (Abcam, UK) was used as an internal control.</p><h5 id="sec2.6">2.6. Viability Test (MTT) in Neural Differentiated Cells</h5><p> MTT (3-[4,5-dimethylthiazol-2-yl]-2,5-diphenyltetrazolium bromide) assay is a useful colorimetric test for detection of cell viability. MTT is for measuring the activity of cellular enzymes that reduce the yellow tetrazolium dye, to its insoluble formazan, giving a purple color. Differentiated mesenchymal stem cells were tested for their survival time in the presence or absence of FLX. The EnSCs were plated into 96 well enzyme linked immunosorbent assay (ELISA) plates, and the differentiation process was repeated as described previously in Section <a href="#sec2.2">2.2</a>. After the differentiation for replacing the culture media, FLX was added to three of the wells and PBS was used as a negative control in three other wells. Culture plates were incubated for one week. During incubation (7d), culture media were replaced with medium, containing FLX, FLX + LY294002, and PBS. Cell viability was assessed by MTT assay kit (Biotium, Hayward, USA). The MTT reagent (10<i></i>L) was added to the wells and incubated for 3h. At the end of the incubation period, the medium was removed and 100<i></i>L DMSO was added into each well. To dissolve the formazan crystals, the supernatant was pipetted several times. Absorbance was measured on an ELISA plate reader at a wavelength of 540nm.</p><h5 id="sec2.7">2.7. Labeling Cell with 5-Bromo-20-deoxyuridine</h5><p> One <i></i>M BrdU was added to the cultures for 6h on the 8th day of FLX induction. The cells were observed on the 9th day of BrdU labeling and then fixed on the 10th day of development and stained for BrdU and Nestin with anti-BrdU monoclonal antibody (Sigma, St. Louis) overnight at 4C and labeled with secondary antibody conjugated with Rhodamine for 120 minutes at room temperature. BrdU and Nestin positive cells were counted in 10 microscopic fields. The percentage and standard deviation of double stained cells among all Nestin positive cells were calculated.</p><h5 id="sec2.8">2.8. Statistical Analyses</h5><p> Data shown were expressed as means  S.D. from data obtained in three independent experiments. MTT and western blot results are obtained from six independent experiments. ANOVA was used to compare the effects of all treatments. Differences of viability within experimental groups were determined by the Mann-Whitney test. Differences were considered statistically significant at <svg height="11.85" id="M1" style="vertical-align:-0.546pt;width:58.712502px;" version="1.1" viewbox="0 0 58.712502 11.85" width="58.712502" xmlns="http://www.w3.org/2000/svg" xmlns:xlink="http://www.w3.org/1999/xlink">
<g transform="matrix(.017,-0,0,-.017,.062,11.113)"><path d="M619 482q0 -69 -40.5 -119t-96 -72.5t-118.5 -26.5h-44l-70 20l-31 -151q-14 -67 0.5 -83t89.5 -22l-5 -28h-287l8 28q65 7 81.5 22t29.5 83l79 398q12 56 0.5 70.5t-78.5 20.5l7 28h255q108 0 164 -43t56 -125zM524 478q0 141 -146 141q-25 0 -47 -8q-16 -6 -20.5 -13.5&#10;t-10.5 -39.5l-43 -241q37 -13 83 -13q67 0 125.5 45t58.5 129z" id="x1D443"></path></g><g transform="matrix(.017,-0,0,-.017,15.582,11.113)"><path d="M531 71l-474 214v50l474 215v-56l-416 -184l416 -183v-56zM531 -40h-474v50h474v-50z" id="x2264"></path></g><g transform="matrix(.017,-0,0,-.017,30.286,11.113)"><path d="M241 635q53 0 94 -28.5t63.5 -76t33.5 -102.5t11 -116q0 -58 -11 -112.5t-34 -103.5t-63.5 -78.5t-94.5 -29.5t-95 28t-64.5 75t-34.5 102.5t-11 118.5q0 58 11.5 112.5t34.5 103t64.5 78t95.5 29.5zM238 602q-32 0 -55.5 -25t-35.5 -68t-17.5 -91t-5.5 -105&#10;q0 -76 10 -138.5t37 -107.5t69 -45q32 0 55.5 25t35.5 68.5t17.5 91.5t5.5 105t-5.5 105.5t-18 92t-36 68t-56.5 24.5z" id="x30"></path></g><g transform="matrix(.017,-0,0,-.017,38.446,11.113)"><path d="M113 -12q-24 0 -39.5 16t-15.5 42q0 24 16 40.5t40 16.5t40 -16.5t16 -40.5q0 -26 -16 -42t-41 -16z" id="x2E"></path></g><g transform="matrix(.017,-0,0,-.017,42.321,11.113)"><use xlink:href="#x30"></use></g><g transform="matrix(.017,-0,0,-.017,50.481,11.113)"><path d="M153 550l-26 -186q79 31 111 31q90 0 141.5 -51t51.5 -119q0 -93 -89 -166q-85 -69 -173 -71q-32 0 -61.5 11.5t-41.5 23.5q-18 17 -17 34q2 16 22 33q14 9 26 -1q61 -50 124 -50q60 0 93 43.5t33 104.5q0 69 -41.5 110t-121.5 41q-53 0 -102 -20l38 305h286l6 -8&#10;l-26 -65h-233z" id="x35"></path></g>
</svg>.</p><h4 id="results">3. Results</h4><h5 id="sec3.1">3.1. Human Endometrial Stem Cell Culture</h5><p> Human EnSCs analysis by FACS showed that more than 90% of the cells were CD146+, CD105+, and CD90+ (Figure <a href="fig1/" target="_blank">1</a>). This test confirms the true isolation of stem cells from the lining womb. To determine whether the hEnSCs could respond to FLX or not, we treated the stem cells with 110<i></i>g serial concentrations of FLX over a period of 10d on collagen precoated and DMSO pretreated plates. In this work, human EnSCs with spindle shaped morphology were cultured (Figure <a href="fig2/#a" target="_blank">2(a)</a>). After 10d, fibroblast-like cells with spindle-shape morphology appeared on culture dishes (Figure <a href="fig2/#b" target="_blank">2(b)</a>). Considering the role of FLX, we investigated its effect on the stem cell differentiation. Dendrite and axon formation and also neurite outgrowth that are phenotypic changes into neural fate were obvious (Figure <a href="fig2/#c" target="_blank">2(c)</a>), and it was comparable with retinoic acid effects as a positive control (Figure <a href="fig2/#d" target="_blank">2(d)</a>).</p><div class="floats-partial-section partial-carousel-wrapper" data-section="fig1"><div class="floats-partial-content fig-content-fig1"><div class="partial-carousel--single-image"><img alt="(a)" name="582526.fig.001a" src="https://static-01.hindawi.com/articles/bmri/volume-2013/582526/figures/582526.fig.001a.jpg" /><br /><strong>(a)</strong></div><div class="partial-carousel--single-image"><img alt="(b)" name="582526.fig.001b" src="https://static-01.hindawi.com/articles/bmri/volume-2013/582526/figures/582526.fig.001b.jpg" /><br /><strong>(b)</strong></div><div class="partial-carousel--single-image"><img alt="(c)" name="582526.fig.001c" src="https://static-01.hindawi.com/articles/bmri/volume-2013/582526/figures/582526.fig.001c.jpg" /><br /><strong>(c)</strong></div></div><div class="floats-partial-middle"><div class="floats-partial-middle--thumbs fig-thumbs-fig1"><button class="partial-carousel-dot" aria-label="(a)"><img alt="(a)" name="582526.fig.001a" src="https://static-01.hindawi.com/articles/bmri/volume-2013/582526/figures/582526.fig.001a.jpg" /><br /><strong>(a)</strong></button><button class="partial-carousel-dot" aria-label="(b)"><img alt="(b)" name="582526.fig.001b" src="https://static-01.hindawi.com/articles/bmri/volume-2013/582526/figures/582526.fig.001b.jpg" /><br /><strong>(b)</strong></button><button class="partial-carousel-dot" aria-label="(c)"><img alt="(c)" name="582526.fig.001c" src="https://static-01.hindawi.com/articles/bmri/volume-2013/582526/figures/582526.fig.001c.jpg" /><br /><strong>(c)</strong></button></div><div class="partial-carousel-next-prev fig-nav-fig1"><button class="carousel-prev" aria-label="Previous"></button><button class="carousel-next" aria-label="Next"></button></div></div><div class="floats-partial-footer"><div class="floats-partial-caption"><span class="caption-text">Figure 1</span><a aria-label="full view" class="caption-partial-url" href="fig1/" title="full view" target="_blank">&nbsp;</a></div><div class="floats-partial-caption-text"><table>Characterization of human endometrial stem cells via fluorescent analyzer cell sorter (FACS). Human EnSCs after the second passage were sorted and analyzed by FACS for CD105<sup>+</sup>, CD146<sup>+</sup>, and CD90<sup>+</sup> markers.</table></div></div></div><div class="floats-partial-section partial-carousel-wrapper" data-section="fig2"><div class="floats-partial-content fig-content-fig2"><div class="partial-carousel--single-image"><img alt="(a)" name="582526.fig.002a" src="https://static-01.hindawi.com/articles/bmri/volume-2013/582526/figures/582526.fig.002a.jpg" /><br /><strong>(a)</strong></div><div class="partial-carousel--single-image"><img alt="(b)" name="582526.fig.002b" src="https://static-01.hindawi.com/articles/bmri/volume-2013/582526/figures/582526.fig.002b.jpg" /><br /><strong>(b)</strong></div><div class="partial-carousel--single-image"><img alt="(c)" name="582526.fig.002c" src="https://static-01.hindawi.com/articles/bmri/volume-2013/582526/figures/582526.fig.002c.jpg" /><br /><strong>(c)</strong></div><div class="partial-carousel--single-image"><img alt="(d)" name="582526.fig.002d" src="https://static-01.hindawi.com/articles/bmri/volume-2013/582526/figures/582526.fig.002d.jpg" /><br /><strong>(d)</strong></div></div><div class="floats-partial-middle"><div class="floats-partial-middle--thumbs fig-thumbs-fig2"><button class="partial-carousel-dot" aria-label="(a)"><img alt="(a)" name="582526.fig.002a" src="https://static-01.hindawi.com/articles/bmri/volume-2013/582526/figures/582526.fig.002a.jpg" /><br /><strong>(a)</strong></button><button class="partial-carousel-dot" aria-label="(b)"><img alt="(b)" name="582526.fig.002b" src="https://static-01.hindawi.com/articles/bmri/volume-2013/582526/figures/582526.fig.002b.jpg" /><br /><strong>(b)</strong></button><button class="partial-carousel-dot" aria-label="(c)"><img alt="(c)" name="582526.fig.002c" src="https://static-01.hindawi.com/articles/bmri/volume-2013/582526/figures/582526.fig.002c.jpg" /><br /><strong>(c)</strong></button><button class="partial-carousel-dot" aria-label="(d)"><img alt="(d)" name="582526.fig.002d" src="https://static-01.hindawi.com/articles/bmri/volume-2013/582526/figures/582526.fig.002d.jpg" /><br /><strong>(d)</strong></button></div><div class="partial-carousel-next-prev fig-nav-fig2"><button class="carousel-prev" aria-label="Previous"></button><button class="carousel-next" aria-label="Next"></button></div></div><div class="floats-partial-footer"><div class="floats-partial-caption"><span class="caption-text">Figure 2</span><a aria-label="full view" class="caption-partial-url" href="fig2/" title="full view" target="_blank">&nbsp;</a></div><div class="floats-partial-caption-text"><table>Morphological characteristics and differentiation of hEnSCs into neural cells. (a) Human EnSC (passage 2) in DMEM low glucose (b), after 10d in DMEM pretreated with DMSO (c), plus 10<i></i>M of FLX and (d) 1<i></i>g/mL of retinoic acid as a positive control (magnification: 400).</table></div></div></div><h5 id="sec3.2">3.2. Expression of Differential Neural Genes</h5><p> The <i>in vitro </i>study is conducted to determine that  the neurogenesis regulating effect could be replicated in cell culture system. One week after the treatment of hEnSCs, we examined the neural markers by RT-PCR. RT-PCR analysis was indicative of the expression of <i>nestin</i>, <i>map-2</i>, and <i><i></i>-tubulin</i> genes as shown in Figure <a href="fig3/" target="_blank">3</a>. </p><div class="floats-partial-section partial-carousel-wrapper" data-section="fig3"><div class="floats-partial-content fig-content-fig3"><div class="partial-carousel--single-image"><img alt="" name="582526.fig.003" src="https://static-01.hindawi.com/articles/bmri/volume-2013/582526/figures/582526.fig.003.jpg" /><br /><strong></strong></div></div><div class="floats-partial-footer"><div class="floats-partial-caption"><span class="caption-text">Figure 3</span><a aria-label="full view" class="caption-partial-url" href="fig3/" title="full view" target="_blank">&nbsp;</a></div><div class="floats-partial-caption-text"><table>Expression of differential genes. Expression of <i>Nestin</i>, <i>Map-2</i>, and <i><i></i>-tubulin </i>neuron markers was analyzed in control culture and FLX (10<i></i>M) treated and induced differentiation culture after 10d.</table></div></div></div><h5 id="sec3.3">3.3. Immunostaining of Neuronal Induced Specific Markers</h5><p>Fluoxetine treated and differentiated mesenchymal stem cells were visualized by the staining of some neuronal markers. Immunocytochemistry was used to analyze the Nestin, MAP-2, and <i></i>-tubulin proteins. The result showed that these proteins were detected after treatment in 10d (Figure <a href="fig4/#a" target="_blank">4(a)</a>). Also a group of cells that were treated with LY294002 as a phosphatidylinositol-3-kinase (PI3-K) inhibitor did not express the neural markers even after 10d treatment by FLX (Figure <a href="fig4/#b" target="_blank">4(b)</a>).</p><div class="floats-partial-section partial-carousel-wrapper" data-section="fig4"><div class="floats-partial-content fig-content-fig4"><div class="partial-carousel--single-image"><img alt="(a)" name="582526.fig.004a" src="https://static-01.hindawi.com/articles/bmri/volume-2013/582526/figures/582526.fig.004a.jpg" /><br /><strong>(a)</strong></div><div class="partial-carousel--single-image"><img alt="(b)" name="582526.fig.004b" src="https://static-01.hindawi.com/articles/bmri/volume-2013/582526/figures/582526.fig.004b.jpg" /><br /><strong>(b)</strong></div></div><div class="floats-partial-middle"><div class="floats-partial-middle--thumbs fig-thumbs-fig4"><button class="partial-carousel-dot" aria-label="(a)"><img alt="(a)" name="582526.fig.004a" src="https://static-01.hindawi.com/articles/bmri/volume-2013/582526/figures/582526.fig.004a.jpg" /><br /><strong>(a)</strong></button><button class="partial-carousel-dot" aria-label="(b)"><img alt="(b)" name="582526.fig.004b" src="https://static-01.hindawi.com/articles/bmri/volume-2013/582526/figures/582526.fig.004b.jpg" /><br /><strong>(b)</strong></button></div><div class="partial-carousel-next-prev fig-nav-fig4"><button class="carousel-prev" aria-label="Previous"></button><button class="carousel-next" aria-label="Next"></button></div></div><div class="floats-partial-footer"><div class="floats-partial-caption"><span class="caption-text">Figure 4</span><a aria-label="full view" class="caption-partial-url" href="fig4/" title="full view" target="_blank">&nbsp;</a></div><div class="floats-partial-caption-text"><table>Immunostaining of hEnSCs differential markers. Expression of neuron markers including Nestin, MAP-2 and <i></i>-tubulin was analyzed in FLX induced differentiation after 10d. The expression of CD11b as a glial marker was not obvious. The size bar is 10<i></i>m (a). Immunostaining of LY294002 treated hEnSCs after culture in FLX supplemented medium. There is not an expression of neuron markers in FLX induced differentiation after 10d (b).</table></div></div></div><p></p><h5 id="sec3.4">3.4. Overexpression of Phosphorylated Akt1</h5><p> Phosphorylation of Akt1 in FLX-treated mesenchymal stem cells as detected by western blot was higher than non-FLX-treated stem cells. Also LY294002 as a PI3-K inhibitor inhibited the phosphorylation of Akt1 significantly (Figure <a href="fig5/" target="_blank">5</a>).</p><div class="floats-partial-section partial-carousel-wrapper" data-section="fig5"><div class="floats-partial-content fig-content-fig5"><div class="partial-carousel--single-image"><img alt="" name="582526.fig.005" src="https://static-01.hindawi.com/articles/bmri/volume-2013/582526/figures/582526.fig.005.jpg" /><br /><strong></strong></div></div><div class="floats-partial-footer"><div class="floats-partial-caption"><span class="caption-text">Figure 5</span><a aria-label="full view" class="caption-partial-url" href="fig5/" title="full view" target="_blank">&nbsp;</a></div><div class="floats-partial-caption-text"><table>Western blot results after treatment of hEnSC with 10<i></i>M fluoxetine after 10d. Protein samples (100<i></i>g) were loaded onto SDS PAGE gels and transferred to PVDF membranes. The induced EnSCs produced an increase expression of phosphorylated Akt1 protein. <i></i>-Actin was used as an internal control.</table></div></div></div><h5 id="sec3.5">3.5. Viability of FLX Treated Cells</h5><p> The effect of FLX on the survival period of the differentiated stem cells was observed directly and investigated by MTT assay. As shown in Figure <a href="fig6/" target="_blank">6</a>, FLX treatment affects the cell survival rate significantly (<svg height="11.375" id="M2" style="vertical-align:-0.1638pt;width:58.712502px;" version="1.1" viewbox="0 0 58.712502 11.375" width="58.712502" xmlns="http://www.w3.org/2000/svg" xmlns:xlink="http://www.w3.org/1999/xlink">
<g transform="matrix(.017,-0,0,-.017,.062,11.112)"><use xlink:href="#x1D443"></use></g><g transform="matrix(.017,-0,0,-.017,15.582,11.112)"><path d="M512 -3l-437 233v51l437 233v-58l-378 -200v-2l378 -199v-58z" id="x3C"></path></g><g transform="matrix(.017,-0,0,-.017,30.286,11.112)"><use xlink:href="#x30"></use></g><g transform="matrix(.017,-0,0,-.017,38.446,11.112)"><use xlink:href="#x2E"></use></g><g transform="matrix(.017,-0,0,-.017,42.321,11.112)"><use xlink:href="#x30"></use></g><g transform="matrix(.017,-0,0,-.017,50.481,11.112)"><use xlink:href="#x35"></use></g>
</svg>) higher than all other groups. While the retinoic acid strongly suppressed cell survival in this assay, the suppressive effect of FLX on differentiated stem cells was very low. The continuance of FLX treatment extended the time and percentage of cell viability (Figure <a href="fig6/" target="_blank">6</a>). The BrdU labeled cells were observed 24h after labeling that showed over 90% of hEnSCs were BrdU positive (Figure <a href="fig7/#a" target="_blank">7(a)</a>). The amounts of Nestin-BrdU positive cells were determined on the 10th day in cultures. The percentage of double stained cells among all Nestin positive cells and standard deviation were calculated from data of 10 microscopic fields. Cultures treated with BrdU and fixed on the 10th day contained about 60% double stained positive cells (Figure <a href="fig7/#b" target="_blank">7(b)</a>).</p><div class="floats-partial-section partial-carousel-wrapper" data-section="fig6"><div class="floats-partial-content fig-content-fig6"><div class="partial-carousel--single-image"><img alt="" name="582526.fig.006" src="https://static-01.hindawi.com/articles/bmri/volume-2013/582526/figures/582526.fig.006.jpg" /><br /><strong></strong></div></div><div class="floats-partial-footer"><div class="floats-partial-caption"><span class="caption-text">Figure 6</span><a aria-label="full view" class="caption-partial-url" href="fig6/" title="full view" target="_blank">&nbsp;</a></div><div class="floats-partial-caption-text"><table>MTT shows EnSCs differentiated neural cell viability rate in the presence of FLX, FLX + LY294002, LY294002, and retinoic acid after one week (<svg height="11.85" id="M3" style="vertical-align:-0.546pt" version="1.1" viewbox="0 0 58.712502 11.85" width="58.712502" xmlns="http://www.w3.org/2000/svg" xmlns:xlink="http://www.w3.org/1999/xlink">
<g transform="matrix(.017,-0,0,-.017,.062,11.113)"><path d="M619 482q0 -69 -40.5 -119t-96 -72.5t-118.5 -26.5h-44l-70 20l-31 -151q-14 -67 0.5 -83t89.5 -22l-5 -28h-287l8 28q65 7 81.5 22t29.5 83l79 398q12 56 0.5 70.5t-78.5 20.5l7 28h255q108 0 164 -43t56 -125zM524 478q0 141 -146 141q-25 0 -47 -8q-16 -6 -20.5 -13.5&#10;t-10.5 -39.5l-43 -241q37 -13 83 -13q67 0 125.5 45t58.5 129z" id="x1D443"></path></g><g transform="matrix(.017,-0,0,-.017,15.582,11.113)"><path d="M531 71l-474 214v50l474 215v-56l-416 -184l416 -183v-56zM531 -40h-474v50h474v-50z" id="x2264"></path></g><g transform="matrix(.017,-0,0,-.017,30.286,11.113)"><path d="M241 635q53 0 94 -28.5t63.5 -76t33.5 -102.5t11 -116q0 -58 -11 -112.5t-34 -103.5t-63.5 -78.5t-94.5 -29.5t-95 28t-64.5 75t-34.5 102.5t-11 118.5q0 58 11.5 112.5t34.5 103t64.5 78t95.5 29.5zM238 602q-32 0 -55.5 -25t-35.5 -68t-17.5 -91t-5.5 -105&#10;q0 -76 10 -138.5t37 -107.5t69 -45q32 0 55.5 25t35.5 68.5t17.5 91.5t5.5 105t-5.5 105.5t-18 92t-36 68t-56.5 24.5z" id="x30"></path></g><g transform="matrix(.017,-0,0,-.017,38.446,11.113)"><path d="M113 -12q-24 0 -39.5 16t-15.5 42q0 24 16 40.5t40 16.5t40 -16.5t16 -40.5q0 -26 -16 -42t-41 -16z" id="x2E"></path></g><g transform="matrix(.017,-0,0,-.017,42.321,11.113)"><path d="M241 635q53 0 94 -28.5t63.5 -76t33.5 -102.5t11 -116q0 -58 -11 -112.5t-34 -103.5t-63.5 -78.5t-94.5 -29.5t-95 28t-64.5 75t-34.5 102.5t-11 118.5q0 58 11.5 112.5t34.5 103t64.5 78t95.5 29.5zM238 602q-32 0 -55.5 -25t-35.5 -68t-17.5 -91t-5.5 -105&#10;q0 -76 10 -138.5t37 -107.5t69 -45q32 0 55.5 25t35.5 68.5t17.5 91.5t5.5 105t-5.5 105.5t-18 92t-36 68t-56.5 24.5z" id="x30"></path></g><g transform="matrix(.017,-0,0,-.017,50.481,11.113)"><path d="M153 550l-26 -186q79 31 111 31q90 0 141.5 -51t51.5 -119q0 -93 -89 -166q-85 -69 -173 -71q-32 0 -61.5 11.5t-41.5 23.5q-18 17 -17 34q2 16 22 33q14 9 26 -1q61 -50 124 -50q60 0 93 43.5t33 104.5q0 69 -41.5 110t-121.5 41q-53 0 -102 -20l38 305h286l6 -8&#10;l-26 -65h-233z" id="x35"></path></g>
</svg>). The numbers from the left side are as follows: (1) 1<i></i>M FLX, (2) 5<i></i>M FLX, (3) 10<i></i>M FLX, (4) 10<i></i>M FLX + 10<i></i>M LY294002, (5) 10<i></i>M LY294002, (6) 1<i></i>M retinoic acid, (7) neural differentiated cells without FLX supplement, and (8) undifferentiated mesenchymal stem cells.</table></div></div></div><div class="floats-partial-section partial-carousel-wrapper" data-section="fig7"><div class="floats-partial-content fig-content-fig7"><div class="partial-carousel--single-image"><img alt="(a)" name="582526.fig.007a" src="https://static-01.hindawi.com/articles/bmri/volume-2013/582526/figures/582526.fig.007a.jpg" /><br /><strong>(a)</strong></div><div class="partial-carousel--single-image"><img alt="(b)" name="582526.fig.007b" src="https://static-01.hindawi.com/articles/bmri/volume-2013/582526/figures/582526.fig.007b.jpg" /><br /><strong>(b)</strong></div></div><div class="floats-partial-middle"><div class="floats-partial-middle--thumbs fig-thumbs-fig7"><button class="partial-carousel-dot" aria-label="(a)"><img alt="(a)" name="582526.fig.007a" src="https://static-01.hindawi.com/articles/bmri/volume-2013/582526/figures/582526.fig.007a.jpg" /><br /><strong>(a)</strong></button><button class="partial-carousel-dot" aria-label="(b)"><img alt="(b)" name="582526.fig.007b" src="https://static-01.hindawi.com/articles/bmri/volume-2013/582526/figures/582526.fig.007b.jpg" /><br /><strong>(b)</strong></button></div><div class="partial-carousel-next-prev fig-nav-fig7"><button class="carousel-prev" aria-label="Previous"></button><button class="carousel-next" aria-label="Next"></button></div></div><div class="floats-partial-footer"><div class="floats-partial-caption"><span class="caption-text">Figure 7</span><a aria-label="full view" class="caption-partial-url" href="fig7/" title="full view" target="_blank">&nbsp;</a></div><div class="floats-partial-caption-text"><table>Endometrial stem cells labeled by BrdU (a). Cultures were treated with FLX and labeled with BrdU. They were then stained with antibodies against BrdU and nestin, followed by either rhodamine- (for BrdU, red) or FITC- (nestin, green) labeled secondary antibodies (b). Data are representative of 3 independent experiments.</table></div></div></div><h4 id="discussion">4. Discussion</h4><p>  Differentiation of mesenchymal stem cells into a specific lineage, their survival, and functionality are related to molecular regulation. The main finding of this research is that the fluoxetine antidepressant could induce neurogenesis in mesenchymal stem cells and upregulate the phosphorylation of serine/threonine kinase Akt1, and therefore it could be a differentiation and proliferation signaling mediator in cell therapy. </p><p>  Selective serotonin reuptake inhibitors like FLX facilitate signaling of serotonin by inhibiting its reuptake. At the molecular levels, FLX increases synaptic availability of serotonin [<a href="#B14">14</a>]. It has been shown that FLX could inhibit or activate PI3k/Akt or ERK1/2 pathways depending on the cell types and their function [<a href="#B15">15</a><a href="#B17">17</a>]. So it could have a dual role in the cancer therapy and cell therapy in regenerative medicine. For this purpose, we selected the Akt signaling to determine its role in mesenchymal stem cell proliferation, differentiation, and survival. </p><p>  First, our <i>in vitro </i>study was conducted to determine the possibility of neurogenesis by FLX in the mesenchymal stem cell system (Figures <a href="fig2/#a" target="_blank">2(a)</a> and <a href="fig2/#b" target="_blank">2(b)</a>). Our results demonstrated that hEnSCs could be induced to differentiate into neurons in the presence of FLX (Figure <a href="fig2/#c" target="_blank">2(c)</a>) as was seen in cells treated with retinoic acid (Figure <a href="fig2/#d" target="_blank">2(d)</a>). High concentrations of FLX have nonserotoninergic effects on cells [<a href="#B5">5</a>]. Nonserotoninergic targets of fluoxetine that mediate its other effects are likely to have a lower binding affinity or lower availability for FLX. Inhibition of cytochrome P450 is known to be due to a nonserotoninergic effect of FLX [<a href="#B18">18</a>]. Lee et al. (2008) showed that liver cytochrome P450-dependent ROS formation is responsible for cyclin-A downregulation and inhibition of neural progenitor cell proliferation [<a href="#B19">19</a>] so inhibition of cytochrome P450 may inhibit cyclin-A downregulation and restoring cyclin-A reverse inhibition of neural progenitor cell proliferation. However, this induction did not occur in the brain and suggested a tissue-specific response [<a href="#B20">20</a>]. It has been demonstrated that the SSRIs interact with the <i>eag </i>voltage-gated K<sub>1</sub> channel [<a href="#B21">21</a>], and  voltage-gated potassium channels play a functional role in the development of human neural progenitor cells and differentiation of neurons [<a href="#B22">22</a>]. Also studies by de Oliveira and colleagues in 2012 showed that <i>eag</i> potassium channel expression in the rat hippocampus has been associated with neural cell survival and transient brain ischemia [<a href="#B23">23</a>]. </p><p>  In our experiment, fluoxetine-induced hEnSCs displayed neuronal morphology with axon formation and neurite outgrowth and expressed Nestin and other neuronal specific molecular markers by the reverse transcriptase polymerase chain reaction (Figure <a href="fig3/" target="_blank">3</a>) and immunocytochemistry (Figure <a href="fig4/#a" target="_blank">4(a)</a>) assays. EnSCs cultured in serum-free DMEM/F12 medium could not differentiate or even proliferated constantly. These findings indicate FLX-induced EnSCs may provide a stem-cell-based way to generate neuronal cells for the treatment of neurodegenerative diseases. This finding could determine that the endometrial stem cells express serotonin receptors. In neuropharmacology, it may be beneficial to study the effect of the different antidepressants on the neurogenesis since this provides insights into the regulation of stem cell proliferation. </p><p>  Regeneration of neurons that undergo cell death soon after injury is the main goal of all cell-based therapies. From the point that neurogenesis has the capacity to enhance brain repair and/or spinal cord repair after ischemia and/or trauma by replacement of dead cells or seriously injured cells FLX neurogenesis could lead to recovery of these cells. FLX would appear to be a candidate as a neurogenesis factor. Our experiment showed that the hEnSCs expressed neural cell markers after FLX treatment, but there was no expression of CD11b marker that is a specific glial marker (Figure <a href="fig4/#a" target="_blank">4(a)</a>). This is an important point because glial scar formation that occurs following CNS injuries is an important obstacle of neuroregeneration. FLX could introduce a regenerative product in neuronal injuries and find its position in regenerative pharmacology.</p><p>  Many groups have examined the potential of neuron replacement from embryonic stem cells [<a href="#B24">24</a>], induced pluripotent stem cells (iPS) [<a href="#B25">25</a>, <a href="#B26">26</a>], and cord blood derived stem cells. Endometrial stem cells have demonstrated superior potential. They expand rapidly and they have fewer technical and ethical problems so they have great potential as therapeutic agents and autologous grafts [<a href="#B2">2</a>]. Our team has previously shown that the endometrial stem cells could be differentiated successfully into other lineages of cells especially neural cells [<a href="#B1">1</a>, <a href="#B11">11</a>]. It represents a progress in the development of a new source of neurons. </p><p>  We further confirmed the protective mechanisms of Akt1 phosphorylation as a survival signaling that introduces this pathway as a potential target for stem cell survival after differentiation of mesenchymal stem cells (Figure <a href="fig6/" target="_blank">6</a>). PI3k/Akt is the important cell survival pathways and phosphorylation of Akt mediates anti-apoptosis in many kinds of cells [<a href="#B27">27</a>]. In 2003, Kim et al. have shown that the Akt activation results in phosphorylation and then inactivation of the pro-apoptotic protein glycogen synthase kinase 3 (GSK3b), thus extending the cell survival period [<a href="#B28">28</a>]. In support of the role of Akt1 phosphorylation, we found that the PI3K inhibitor LY294002 in the concentration of 10<i></i>M decreased the FLX mediated Akt phosphorylation (Figure <a href="fig5/" target="_blank">5</a>), differentiation (Figure <a href="fig4/#b" target="_blank">4(b)</a>), and the viability of neuronal differentiated cells (Figure <a href="fig6/" target="_blank">6</a>). This suggests a key role for activating Akt1 in the protection of mesenchymal stem cell from the precocious death. Also we have labeled the hEnSCs with BrdU to obtain more exact cell proliferation rate (Figure <a href="fig7/#a" target="_blank">7(a)</a>). The FLX treated stem cells that were labeled with BrdU showed double-staining for both BrdU and Nestin on the 10th day. Cells acquiring Nestin positive phenotype seemed to go through cell cycles enough to dilute the BrdU label to the non-detectable levels. In our experiment, BrdU was added on the 8th day of induction, and about half of nestin positive cells carried BrdU-label on the 10th day (Figure <a href="fig7/#b" target="_blank">7(b)</a>). In cultures that FLX was absent about 70% of Nestin positive cells carried BrdU-label.</p><p>  In 2006, Frebel and Wiese confirmed the neuronal survival and differentiation implicated PI3-K/AKT in synaptic plasticity, learning, and memory in the mammalian brain [<a href="#B29">29</a>].</p><p>  Although this finding supports the neurogenesis role of SSRIs, it has been suggested that excessive neurogenesis is not beneficial and could result in inappropriate migration into existing neural networks. Scharfman and Hen believe that this manner could cause some pathological conditions as epilepsy [<a href="#B30">30</a>], but previously Rush et al. reporting that SSRIs could lose their effect after long-term use [<a href="#B31">31</a>]. This has been called relapse during maintenance treatment. A possible mechanism underlying this effect is the weakness of neurogenesis because of excessive stimulation. So it is possible that long-term SSRI therapy might affect PI3/Akt pathway and its activation that leads to cognitive functions by disrupting the normal regulation of neurogenesis.</p><h4 id="conclusion">5. Conclusion</h4><p>   In conclusion our data argue with fluoxetine effect on mesenchymal stem cell neurogenesis and its role in the phosphorylation of Akt1 in the differentiated cells to increase the survival rate of differentiated cells.</p><h4 id="conflict-of-interests">Conflict of Interests</h4><p> The authors have no conflict of interests.</p></div><div class="xml-content"><h4 class="references" id="references">References</h4><ol><li id="B1">M. Noureddini, J. Verdi, S. A. Mortazavi Tabatabaei, S. Sharif, and A. Shoae Hassani, Human endometrial stem cell neurogenesis in response to NGF and bFGF, <i>Cell Biology International</i>, vol. 36, no. 1, pp. 961966, 2012. <span class="reflinks">View at: <a href="https://scholar.google.com/scholar_lookup?title=Human%20endometrial%20stem%20cell%20neurogenesis%20in%20response%20to%20NGF%20and%20bFGF&author=M. Noureddini&author=J. Verdi&author=S. A. Mortazavi Tabatabaei&author=S. Sharif&author=&author=A. Shoae Hassani&publication_year=2012" target="_blank">Google Scholar</a></span><li id="B2">A. Shoae-Hassani, S. A. Mortazavi-Tabatabaei, S. Sharif, H. Rezaei-Khaligh, and J. Verdi, DHEA provides a microenvironment for endometrial stem cells neurogenesis, <i>Medical Hypotheses</i>, vol. 76, no. 6, pp. 843846, 2011. <span class="reflinks">View at: <a href="https://doi.org/10.1016/j.mehy.2011.02.033">Publisher Site</a><span class ="sep"> | </span><a href="https://scholar.google.com/scholar_lookup?title=DHEA%20provides%20a%20microenvironment%20for%20endometrial%20stem%20cells%20neurogenesis&author=A. Shoae-Hassani&author=S. A. Mortazavi-Tabatabaei&author=S. Sharif&author=H. Rezaei-Khaligh&author=&author=J. Verdi&publication_year=2011" target="_blank">Google Scholar</a></span><li id="B3">H. A. Cameron, Adult neurogenesis is regulated by adrenal steroids in the dentate gyrus, <i>Neuroscience</i>, vol. 61, no. 2, pp. 203209, 1994. <span class="reflinks">View at: <a href="https://doi.org/10.1016/0306-4522(94)90224-0">Publisher Site</a><span class ="sep"> | </span><a href="https://scholar.google.com/scholar_lookup?title=Adult%20neurogenesis%20is%20regulated%20by%20adrenal%20steroids%20in%20the%20dentate%20gyrus&author=H. A. Cameron&publication_year=1994" target="_blank">Google Scholar</a></span><li id="B4">P.-M. Lledo, M. Alonso, and M. S. Grubb, Adult neurogenesis and functional plasticity in neuronal circuits, <i>Nature Reviews Neuroscience</i>, vol. 7, no. 3, pp. 179193, 2006. <span class="reflinks">View at: <a href="https://doi.org/10.1038/nrn1867">Publisher Site</a><span class ="sep"> | </span><a href="https://scholar.google.com/scholar_lookup?title=Adult%20neurogenesis%20and%20functional%20plasticity%20in%20neuronal%20circuits&author=P.-M. Lledo&author=M. Alonso&author=&author=M. S. Grubb&publication_year=2006" target="_blank">Google Scholar</a></span><li id="B5">R. Ranganathan, E. R. Sawin, C. Trent, and H. R. Horvitz, Mutations in the <i>Caenorhabditis elegans</i>serotonin reuptake transporter MOD-5 reveal serotonin-dependent and -independent activities of fluoxetine, <i>Journal of Neuroscience</i>, vol. 21, no. 16, pp. 58715884, 2001. <span class="reflinks">View at: <a href="https://scholar.google.com/scholar_lookup?title=Mutations%20in%20the%20Caenorhabditis%20elegansserotonin%20reuptake%20transporter%20MOD-5%20reveal%20serotonin-dependent%20and%20-independent%20activities%20of%20fluoxetine&author=R. Ranganathan&author=E. R. Sawin&author=C. Trent&author=&author=H. R. Horvitz&publication_year=2001" target="_blank">Google Scholar</a></span><li id="B6">A. Abdipranoto, S. Wu, S. Stayte, and B. Vissel, The role of neurogenesis in neurodegenerative diseases and its implications for therapeutic development, <i>CNS and Neurological Disorders-Drug Targets</i>, vol. 7, no. 2, pp. 187210, 2008. <span class="reflinks">View at: <a href="https://doi.org/10.2174/187152708784083858">Publisher Site</a><span class ="sep"> | </span><a href="https://scholar.google.com/scholar_lookup?title=The%20role%20of%20neurogenesis%20in%20neurodegenerative%20diseases%20and%20its%20implications%20for%20therapeutic%20development&author=A. Abdipranoto&author=S. Wu&author=S. Stayte&author=&author=B. Vissel&publication_year=2008" target="_blank">Google Scholar</a></span><li id="B7">H. Dudek, S. R. Datta, T. F. Franke et al., Regulation of neuronal survival by the serine-threonine protein kinase Akt, <i>Science</i>, vol. 275, no. 5300, pp. 661665, 1997. <span class="reflinks">View at: <a href="https://doi.org/10.1126/science.275.5300.661">Publisher Site</a><span class ="sep"> | </span><a href="https://scholar.google.com/scholar_lookup?title=Regulation%20of%20neuronal%20survival%20by%20the%20serine-threonine%20protein%20kinase%20Akt&author=H. Dudek&author=S. R. Datta&author=T. F. Franke et al.&publication_year=1997" target="_blank">Google Scholar</a></span><li id="B8">S. G. Kennedy, E. S. Kandel, T. K. Cross, and N. Hay, Akt/protein kinase B inhibits cell death by preventing the release of cytochrome C from mitochondria, <i>Molecular and Cellular Biology</i>, vol. 19, no. 8, pp. 58005810, 1999. <span class="reflinks">View at: <a href="https://scholar.google.com/scholar_lookup?title=Akt/protein%20kinase%20B%20inhibits%20cell%20death%20by%20preventing%20the%20release%20of%20cytochrome%20C%20from%20mitochondria&author=S. G. Kennedy&author=E. S. Kandel&author=T. K. Cross&author=&author=N. Hay&publication_year=1999" target="_blank">Google Scholar</a></span><li id="B9">A. Brunet, S. R. Datta, and M. E. Greenberg, Transcription-dependent and&#x2014;independent control of neuronal survival by the PI3K-Akt signaling pathway, <i>Current Opinion in Neurobiology</i>, vol. 11, no. 3, pp. 297305, 2001. <span class="reflinks">View at: <a href="https://doi.org/10.1016/S0959-4388(00)00211-7">Publisher Site</a><span class ="sep"> | </span><a href="https://scholar.google.com/scholar_lookup?title=Transcription-dependent%20andindependent%20control%20of%20neuronal%20survival%20by%20the%20PI3K-Akt%20signaling%20pathway&author=A. Brunet&author=S. R. Datta&author=&author=M. E. Greenberg&publication_year=2001" target="_blank">Google Scholar</a></span><li id="B10">T. F. Franke, C. P. Hornik, L. Segev, G. A. Shostak, and C. Sugimoto, PI3K/Akt and apoptosis: size matters, <i>Oncogene</i>, vol. 22, no. 56, pp. 89838998, 2003. <span class="reflinks">View at: <a href="https://doi.org/10.1038/sj.onc.1207115">Publisher Site</a><span class ="sep"> | </span><a href="https://scholar.google.com/scholar_lookup?title=PI3K/Akt%20and%20apoptosis:%20size%20matters&author=T. F. Franke&author=C. P. Hornik&author=L. Segev&author=G. A. Shostak&author=&author=C. Sugimoto&publication_year=2003" target="_blank">Google Scholar</a></span><li id="B11">A. Shoae-Hassani, A. M. Seifalian, S. A. Mortazavi-Tabatabaei, S. Sharif, A. Azimi, and J. Verdi, Differentiation of human endometrial stem cells into urothelial cells on a three-dimensional nanofibrous silk-collagen scaffold: an autologous cell resource for reconstruction of the urinary bladder wall, <i>Journal of Tissue Engineering and Regenerative Medicine</i>, 2013. <span class="reflinks">View at: <a href="https://doi.org/10.1002/term.1632">Publisher Site</a><span class ="sep"> | </span><a href="https://scholar.google.com/scholar_lookup?title=Differentiation%20of%20human%20endometrial%20stem%20cells%20into%20urothelial%20cells%20on%20a%20three-dimensional%20nanofibrous%20silk-collagen%20scaffold:%20an%20autologous%20cell%20resource%20for%20reconstruction%20of%20the%20urinary%20bladder%20wall&author=A. Shoae-Hassani&author=A. M. Seifalian&author=S. A. Mortazavi-Tabatabaei&author=S. Sharif&author=A. Azimi&author=&author=J. Verdi&publication_year=2013" target="_blank">Google Scholar</a></span><li id="B12">C. E. Gargett, Uterine stem cells: what is the evidence? <i>Human Reproduction Update</i>, vol. 13, no. 1, pp. 87101, 2007. <span class="reflinks">View at: <a href="https://doi.org/10.1093/humupd/dml045">Publisher Site</a><span class ="sep"> | </span><a href="https://scholar.google.com/scholar_lookup?title=Uterine%20stem%20cells:%20what%20is%20the%20evidence?&author=C. E. Gargett&publication_year=2007" target="_blank">Google Scholar</a></span><li id="B13">A. Shoae-Hassani, S. A. Mortazavi-Tabatabaei, S. Sharif, S. Madadi, H. Rezaei-Khaligh, and J. Verdi, Recombinant lambda bacteriophage displaying nanobody towards third domain of Her-II epitope inhibits proliferation of breast carcinoma SKBR-3 cell line, <i>Archivum Immunologiae et Therapiae Experimentalis</i>, vol. 61, no. 1, pp. 7583, 2013. <span class="reflinks">View at: <a href="https://doi.org/10.1007/s00005-012-0206-x">Publisher Site</a><span class ="sep"> | </span><a href="https://scholar.google.com/scholar_lookup?title=Recombinant%20lambda%20bacteriophage%20displaying%20nanobody%20towards%20third%20domain%20of%20Her-II%20epitope%20inhibits%20proliferation%20of%20breast%20carcinoma%20SKBR-3%20cell%20line&author=A. Shoae-Hassani&author=S. A. Mortazavi-Tabatabaei&author=S. Sharif&author=S. Madadi&author=H. Rezaei-Khaligh&author=&author=J. Verdi&publication_year=2013" target="_blank">Google Scholar</a></span><li id="B14">F. Karege, M. Schwald, and M. Cisse, Postnatal developmental profile of brain-derived neurotrophic factor in rat brain and platelets, <i>Neuroscience Letters</i>, vol. 328, no. 3, pp. 261264, 2002. <span class="reflinks">View at: <a href="https://doi.org/10.1016/S0304-3940(02)00529-3">Publisher Site</a><span class ="sep"> | </span><a href="https://scholar.google.com/scholar_lookup?title=Postnatal%20developmental%20profile%20of%20brain-derived%20neurotrophic%20factor%20in%20rat%20brain%20and%20platelets&author=F. Karege&author=M. Schwald&author=&author=M. Cisse&publication_year=2002" target="_blank">Google Scholar</a></span><li id="B15">G. Mercier, A. M. Lennon, B. Renouf et al., MAP kinase activation by fluoxetine and its relation to gene expression in cultured rat astrocytes, <i>Journal of Molecular Neuroscience</i>, vol. 24, no. 2, pp. 207216, 2004. <span class="reflinks">View at: <a href="https://doi.org/10.1385/JMN:24:2:207">Publisher Site</a><span class ="sep"> | </span><a href="https://scholar.google.com/scholar_lookup?title=MAP%20kinase%20activation%20by%20fluoxetine%20and%20its%20relation%20to%20gene%20expression%20in%20cultured%20rat%20astrocytes&author=G. Mercier&author=A. M. Lennon&author=B. Renouf et al.&publication_year=2004" target="_blank">Google Scholar</a></span><li id="B16">F. Fumagalli, R. Molteni, F. Calabrese, A. Frasca, G. Racagni, and M. A. Riva, Chronic fluoxetine administration inhibits extracellular signal-regulated kinase 1/2 phosphorylation in rat brain, <i>Journal of Neurochemistry</i>, vol. 93, no. 6, pp. 15511560, 2005. <span class="reflinks">View at: <a href="https://doi.org/10.1111/j.1471-4159.2005.03149.x">Publisher Site</a><span class ="sep"> | </span><a href="https://scholar.google.com/scholar_lookup?title=Chronic%20fluoxetine%20administration%20inhibits%20extracellular%20signal-regulated%20kinase%201/2%20phosphorylation%20in%20rat%20brain&author=F. Fumagalli&author=R. Molteni&author=F. Calabrese&author=A. Frasca&author=G. Racagni&author=&author=M. A. Riva&publication_year=2005" target="_blank">Google Scholar</a></span><li id="B17">E. Ha, K. H. Jung, B.-K. Choe et al., Fluoxetine increases the nitric oxide production via nuclear factor kappa B-mediated pathway in BV2 murine microglial cells, <i>Neuroscience Letters</i>, vol. 397, no. 3, pp. 185189, 2006. <span class="reflinks">View at: <a href="https://doi.org/10.1016/j.neulet.2005.12.022">Publisher Site</a><span class ="sep"> | </span><a href="https://scholar.google.com/scholar_lookup?title=Fluoxetine%20increases%20the%20nitric%20oxide%20production%20via%20nuclear%20factor%20kappa%20B-mediated%20pathway%20in%20BV2%20murine%20microglial%20cells&author=E. Ha&author=K. H. Jung&author=B.-K. Choe et al.&publication_year=2006" target="_blank">Google Scholar</a></span><li id="B18">R. K. Choy and J. H. Thomas, Fluoxetine-resistant mutants in <i>C. elegans</i> define a novel family of transmembrane proteins, <i>Molecular Cell</i>, vol. 4, no. 2, pp. 143152, 1999. <span class="reflinks">View at: <a href="https://doi.org/10.1016/S1097-2765(00)80362-7">Publisher Site</a><span class ="sep"> | </span><a href="https://scholar.google.com/scholar_lookup?title=Fluoxetine-resistant%20mutants%20in%20C.%20elegans%20define%20a%20novel%20family%20of%20transmembrane%20proteins&author=R. K. Choy &author=J. H. Thomas&publication_year=1999" target="_blank">Google Scholar</a></span><li id="B19">C.-T. Lee, J. Chen, T. Hayashi et al., A mechanism for the inhibition of neural progenitor cell proliferation by cocaine, <i>PLoS Medicine</i>, vol. 5, no. 6, article e117, 2008. <span class="reflinks">View at: <a href="https://doi.org/10.1371/journal.pmed.0050117">Publisher Site</a><span class ="sep"> | </span><a href="https://scholar.google.com/scholar_lookup?title=A%20mechanism%20for%20the%20inhibition%20of%20neural%20progenitor%20cell%20proliferation%20by%20cocaine&author=C.-T. Lee&author=J. Chen&author=T. Hayashi et al.&publication_year=2008" target="_blank">Google Scholar</a></span><li id="B20">W. J. Ray, G. Bain, M. Yao, and D. I. Gottlieb, CYP26, a novel mammalian cytochrome P450, is induced by retinoic acid and defines a new family, <i>Journal of Biological Chemistry</i>, vol. 272, no. 30, pp. 1870218708, 1997. <span class="reflinks">View at: <a href="https://doi.org/10.1074/jbc.272.30.18702">Publisher Site</a><span class ="sep"> | </span><a href="https://scholar.google.com/scholar_lookup?title=CYP26,%20a%20novel%20mammalian%20cytochrome%20P450,%20is%20induced%20by%20retinoic%20acid%20and%20defines%20a%20new%20family&author=W. J. Ray&author=G. Bain&author=M. Yao&author=&author=D. I. Gottlieb&publication_year=1997" target="_blank">Google Scholar</a></span><li id="B21">D. Weinshenker, G. Garriga, and J. H. Thomas, Genetic and pharmacological analysis of neurotransmitters controlling egg laying in <i>C. elegans</i>, <i>Journal of Neuroscience</i>, vol. 15, no. 10, pp. 69756985, 1995. <span class="reflinks">View at: <a href="https://scholar.google.com/scholar_lookup?title=Genetic%20and%20pharmacological%20analysis%20of%20neurotransmitters%20controlling%20egg%20laying%20in%20C.%20elegans&author=D. Weinshenker&author=G. Garriga&author=&author=J. H. Thomas&publication_year=1995" target="_blank">Google Scholar</a></span><li id="B22">G. Schaarschmidt, F. Wegner, S. C. Schwarz, H. Schmidt, and J. Schwarz, Characterization of voltage-gated potassium channels in human neural progenitor cells, <i>PLoS ONE</i>, vol. 4, no. 7, Article ID e6168, 2009. <span class="reflinks">View at: <a href="https://doi.org/10.1371/journal.pone.0006168">Publisher Site</a><span class ="sep"> | </span><a href="https://scholar.google.com/scholar_lookup?title=Characterization%20of%20voltage-gated%20potassium%20channels%20in%20human%20neural%20progenitor%20cells&author=G. Schaarschmidt&author=F. Wegner&author=S. C. Schwarz&author=H. Schmidt&author=&author=J. Schwarz&publication_year=2009" target="_blank">Google Scholar</a></span><li id="B23">R. M. W. de Oliveira, S. Martin, C. L. de Oliveira et al., Eag1, Eag2, and SK3 potassium channel expression in the rat hippocampus after global transient brain ischemia, <i>Journal of Neuroscience Research</i>, vol. 90, no. 3, pp. 632640, 2012. <span class="reflinks">View at: <a href="https://doi.org/10.1002/jnr.22772">Publisher Site</a><span class ="sep"> | </span><a href="https://scholar.google.com/scholar_lookup?title=Eag1,%20Eag2,%20and%20SK3%20potassium%20channel%20expression%20in%20the%20rat%20hippocampus%20after%20global%20transient%20brain%20ischemia&author=R. M. W. de Oliveira&author=S. Martin&author=C. L. de Oliveira et al.&publication_year=2012" target="_blank">Google Scholar</a></span><li id="B24">M. S. Cho, Y.-E. Lee, J. Y. Kim et al., Highly efficient and large-scale generation of functional dopamine neurons from human embryonic stem cells, <i>Proceedings of the National Academy of Sciences of the United States of America</i>, vol. 105, no. 9, pp. 33923397, 2008. <span class="reflinks">View at: <a href="https://doi.org/10.1073/pnas.0712359105">Publisher Site</a><span class ="sep"> | </span><a href="https://scholar.google.com/scholar_lookup?title=Highly%20efficient%20and%20large-scale%20generation%20of%20functional%20dopamine%20neurons%20from%20human%20embryonic%20stem%20cells&author=M. S. Cho&author=Y.-E. Lee&author=J. Y. Kim et al.&publication_year=2008" target="_blank">Google Scholar</a></span><li id="B25">Y.-H. Rhee, J.-Y. Ko, M.-Y. Chang et al., Protein-based human iPS cells efficiently generate functional dopamine neurons and can treat a rat model of Parkinson disease, <i>Journal of Clinical Investigation</i>, vol. 121, no. 6, pp. 23262335, 2011. <span class="reflinks">View at: <a href="https://doi.org/10.1172/JCI45794">Publisher Site</a><span class ="sep"> | </span><a href="https://scholar.google.com/scholar_lookup?title=Protein-based%20human%20iPS%20cells%20efficiently%20generate%20functional%20dopamine%20neurons%20and%20can%20treat%20a%20rat%20model%20of%20Parkinson%20disease&author=Y.-H. Rhee&author=J.-Y. Ko&author=M.-Y. Chang et al.&publication_year=2011" target="_blank">Google Scholar</a></span><li id="B26">A. Shoae-Hassani, S. Sharif, and J. Verdi, The neurosteroid dehydroepiandrosterone could improve somatic cell reprogramming, <i>Cell Biology International</i>, vol. 35, no. 1, pp. 10371041, 2011. <span class="reflinks">View at: <a href="https://doi.org/10.1042/CBI20100927">Publisher Site</a><span class ="sep"> | </span><a href="https://scholar.google.com/scholar_lookup?title=The%20neurosteroid%20dehydroepiandrosterone%20could%20improve%20somatic%20cell%20reprogramming&author=A. Shoae-Hassani&author=S. Sharif&author=&author=J. Verdi&publication_year=2011" target="_blank">Google Scholar</a></span><li id="B27">D. S. Kwon, C. H. Kwon, J. H. Kim, J. S. Woo, J. S. Jung, and Y. K. Kim, Signal transduction of MEK/ERK and PI3K/Akt activation by hypoxia/reoxygenation in renal epithelial cells, <i>European Journal of Cell Biology</i>, vol. 85, no. 11, pp. 11891199, 2006. <span class="reflinks">View at: <a href="https://doi.org/10.1016/j.ejcb.2006.06.001">Publisher Site</a><span class ="sep"> | </span><a href="https://scholar.google.com/scholar_lookup?title=Signal%20transduction%20of%20MEK/ERK%20and%20PI3K/Akt%20activation%20by%20hypoxia/reoxygenation%20in%20renal%20epithelial%20cells&author=D. S. Kwon&author=C. H. Kwon&author=J. H. Kim&author=J. S. Woo&author=J. S. Jung&author=&author=Y. K. Kim&publication_year=2006" target="_blank">Google Scholar</a></span><li id="B28">J. W. Kim, J. E. Lee, M. J. Kim, E.-G. Cho, S.-G. Cho, and E.-J. Choi, Glycogen synthase kinase 3<i>&#x3b2;</i> is a natural activator of mitogen-activated protein kinase/extracellular signal-regulated kinase kinase kinase 1 (MEKK1), <i>Journal of Biological Chemistry</i>, vol. 278, no. 16, pp. 1399514001, 2003. <span class="reflinks">View at: <a href="https://doi.org/10.1074/jbc.M300253200">Publisher Site</a><span class ="sep"> | </span><a href="https://scholar.google.com/scholar_lookup?title=Glycogen%20synthase%20kinase%203%20is%20a%20natural%20activator%20of%20mitogen-activated%20protein%20kinase/extracellular%20signal-regulated%20kinase%20kinase%20kinase%201%20(MEKK1)&author=J. W. Kim&author=J. E. Lee&author=M. J. Kim&author=E.-G. Cho&author=S.-G. Cho&author=&author=E.-J. Choi&publication_year=2003" target="_blank">Google Scholar</a></span><li id="B29">K. Frebel and S. Wiese, Signalling molecules essential for neuronal survival and differentiation, <i>Biochemical Society Transactions</i>, vol. 34, no. 6, pp. 12871290, 2006. <span class="reflinks">View at: <a href="https://doi.org/10.1042/BST0341287">Publisher Site</a><span class ="sep"> | </span><a href="https://scholar.google.com/scholar_lookup?title=Signalling%20molecules%20essential%20for%20neuronal%20survival%20and%20differentiation&author=K. Frebel &author=S. Wiese&publication_year=2006" target="_blank">Google Scholar</a></span><li id="B30">H. E. Scharfman and R. Hen, Is more neurogenesis always better? <i>Science</i>, vol. 315, no. 5810, pp. 336338, 2007. <span class="reflinks">View at: <a href="https://doi.org/10.1126/science.1138711">Publisher Site</a><span class ="sep"> | </span><a href="https://scholar.google.com/scholar_lookup?title=Is%20more%20neurogenesis%20always%20better?&author=H. E. Scharfman &author=R. Hen&publication_year=2007" target="_blank">Google Scholar</a></span><li id="B31">A. J. Rush, M. H. Trivedi, S. R. Wisniewski et al., Acute and longer-term outcomes in depressed outpatients requiring one or several treatment steps: a STAR&#x2a;D report, <i>American Journal of Psychiatry</i>, vol. 163, no. 11, pp. 19051917, 2006. <span class="reflinks">View at: <a href="https://doi.org/10.1176/appi.ajp.163.11.1905">Publisher Site</a><span class ="sep"> | </span><a href="https://scholar.google.com/scholar_lookup?title=Acute%20and%20longer-term%20outcomes%20in%20depressed%20outpatients%20requiring%20one%20or%20several%20treatment%20steps:%20a%20STAR*D%20report&author=A. J. Rush&author=M. H. Trivedi&author=S. R. Wisniewski et al.&publication_year=2006" target="_blank">Google Scholar</a></span></li></ol></div><div class="xml-content"><h4 class="copyright" id="copyright">Copyright</h4><p>Copyright &#xa9; 2013 Anahita Rahmani et al. This is an open access article distributed under the <a rel="license" href="http://creativecommons.org/licenses/by/3.0/">  Creative Commons Attribution License</a>, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.</p></div></div></article></div></div></div><div class="biblio__Wrapper-sc-1nou1lz-0 eyHfWh journal_article__BiblioIntegratorWidget-sc-12fk6zy-5 dbAANp article_widget biblioWrapper hide"><hr/><h4 class="biblio__H4-sc-1nou1lz-2 becpDt hrTitleRef">More related articles</h4><div id="biblio_widget" class="biblio__BiblioWrapper-sc-1nou1lz-1 kbSZJl"></div></div></div></div><div class="threeColumn__RightWrapper-sc-1bf4078-2 jzTMLK rightWrapper" id="rightSectionMenu"><div><div class="journal_article__ArticleStickyTopToolbar-sc-12fk6zy-0 gbrQxi article_sticky_top_toolbar"><div class="sc-cBdUnI hRnXob article_top_toolbar"><a class="sc-htpNat bUhGXt link sc-jtRfpW dUABlg sc-exkUMo hymroZ pdf_desktop button__group" href="https://downloads.hindawi.com/journals/bmri/2013/582526.pdf" aria-label="" target="_blank" id="toolbar__dcNavSmall"><span><img alt=" " class="sc-EHOje jOLhQl sc-kTUwUJ eujois" title="" role="presentation" src="https://static-01.hindawi.com/next_assets/cpr9K8AjZYaP4CWVbtn5c/_next/static/node_modules/hindawi-ui/src/icon/svg/pdf.svg" height="24"/><span class="text">PDF</span></span><span class="sc-htoDjs bqeMOy sc-dqBHgY cQgXqt fileArrow icon-colored _3P4iUn1NDM5G77nWCamJ4l icon-themeable" title="" font-size="20"></span></a><a class="sc-htpNat bUhGXt link sc-jtRfpW dUABlg sc-kcDeIU cbcyj ref_desktop" href="/journals/bmri/2013/582526.ris" aria-label="" target="" id="toolbar__dcNavLarge"><span><img alt=" " class="sc-EHOje jOLhQl sc-kTUwUJ eujois" title="" role="presentation" src="data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHhtbG5zOnhsaW5rPSJodHRwOi8vd3d3LnczLm9yZy8xOTk5L3hsaW5rIiB3aWR0aD0iMTgiIGhlaWdodD0iMjIiIHZpZXdCb3g9IjAgMCAxOCAyMiI+PGRlZnM+PGNsaXBQYXRoIGlkPSJhIj48cGF0aCBkPSJNMywyMmEzLDMsMCwwLDEtMy0zVjNBMywzLDAsMCwxLDMsMGg4YS45OTEuOTkxLDAsMCwxLC41NzMuMTgxbDAsMCwuMDA4LjAwNmEuOTU1Ljk1NSwwLDAsMSwuMTIyLjFsNiw2YTEuMDI1LDEuMDI1LDAsMCwxLC4xLjEyMmwuMDA2LjAxLDAsMEExLDEsMCwwLDEsMTgsNi45NzVWMTlhMywzLDAsMCwxLTMsM1pNMiwzVjE5YTEsMSwwLDAsMCwxLDFIMTVhMSwxLDAsMCwwLDEtMVY4SDExYTEsMSwwLDAsMS0xLTFWMkgzQTEsMSwwLDAsMCwyLDNaTTEyLDZoMi41ODdMMTIsMy40MTRaTTUsMTdhMSwxLDAsMSwxLDAtMmg4YTEsMSwwLDEsMSwwLDJabTAtNGExLDEsMCwxLDEsMC0yaDhhMSwxLDAsMSwxLDAsMlpNNSw5QTEsMSwwLDEsMSw1LDdIN0ExLDEsMCwwLDEsNyw5WiIgdHJhbnNmb3JtPSJ0cmFuc2xhdGUoMyAxKSIvPjwvY2xpcFBhdGg+PC9kZWZzPjxnIHRyYW5zZm9ybT0idHJhbnNsYXRlKC0zIC0xKSI+PHBhdGggZD0iTTMsMjJhMywzLDAsMCwxLTMtM1YzQTMsMywwLDAsMSwzLDBoOGEuOTkxLjk5MSwwLDAsMSwuNTczLjE4MWwwLDAsLjAwOC4wMDZhLjk1NS45NTUsMCwwLDEsLjEyMi4xbDYsNmExLjAyNSwxLjAyNSwwLDAsMSwuMS4xMjJsLjAwNi4wMSwwLDBBMSwxLDAsMCwxLDE4LDYuOTc1VjE5YTMsMywwLDAsMS0zLDNaTTIsM1YxOWExLDEsMCwwLDAsMSwxSDE1YTEsMSwwLDAsMCwxLTFWOEgxMWExLDEsMCwwLDEtMS0xVjJIM0ExLDEsMCwwLDAsMiwzWk0xMiw2aDIuNTg3TDEyLDMuNDE0Wk01LDE3YTEsMSwwLDEsMSwwLTJoOGExLDEsMCwxLDEsMCwyWm0wLTRhMSwxLDAsMSwxLDAtMmg4YTEsMSwwLDEsMSwwLDJaTTUsOUExLDEsMCwxLDEsNSw3SDdBMSwxLDAsMCwxLDcsOVoiIHRyYW5zZm9ybT0idHJhbnNsYXRlKDMgMSkiLz48ZyBjbGlwLXBhdGg9InVybCgjYSkiPjxyZWN0IHdpZHRoPSIyNCIgaGVpZ2h0PSIyNCIgZmlsbD0icmdiYSgwLDAsMCwwKSIvPjxyZWN0IHdpZHRoPSIyNCIgaGVpZ2h0PSIyNCIvPjwvZz48L2c+PC9zdmc+" height="24"/><span class="text">Download Citation</span></span><span class="sc-htoDjs bqeMOy sc-dqBHgY cQgXqt fileArrow icon-colored _3P4iUn1NDM5G77nWCamJ4l icon-themeable" title="" font-size="20"></span></a><a class="sc-htpNat bUhGXt link sc-jtRfpW dUABlg sc-BngTV hmDWcT ref_desktop" href="/journals/bmri/2013/582526.ris" aria-label="" target="" id="toolbar__dcNavSmall"><span><img alt=" " class="sc-EHOje jOLhQl sc-kTUwUJ eujois" title="" role="presentation" src="data:image/svg+xml;base64,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" height="24"/><span class="text">Citation</span></span><span class="sc-htoDjs bqeMOy sc-dqBHgY cQgXqt fileArrow icon-colored _3P4iUn1NDM5G77nWCamJ4l icon-themeable" title="" font-size="20"></span></a></div></div><div class="journal_article__ArticleStickyBottomToolbar-sc-12fk6zy-1 isgRZA article_sticky_bottom_toolbar"><div class="sc-cTjmhe ihmyEq article_bottom_toolbar"><div class="sc-cugefK itFKcQ accordion" property="background-color" color="#D8D8D8" id="toolbar__dofNav"><span><img alt=" " class="sc-EHOje jOLhQl sc-bfYoXt cGuwDn" title="" role="presentation" src="data:image/svg+xml;base64,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" height="24"/><span class="sc-dRFtgE jrsDZP">Download other formats</span><span class="sc-gkFcWv gWTCXQ">More</span></span><span class="sc-htoDjs bMdQcY sc-gbOuXE jGPvPL icon-colored _1CwL9R82TPl2HxDleeYGDR icon-themeable" title="" font-size="11"></span></div><div class="sc-fnwBNb etzuBr"><a class="sc-htpNat bUhGXt link sc-iNhVCk gWgCNb open_panel" href="https://downloads.hindawi.com/journals/bmri/2013/582526.epub" aria-label="ePub" property="background-color" color="#D8D8D8"><div class="sc-eAKXzc WHkfb">ePub</div><img alt=" " class="sc-EHOje jOLhQl sc-bfYoXt cGuwDn" title="" role="presentation" src="data:image/svg+xml;base64,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" height="24"/></a><a class="sc-htpNat bUhGXt link sc-iNhVCk gWgCNb open_panel" href="https://downloads.hindawi.com/journals/bmri/2013/582526.xml" aria-label="XML" property="background-color" color="#D8D8D8"><div class="sc-eAKXzc WHkfb">XML</div><img alt=" " class="sc-EHOje jOLhQl sc-bfYoXt cGuwDn" title="" role="presentation" src="data:image/svg+xml;base64,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" height="24"/></a></div><a class="sc-htpNat bUhGXt link sc-imABML ibWUzs" href="https://reprints.hindawi.com/582526/confirm" aria-label="Order Printed Copies" target="_blank" property="background-color" color="#D8D8D8" id="toolbar__opcNav"><span><img alt=" " class="sc-EHOje jOLhQl sc-bfYoXt cGuwDn" title="" role="presentation" src="data:image/svg+xml;base64,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" height="24"/><span class="sc-dRFtgE jrsDZP">Order printed copies</span><span class="sc-gkFcWv gWTCXQ">Order</span></span><span class="sc-htoDjs kNoiZu sc-gbOuXE jGPvPL right__icon icon-colored _32KP5uexH-Bgs7Kj8Gk1Tz icon-themeable" title="" font-size="16"></span></a><div class="sc-hBbWxd kdRRST"><div class="sc-dyGzUR cHatnS"><div>Views<span>2763</span></div><div>Downloads<span>1049</span></div></div><div><div class="sc-drKuOJ kxdGAZ"><span class="__dimensions_badge_embed__" data-doi="10.1155/2013/582526" data-style="small_circle"></span>Citations</div></div></div><nav class="sc-bRBYWo fXBKFa sc-hUfwpO jHPgUP" id="toolbar__iconNav"><h3 class="sc-Rmtcm hNPrIr">Share Post</h3><ul class="sc-hzDkRC bnbfTS"><li class="iconBorder"><a class="sc-htpNat bUhGXt link" href="https://twitter.com/share?url=https://doi.org/10.1155/2013/582526&amp;via=Hindawi" aria-label="Sharing on Twitter" rel="noopener noreferrer" target="_blank"><img alt=" " class="sc-EHOje jOLhQl socialTwitter" title="" role="presentation" src="data:image/svg+xml;base64,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" height="24"/></a></li><li class="iconBorder"><a class="sc-htpNat bUhGXt link" href="https://www.linkedin.com/shareArticle/?url=https://doi.org/10.1155/2013/582526" aria-label="Sharing on Linkedin" rel="noopener noreferrer" target="_blank"><img alt=" " class="sc-EHOje jOLhQl socialLinkedin" title="" role="presentation" src="https://static-01.hindawi.com/next_assets/cpr9K8AjZYaP4CWVbtn5c/_next/static/node_modules/hindawi-ui/src/icon/svg/socialLinkedin.svg" height="24"/></a></li><li class="iconBorder"><a class="sc-htpNat bUhGXt link" href="https://www.facebook.com/sharer/sharer.php?u=https://doi.org/10.1155/2013/582526" aria-label="Sharing on Facebook" rel="noopener noreferrer" target="_blank"><img alt=" " class="sc-EHOje jOLhQl socialFacebook" title="" role="presentation" src="https://static-01.hindawi.com/next_assets/cpr9K8AjZYaP4CWVbtn5c/_next/static/node_modules/hindawi-ui/src/icon/svg/socialFacebook-HINDAWI.svg" height="24"/></a></li><li class="iconBorder"><div class="wechat-container"><img alt=" " class="sc-EHOje jOLhQl socialWechat" title="" role="presentation" src="data:image/svg+xml;base64,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" height="24"/><div class="addthis_inline_share_toolbox"></div><script type="text/javascript" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=ra-5ec5076f7164b9b5"></script></div></li><li><a class="sc-htpNat bUhGXt link" href="mailto:?subject=Neurogenesis and Increase in Differentiated Neural Cell Survival via Phosphorylation of Akt1 after Fluoxetine Treatment of Stem Cells&amp;body=https://doi.org/10.1155/2013/582526" aria-label="Sharing on Mail" target="_blank"><img alt=" " class="sc-EHOje jOLhQl socialMail" title="" role="presentation" src="data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHhtbG5zOnhsaW5rPSJodHRwOi8vd3d3LnczLm9yZy8xOTk5L3hsaW5rIiB3aWR0aD0iMjIuOTE3IiBoZWlnaHQ9IjE4IiB2aWV3Qm94PSIwIDAgMjIuOTE3IDE4Ij48ZGVmcz48Y2xpcFBhdGggaWQ9ImEiPjxwYXRoIGQ9Ik0zLjEyNSwxOEEzLjA2NywzLjA2NywwLDAsMSwwLDE1VjMuMDFDMCwzLDAsMi45OSwwLDIuOThBMy4wNjgsMy4wNjgsMCwwLDEsMy4xMjUsMEgxOS43OTJhMy4wNjgsMy4wNjgsMCwwLDEsMy4xMjYsM1YxNWEzLjA2OCwzLjA2OCwwLDAsMS0zLjEyNiwzWk0yLjA4MywxNWExLjAyMiwxLjAyMiwwLDAsMCwxLjA0MiwxSDE5Ljc5MmExLjAyMiwxLjAyMiwwLDAsMCwxLjA0Mi0xVjQuOTIxbC04Ljc3OCw1LjlhMS4wNzYsMS4wNzYsMCwwLDEtMS4xOTQsMGwtOC43NzgtNS45Wk0xMS40NTgsOC43OGw5LjI2NS02LjIyNkExLjA0NywxLjA0NywwLDAsMCwxOS43OTIsMkgzLjEyNWExLjA0NywxLjA0NywwLDAsMC0uOTMyLjU1M1oiIHRyYW5zZm9ybT0idHJhbnNsYXRlKDApIi8+PC9jbGlwUGF0aD48L2RlZnM+PGcgdHJhbnNmb3JtPSJ0cmFuc2xhdGUoMCkiIGNsaXAtcGF0aD0idXJsKCNhKSI+PGcgdHJhbnNmb3JtPSJ0cmFuc2xhdGUoLTEuMDQyIC0zKSI+PHJlY3Qgd2lkdGg9IjI1IiBoZWlnaHQ9IjI0IiBmaWxsPSJyZ2JhKDAsMCwwLDApIi8+PHJlY3Qgd2lkdGg9IjI0IiBoZWlnaHQ9IjI0IiBmaWxsPSIjNmJhNDM5Ii8+PC9nPjwvZz48L3N2Zz4=" height="24"/></a></li></ul></nav></div></div><div class="biblio__Wrapper-sc-1nou1lz-0 cBTaXT journal_article__BiblioIntegratorSidebar-sc-12fk6zy-4 cYsVdk biblioWrapperRight biblioWrapper hide"><hr/><h4 class="biblio__H4-sc-1nou1lz-2 becpDt hrTitleRef">Related articles</h4><div id="biblio_sidebar" class="biblio__BiblioWrapper-sc-1nou1lz-1 kbSZJl"></div></div></div></div></div></div></main><footer class="sc-jKJlTe inBNwS"><section class="sc-eNQAEJ dkutRV"><div class="sc-bZQynM bNmdOy E_HUmlU2Hj3PpkDmWzKPd primary__footer footer__bodypadding"><div class="sc-hMqMXs hlGpbO mobile">Follow us:<nav role="navigation" class="sc-kkGfuU filPdg"><a class="sc-htpNat bUhGXt link sc-kEYyzF ecHxGW" href="https://twitter.com/hindawi" aria-label="Twitter" rel="noopener noreferrer" target="_blank"><img alt=" " class="sc-EHOje TsaZF" title="" role="presentation" src="data:image/svg+xml;base64,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" height="40"/></a><a class="sc-htpNat bUhGXt link sc-kEYyzF ecHxGW" href="https://www.linkedin.com/company/hindawilimited/" aria-label="LinkedIn" rel="noopener noreferrer" target="_blank"><img alt=" " class="sc-EHOje TsaZF" title="" role="presentation" src="data:image/svg+xml;base64,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" height="40"/></a><a class="sc-htpNat bUhGXt link sc-kEYyzF ecHxGW" href="https://www.youtube.com/channel/UCDIK_O7FATPEkhad_sQVaSg" aria-label="Youtube" rel="noopener noreferrer" target="_blank"><img alt=" " class="sc-EHOje TsaZF" title="" role="presentation" src="data:image/svg+xml;base64,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" height="40"/></a><a class="sc-htpNat bUhGXt link sc-kEYyzF ecHxGW" href="https://www.facebook.com/HindawiLimited/" aria-label="Facebook" rel="noopener noreferrer" target="_blank"><img alt=" " class="sc-EHOje TsaZF" title="" role="presentation" src="data:image/svg+xml;base64,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" height="40"/></a></nav></div><nav class="E_HUmlU2Hj3PpkDmWzKPd _3wm8FgzqRuRWouJG31YgKx" role="navigation"><ul class="_2k5c8zEhMT-84kRD4oDgAz _1SoDWGr_FVsil9klRfjnhb"><li><a class="sc-htpNat bUhGXt link about_us" href="/about/" aria-label="About us">About us</a></li><li><a class="sc-htpNat bUhGXt link contact_us" href="/about/contact/" aria-label="Contact us">Contact us</a></li><li><a class="sc-htpNat bUhGXt link partnerships" href="/publishing-partnerships/" aria-label="Partnerships">Partnerships</a></li><li><a class="sc-htpNat bUhGXt link blog" href="/blog/" aria-label="Blog">Blog</a></li></ul><ul class="_2k5c8zEhMT-84kRD4oDgAz _1SoDWGr_FVsil9klRfjnhb"><li><a class="sc-htpNat bUhGXt link journals" href="/journals/" aria-label="Journals">Journals</a></li><li><a class="sc-htpNat bUhGXt link article_processing_charges" href="/publish-research/authors/article-processing-charges/" aria-label="Article Processing Charges">Article Processing Charges</a></li><li><a class="sc-htpNat bUhGXt link print_editions" href="/print-editions/" aria-label="Print editions">Print editions</a></li></ul><ul class="_2k5c8zEhMT-84kRD4oDgAz _1SoDWGr_FVsil9klRfjnhb"><li><a class="sc-htpNat bUhGXt link authors" href="/publish-research/authors/" aria-label="Authors">Authors</a></li><li><a class="sc-htpNat bUhGXt link editors" href="/publish-research/editors/" aria-label="Editors">Editors</a></li><li><a class="sc-htpNat bUhGXt link reviewers" href="/publish-research/reviewers/" aria-label="Reviewers">Reviewers</a></li></ul><ul class="_2k5c8zEhMT-84kRD4oDgAz _1SoDWGr_FVsil9klRfjnhb"><li><a class="sc-htpNat bUhGXt link hindawi_xml_corpus" href="/hindawi-xml-corpus/" aria-label="Hindawi XML Corpus">Hindawi XML Corpus</a></li><li><a class="sc-htpNat bUhGXt link open_archives_initiative" href="/open-archives-initiative/" aria-label="Open Archives Initiative">Open Archives Initiative</a></li><li><a class="sc-htpNat bUhGXt link fraud_prevention" href="/preventing-and-protecting-against-fraud/" aria-label="Fraud prevention">Fraud prevention</a></li></ul></nav><div class="sc-hMqMXs hlGpbO desktop">Follow us:<nav role="navigation" class="sc-kkGfuU filPdg"><a class="sc-htpNat bUhGXt link sc-kEYyzF ecHxGW" href="https://twitter.com/hindawi" aria-label="Twitter" rel="noopener noreferrer" target="_blank"><img alt=" " class="sc-EHOje TsaZF" title="" role="presentation" src="data:image/svg+xml;base64,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" height="40"/></a><a class="sc-htpNat bUhGXt link sc-kEYyzF ecHxGW" href="https://www.linkedin.com/company/hindawilimited/" aria-label="LinkedIn" rel="noopener noreferrer" target="_blank"><img alt=" " class="sc-EHOje TsaZF" title="" role="presentation" src="data:image/svg+xml;base64,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" height="40"/></a><a class="sc-htpNat bUhGXt link sc-kEYyzF ecHxGW" href="https://www.youtube.com/channel/UCDIK_O7FATPEkhad_sQVaSg" aria-label="Youtube" rel="noopener noreferrer" target="_blank"><img alt=" " class="sc-EHOje TsaZF" title="" role="presentation" src="data:image/svg+xml;base64,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" height="40"/></a><a class="sc-htpNat bUhGXt link sc-kEYyzF ecHxGW" href="https://www.facebook.com/HindawiLimited/" aria-label="Facebook" rel="noopener noreferrer" target="_blank"><img alt=" " class="sc-EHOje TsaZF" title="" role="presentation" src="data:image/svg+xml;base64,PHN2ZyB3aWR0aD0iNDAiIGhlaWdodD0iMzkiIHZpZXdCb3g9IjAgMCA0MCAzOSIgZmlsbD0ibm9uZSIgeG1sbnM9Imh0dHA6Ly93d3cudzMub3JnLzIwMDAvc3ZnIj48cGF0aCBkPSJNNDAgMTkuNDU5NUM0MCA4LjcxMzk0IDMxLjA0NCAwIDIwIDBDOC45NTU5OSAwIDAgOC43MTM5NCAwIDE5LjQ1OTVDMCAzMC4yMDUgOC45NTU5OSAzOC45MTg5IDIwIDM4LjkxODlDMjAuMTE3NSAzOC45MTg5IDIwLjIzNDQgMzguOTE2NSAyMC4zNTE2IDM4LjkxNDVWMjMuNzY2MUgxNi4wNTQ3VjE4Ljg5MzhIMjAuMzUxNlYxNS4zMDg0QzIwLjM1MTYgMTEuMTUwMiAyMi45NjA1IDguODg3MDUgMjYuNzcyOCA4Ljg4NzA1QzI4LjU5ODMgOC44ODcwNSAzMC4xNjc1IDkuMDE5NDggMzAuNjI1IDkuMDc4NTdWMTMuNDI0NEgyNy45OTYyQzI1LjkyMjIgMTMuNDI0NCAyNS41MjA2IDE0LjM4MzUgMjUuNTIwNiAxNS43OTA2VjE4Ljg5MzhIMzAuNDc5N0wyOS44MzM0IDIzLjc2NjFIMjUuNTIwNlYzOC4xNjcxQzMzLjg4MDMgMzUuODM1MyA0MCAyOC4zNDE4IDQwIDE5LjQ1OTVaIiBmaWxsPSIjRjJGMkYyIj48L3BhdGg+PC9zdmc+" height="40"/></a></nav></div></div></section><div class="sc-bZQynM bNmdOy"><section class="sc-iAyFgw gCiATD"><a class="sc-htpNat bUhGXt link" href="/privacy/" aria-label="Privacy Policy">Privacy Policy<!-- --> <!-- -->  |  </a><a class="sc-htpNat bUhGXt link" href="/terms/" aria-label="Terms of Service">Terms of Service<!-- --> <!-- -->  |  </a><a class="sc-htpNat bUhGXt link" href="/responsible-disclosure-policy/" aria-label="Responsible Disclosure Policy">Responsible Disclosure Policy<!-- --> <!-- -->  |  </a><a class="sc-htpNat bUhGXt link" href="/cookie-policy/" aria-label="Cookie Policy">Cookie Policy<!-- --> <!-- -->  |  </a><a class="sc-htpNat bUhGXt link" href="/copyright/" aria-label="Copyright">Copyright<!-- --> <!-- -->  |  </a><a class="sc-htpNat bUhGXt link" href="/modern-slavery-statement/" aria-label="Modern slavery statement">Modern slavery statement<!-- --> </a></section></div></footer><div class="sc-OxbzP eEFYIL  advWrapper hideBanner"><span><p>Article of the Year Award: Outstanding research contributions of 2020, as selected by our Chief Editors.&nbsp;<a href="https://www.hindawi.com/article-year-award/" rel="noopener noreferrer" target="_blank">Read the winning articles</a>.</p>
</span><button class="sc-bYnzgO dsXEHZ"><img alt=" " class="sc-EHOje iiusBg sc-cPuPxo iXKuYd" title="" role="presentation" src="data:image/svg+xml;base64,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" height="16"/></button></div></div></div><noscript>
        <iframe src="//www.googletagmanager.com/ns.html?id=GTM-MQ4MGW"
            height="0" width="0" style="display:none;visibility:hidden"></iframe></noscript></div><script id="__NEXT_DATA__" type="application/json">{"dataManager":"[]","props":{"pageProps":{"isLiveUrl":true,"appConfig":{"journals":{"call_for_paper":{"title":"Call for papers","description":"\u003cp\u003eThis Issue is now open for submissions.\u003c/p\u003e\n\u003cp\u003ePapers are published upon acceptance, regardless of the Special Issue publication date.\u003c/p\u003e\n"},"article_left_nav_keywords":["Introduction","Materials and Methods","Results","Discussion","Conclusion","Abstract","Data Availability","Additional Points","Ethical Approval","Consent","Disclosure","Conflicts of Interests","Authors Contributions","Funding Statement","Acknowledgements","Acknowledgments","Supplementary Materials","Reference","Dataset Description","Dataset Files","Abstract","Introduction","Introduction and Materials","Introduction and Methods","Materials","Materials and Methods","Methods","Results","Discussion","Results and Discussion","Discussion and Conclusion","Results and Conclusion","Conclusion","Conclusions","Data Availability","Additional Points","Ethical Approval","Consent","Disclosure","Conflicts of Interest","Authors Contributions","Funding Statement","Acknowledgements","Supplementary Materials","References","Appendix","Abbreviations","Preliminaries","Introduction and Preliminaries","Notation","Proof of Theorem","Proofs","Analysis of Results","Examples","Numerical Example","Applications","Numerical Simulation","Model","Model Formulation","Systematic Palaeontology","Nomenclatural Acts","Taxonomic Implications","Experimental","Synthesis","Overview","Characterization","Background","Experimental","Theories","Calculations","Model Verification","Model Implementation","Geographic location","Study Area","Geological setting","Data Collection","Field Testing","Data and Sampling","Dataset","Literature Review","Related Works","Related Work","System Model","Methods and Data","Experimental Results","Results and Analysis","Evaluation","Implementation","Case Presentation","Case Report","Search Terms","Case Description","Case Series","Background","Limitations","Additional Points","Case","Case 1"," Case 2 etc.","Concern Details","Retraction Details"," Copyright"],"journal_nav_static_text":"","newsletters":{"text":"","link":{"url":null},"hide_marketing_msg":null},"si_message":{"open":{"title":"Special Issues","text":"We currently have a number of Special Issues open for submission. Special Issues highlight emerging areas of research within a field, or provide a venue for a deeper investigation into an existing research area.","type":"special","link":{"title":"Submit to Special Issue","url":"/journals/bmri/osi"}},"propose":{"title":"Special Issues","text":"Do you think there is an emerging area of research that really needs to be highlighted? Or an existing research area that has been overlooked or would benefit from deeper investigation? Raise the profile of a research area by leading a Special Issue.","type":"special","link":{"title":"Submit your proposal","url":"/si-proposal"}},"abstract":{"title":"Abstracting and Indexing","text":"This journal's articles appear in a wide range of abstracting and indexing databases, and are covered by numerous other services that aid discovery and access. Find out more about where and how the content of this journal is available.","type":"special","link":{"title":"Find out more","url":"/abstract-msg"}}},"menu":{"prsi":"/publish-research/editors/special-issues/proposing-special-issue","asi":"/publish-research/editors/special-issues","pe":"/publish-research/authors/publication-ethics","fr":"/publish-research/reviewers","fe":"/publish-research/editors"},"featured_article_message":{"ceased":{"title":"{journal_name} has ceased publication and is no longer accepting submissions.","summary":"All previously published articles are available through the Table of Contents. \r\n\r\nThe journal is archived in Portico and via the LOCKSS initiative, which provides permanent archiving for electronic scholarly journals."},"sold":{"title":"{journal_name} is not currently considering new submissions.","summary":"All previously published articles are available through the Table of Contents. The journal is archived in Portico and via the LOCKSS initiative, which provides permanent archiving for electronic scholarly journals."}},"journal_manuscript_link":"https://review.hindawi.com/submit?journal={journal_subcode}","contact_us":{"title":"Contact","text":"\u003cp\u003eEditorial enquiries should be directed to\u0026nbsp;\u003ca href=\"mailto:{journal_subcode}@hindawi.com\"\u003e{journal_subcode}@hindawi.com\u003c/a\u003e.\u003c/p\u003e\r\n\r\n\u003cp\u003eGeneral enquiries should be directed to \u003ca href=\"mailto:help@hindawi.com\"\u003ehelp@hindawi.com\u003c/a\u003e.\u003c/p\u003e\r\n\r\n\u003cp\u003e\u0026nbsp;\u003c/p\u003e\r\n"},"open_access":{"title":"Open Access","text":"\u003cp dir=\"ltr\"\u003e\u003cem\u003e{journal_name}\u003c/em\u003e is an open access journal. All articles are immediately available to read and reuse upon publication. More information about our Open Access policy can be found on our \u003ca href=\"https://www.hindawi.com/copyright/\"\u003ecopyright page\u003c/a\u003e.\u003c/p\u003e\r\n"},"default_image":{"small":"","large":""}},"manuscript_link":"https://mts.hindawi.com/","willey_link":"/publishing-partnerships/wiley-hindawi-publishing-partnership","gdpr_message":"","order_printed_url":"https://reprints.hindawi.com/{article_id}/confirm","adv_banner_message":"\u003cp\u003eArticle of the Year Award: Outstanding research contributions of 2020, as selected by our Chief Editors.\u0026nbsp;\u003ca href=\"https://www.hindawi.com/article-year-award/\" rel=\"noopener noreferrer\" target=\"_blank\"\u003eRead the winning articles\u003c/a\u003e.\u003c/p\u003e\r\n","theme":"HINDAWI","logo":"https://preprod-admin.w2o.hindawi.com/themes/custom/hindawi_extended/logo.svg","favicon":"https://preprod-admin.w2o.hindawi.com/themes/custom/hindawi_extended/favicon.ico","social_share_options":["facebook","twitter","linkedin","wechat","mail"],"use_journal_etoc_pages":true,"GTM_ID":"GTM-MQ4MGW","SITE_NAME":"Hindawi","secureSiteUrl":"https://www.hindawi.com","features":{"isMaintenanceOn":false},"useLazyLoad":false,"hasJournalReportPage":false},"data":{"id":6603,"title":"BioMed Research International","journal_manuscript_link":"","image":{"url":"https://static-01.hindawi.com/s3fs-public/styles/featured_hero_banner/public/2020-01/bmri_hero_0.jpg?itok=wJOUAZSY","alt":" BioMed Research International "},"text_colour_code":"#ffffff","about_journal":"/journals/bmri/about","is_wiley_partner":0,"metrics_data":{"id":6603,"title":"BioMed Research International","url":"/journals/bmri","apc":{"label":"APC","value":"$2550","link":{"text":"","url":""}},"image":{"url":"https://images.hindawi.com/journals/bmri/bmri.banner.small.jpg","alt":"BioMed Research International"},"metrics":[{"label":"Acceptance rate","value":"31%"},{"label":"Submission to final decision","value":"67 days"},{"label":"Acceptance to publication","value":"30 days"},{"label":"CiteScore","value":"4.100"},{"label":"Journal Citation Indicator","value":"0.610"},{"label":"Impact Factor","value":"3.411"}],"logos":[],"toolbar_metrics_or_logo":"metrics","partner_link":false},"links_block":[{"title":"Author guidelines","link":"/journals/bmri/guidelines","icon_class":"fileText"},{"title":"Editorial board","link":"/journals/bmri/editors","icon_class":"users"},{"title":"Databases and indexing","link":"/journals/bmri/ai","icon_class":"desktop"}],"featured_type":"automatic","status":1,"journal_level":4,"journal_subcode":"bmri","journal_issn":"2314-6133","hide_marketing_msg":1,"publishing_collaborations":[],"journal_blocks":[{"title":"Journal profile","text":"\u003cp\u003e\u003cem\u003eBioMed Research International\u003c/em\u003e publishes original research articles and\u0026nbsp;review articles covering a wide range of subjects within the biomedical sciences. The journal will accept both basic and translational research.\u003c/p\u003e\r\n","type":"profile","link":{"title":"About this journal","url":"/journals/bmri/about"}},{"title":"Editor spotlight","text":"\u003cp\u003e\u003cem\u003eBioMed Research International\u003c/em\u003e maintains an Editorial Board of practicing researchers from around the world, to ensure manuscripts are handled by editors who are experts in the field of study.\u003c/p\u003e\r\n","type":"spotlight","link":{"title":"Meet the editorial board","url":"/journals/bmri/editors"}},{"title":"Special Issues","text":"We currently have a number of Special Issues open for submission. Special Issues highlight emerging areas of research within a field, or provide a venue for a deeper investigation into an existing research area.","type":"special","link":{"title":"Submit to Special Issue","url":"/journals/bmri/osi"}}],"si_message_type":{"type":"open","link":{"title":"Submit to Special Issue","url":"/journals/bmri/osi"}},"meta_info":{"title":"BioMed Research International | Hindawi","meta_data":[{"name":"title","content":"BioMed Research International | Hindawi"},{"name":"description","content":"BioMed Research International publishes original research articles andreview articles covering a wide range of subjects within the biomedical sciences. The journal will accept both basic and translational research."},{"property":"og:site_name","content":"Hindawi"},{"property":"og:url","content":"current_url"},{"property":"og:title","content":"BioMed Research International"},{"property":"og:description","content":"BioMed Research International publishes original research articles andreview articles covering a wide range of subjects within the biomedical sciences. The journal will accept both basic and translational research."},{"property":"og:image","content":"https://images.hindawi.com/journals/bmri/bmri.banner.jpg"},{"property":"og:image:type","content":"image/jpeg"},{"property":"og:image:width","content":"600"},{"property":"og:image:height","content":"315"},{"name":"twitter:card","content":"summary_large_image"},{"name":"twitter:description","content":"BioMed Research International publishes original research articles andreview articles covering a wide range of subjects within the biomedical sciences. The journal will accept both basic and translational research."},{"name":"twitter:site","content":"Hindawi"},{"name":"twitter:title","content":"BioMed Research International"},{"name":"twitter:url","content":"current_url"},{"name":"twitter:image","content":"https://images.hindawi.com/journals/bmri/bmri.banner.jpg"}]},"journal_header_uses_logo":false,"global_manuscript_link":"https://review.hindawi.com/submit?journal=bmri","newsletters":{"text":"","link":{"url":null},"hide_marketing_msg":null}},"meta":{"meta_data":[{"name":"title","content":"Neurogenesis and Increase in Differentiated Neural Cell Survival via Phosphorylation of Akt1 after Fluoxetine Treatment of Stem Cells"},{"rel":"canonical","href":"https://www.hindawi.com/journals/bmri/2013/582526/"},{"name":"description","content":"Fluoxetine (FLX) is a selective serotonin reuptake inhibitor (SSRI). Its action is possibly through an increase in neural cell survival. The mechanism of improved survival rate of neurons by FLX may relate to the overexpression of some kinases such as Akt protein. Akt1 (a serine/threonine kinase) plays a key role in the modulation of cell proliferation and survival. Our study evaluated the effects of FLX on mesenchymal stem cell (MSC) fate and Akt1 phosphorylation levels in MSCs. Evaluation tests included reverse transcriptase polymerase chain reaction, western blot, and immunocytochemistry assays. Nestin, MAP-2, and \u003ci\u003e\u0026#x3b2;\u003c/i\u003e-tubulin were detected after neurogenesis as neural markers. Ten \u003ci\u003e\u0026#x3bc;\u003c/i\u003eM of FLX upregulated phosphorylation of Akt1 protein in induced hEnSC significantly. Also FLX did increase viability of these MSCs. Continuous FLX treatment after neurogenesis elevated the survival rate of differentiated neural cells probably by enhanced induction of Akt1 phosphorylation. This study addresses a novel role of FLX in neurogenesis and differentiated neural cell survival that may contribute to explaining the therapeutic action of fluoxetine in regenerative pharmacology."},{"property":"og:url","content":"current_url"},{"property":"og:type","content":"website"},{"property":"og:image","content":"https://images.hindawi.com/journals/bmri/bmri.banner.jpg"},{"property":"og:image:type","content":"image/jpeg"},{"property":"og:image:width","content":"600"},{"property":"og:image:height","content":"315"},{"property":"og:title","content":"Neurogenesis and Increase in Differentiated Neural Cell Survival via Phosphorylation of Akt1 after Fluoxetine Treatment of Stem Cells"},{"name":"twitter:site","content":"website"},{"name":"twitter:card","content":"summary_large_image"},{"name":"twitter:image","content":"https://images.hindawi.com/journals/bmri/bmri.banner.jpg"},{"name":"twitter:title","content":"Neurogenesis and Increase in Differentiated Neural Cell Survival via Phosphorylation of Akt1 after Fluoxetine Treatment of Stem Cells"},{"property":"og:description","content":"Fluoxetine (FLX) is a selective serotonin reuptake inhibitor (SSRI). Its action is possibly through an increase in neural cell survival. The mechanism of improved survival rate of neurons by FLX may relate to the overexpression of some kinases such as Akt protein. Akt1 (a serine/threonine kinase) plays a key role in the modulation of cell proliferation and survival. Our study evaluated the effects of FLX on mesenchymal stem cell (MSC) fate and Akt1 phosphorylation levels in MSCs. Evaluation tests included reverse transcriptase polymerase chain reaction, western blot, and immunocytochemistry assays. Nestin, MAP-2, and \u003ci\u003e\u0026#x3b2;\u003c/i\u003e-tubulin were detected after neurogenesis as neural markers. Ten \u003ci\u003e\u0026#x3bc;\u003c/i\u003eM of FLX upregulated phosphorylation of Akt1 protein in induced hEnSC significantly. Also FLX did increase viability of these MSCs. Continuous FLX treatment after neurogenesis elevated the survival rate of differentiated neural cells probably by enhanced induction of Akt1 phosphorylation. This study addresses a novel role of FLX in neurogenesis and differentiated neural cell survival that may contribute to explaining the therapeutic action of fluoxetine in regenerative pharmacology."},{"name":"twitter:description","content":"Fluoxetine (FLX) is a selective serotonin reuptake inhibitor (SSRI). Its action is possibly through an increase in neural cell survival. The mechanism of improved survival rate of neurons by FLX may relate to the overexpression of some kinases such as Akt protein. Akt1 (a serine/threonine kinase) plays a key role in the modulation of cell proliferation and survival. Our study evaluated the effects of FLX on mesenchymal stem cell (MSC) fate and Akt1 phosphorylation levels in MSCs. Evaluation tests included reverse transcriptase polymerase chain reaction, western blot, and immunocytochemistry assays. Nestin, MAP-2, and \u003ci\u003e\u0026#x3b2;\u003c/i\u003e-tubulin were detected after neurogenesis as neural markers. Ten \u003ci\u003e\u0026#x3bc;\u003c/i\u003eM of FLX upregulated phosphorylation of Akt1 protein in induced hEnSC significantly. Also FLX did increase viability of these MSCs. Continuous FLX treatment after neurogenesis elevated the survival rate of differentiated neural cells probably by enhanced induction of Akt1 phosphorylation. This study addresses a novel role of FLX in neurogenesis and differentiated neural cell survival that may contribute to explaining the therapeutic action of fluoxetine in regenerative pharmacology."},{"name":"citation_title","content":"Neurogenesis and Increase in Differentiated Neural Cell Survival via Phosphorylation of Akt1 after Fluoxetine Treatment of Stem Cells"},{"name":"citation_author","content":"Rahmani, Anahita"},{"name":"citation_author","content":"Kheradmand, Danial"},{"name":"citation_author","content":"Keyhanvar, Peyman"},{"name":"citation_author","content":"Shoae-Hassani, Alireza"},{"name":"citation_author","content":"Darbandi-Azar, Amir"},{"name":"citation_journal_title","content":"BioMed Research International"},{"name":"citation_publisher","content":"Hindawi"},{"name":"citation_volume","content":2013},{"name":"citation_year","content":"2013"},{"name":"citation_date","content":"2013/08/18"},{"name":"citation_online_date","content":"2013/08/18"},{"name":"citation_doi","content":"https://doi.org/10.1155/2013/582526"},{"name":"citation_issn","content":"2314-6133"},{"name":"citation_abstract","content":"Fluoxetine (FLX) is a selective serotonin reuptake inhibitor (SSRI). Its action is possibly through an increase in neural cell survival. The mechanism of improved survival rate of neurons by FLX may relate to the overexpression of some kinases such as Akt protein. Akt1 (a serine/threonine kinase) plays a key role in the modulation of cell proliferation and survival. Our study evaluated the effects of FLX on mesenchymal stem cell (MSC) fate and Akt1 phosphorylation levels in MSCs. Evaluation tests included reverse transcriptase polymerase chain reaction, western blot, and immunocytochemistry assays. Nestin, MAP-2, and \u003ci\u003e\u0026#x3b2;\u003c/i\u003e-tubulin were detected after neurogenesis as neural markers. Ten \u003ci\u003e\u0026#x3bc;\u003c/i\u003eM of FLX upregulated phosphorylation of Akt1 protein in induced hEnSC significantly. Also FLX did increase viability of these MSCs. Continuous FLX treatment after neurogenesis elevated the survival rate of differentiated neural cells probably by enhanced induction of Akt1 phosphorylation. This study addresses a novel role of FLX in neurogenesis and differentiated neural cell survival that may contribute to explaining the therapeutic action of fluoxetine in regenerative pharmacology."},{"name":"citation_fulltext_html_url","content":"current_url"},{"name":"citation_pdf_url","content":"https://downloads.hindawi.com/journals/bmri/2013/582526.pdf"},{"name":"citation_xml_url","content":"https://downloads.hindawi.com/journals/bmri/2013/582526.xml"},{"name":"dc.creator","content":"Rahmani, Anahita"},{"name":"dc.creator","content":"Kheradmand, Danial"},{"name":"dc.creator","content":"Keyhanvar, Peyman"},{"name":"dc.creator","content":"Shoae-Hassani, Alireza"},{"name":"dc.creator","content":"Darbandi-Azar, Amir"},{"name":"dc.title","content":"Neurogenesis and Increase in Differentiated Neural Cell Survival via Phosphorylation of Akt1 after Fluoxetine Treatment of Stem Cells"},{"name":"dc.description","content":"Fluoxetine (FLX) is a selective serotonin reuptake inhibitor (SSRI). Its action is possibly through an increase in neural cell survival. The mechanism of improved survival rate of neurons by FLX may relate to the overexpression of some kinases such as Akt protein. Akt1 (a serine/threonine kinase) plays a key role in the modulation of cell proliferation and survival. Our study evaluated the effects of FLX on mesenchymal stem cell (MSC) fate and Akt1 phosphorylation levels in MSCs. Evaluation tests included reverse transcriptase polymerase chain reaction, western blot, and immunocytochemistry assays. Nestin, MAP-2, and \u003ci\u003e\u0026#x3b2;\u003c/i\u003e-tubulin were detected after neurogenesis as neural markers. Ten \u003ci\u003e\u0026#x3bc;\u003c/i\u003eM of FLX upregulated phosphorylation of Akt1 protein in induced hEnSC significantly. Also FLX did increase viability of these MSCs. Continuous FLX treatment after neurogenesis elevated the survival rate of differentiated neural cells probably by enhanced induction of Akt1 phosphorylation. This study addresses a novel role of FLX in neurogenesis and differentiated neural cell survival that may contribute to explaining the therapeutic action of fluoxetine in regenerative pharmacology."},{"name":"dc.publisher","content":"Hindawi"},{"name":"dc.format","content":"text/html"},{"name":"dc.language","content":"en"},{"name":"dc.identifier","content":"https://doi.org/10.1155/2013/582526"},{"name":"dc.type","content":"Research Article"},{"name":"dc.date","content":"2013/08/18"},{"name":"dcterms.issued","content":"2013/08/18"},{"name":"prism.publicationDate","content":"2013/08/18"},{"name":"prism.volume","content":2013},{"name":"prism.section","content":"Research Article"},{"name":"prism.doi","content":"https://doi.org/10.1155/2013/582526"},{"name":"prism.issn","content":"2314-6133"},{"name":"dc.source","content":"BioMed Research International"},{"name":"prism.publicationName","content":"BioMed Research International"},{"name":"authors","content":"Anahita Rahmani | Danial Kheradmand | ... | Amir Darbandi-Azar"}],"title":"Neurogenesis and Increase in Differentiated Neural Cell Survival via Phosphorylation of Akt1 after Fluoxetine Treatment of Stem Cells","current_url":"https://www.hindawi.com/journals/bmri/2013/582526/","site_url":"https://www.hindawi.com","gdprMsg":"","manuscript_link":"https://mts.hindawi.com/","footerData":{"status":200,"data":{"upper_menu_items":{"footer":[{"title":"About us","external":0,"relative":"/about","expanded":0,"enabled":1},{"title":"Contact us","external":0,"relative":"/about/contact","expanded":0,"enabled":1},{"title":"Partnerships","external":0,"relative":"/publishing-partnerships","expanded":0,"enabled":1},{"title":"Blog","external":0,"relative":"/blog","expanded":0,"enabled":1}],"footer-1":[{"title":"Journals","external":0,"relative":"/journals","expanded":0,"enabled":1},{"title":"Article Processing Charges","external":0,"relative":"/publish-research/authors/article-processing-charges","expanded":0,"enabled":1},{"title":"Print editions","external":0,"relative":"/print-editions","expanded":0,"enabled":1}],"footer-2":[{"title":"Authors","external":0,"relative":"/publish-research/authors","expanded":0,"enabled":1},{"title":"Editors","external":0,"relative":"/publish-research/editors","expanded":0,"enabled":1},{"title":"Reviewers","external":0,"relative":"/publish-research/reviewers","expanded":0,"enabled":1}],"footer-3":[{"title":"Hindawi XML Corpus","external":0,"relative":"/hindawi-xml-corpus","expanded":0,"enabled":1},{"title":"Open Archives Initiative","external":0,"relative":"/open-archives-initiative","expanded":0,"enabled":1},{"title":"Fraud prevention","external":0,"relative":"/preventing-and-protecting-against-fraud","expanded":0,"enabled":1}]},"lower_menu_items":{"lower-footer":[{"title":"Privacy Policy","external":0,"relative":"/privacy","expanded":0,"enabled":1},{"title":"Terms of Service","external":0,"relative":"/terms","expanded":0,"enabled":1},{"title":"Responsible Disclosure Policy","external":0,"relative":"/responsible-disclosure-policy","expanded":0,"enabled":1},{"title":"Cookie Policy","external":0,"relative":"/cookie-policy","expanded":0,"enabled":1},{"title":"Copyright","external":0,"relative":"/copyright","expanded":0,"enabled":1},{"title":"Modern slavery statement","external":0,"relative":"/modern-slavery-statement","expanded":0,"enabled":1}]},"config":{"footer_config_logo":"","footer_config_copyright":""}},"headers":{},"journalCode":"bmri"},"isLiveUrl":true,"advMsg":"\u003cp\u003eArticle of the Year Award: Outstanding research contributions of 2020, as selected by our Chief Editors.\u0026nbsp;\u003ca href=\"https://www.hindawi.com/article-year-award/\" rel=\"noopener noreferrer\" target=\"_blank\"\u003eRead the winning articles\u003c/a\u003e.\u003c/p\u003e\r\n","statusCode":false,"showPreviewButtons":false,"currentPath":"/journals/bmri/2013/582526/","bibblioKey":"0d7b3db3-a45f-4dfa-b751-991c0907e6ab","assetPrefix":"https://static-01.hindawi.com/next_assets/cpr9K8AjZYaP4CWVbtn5c","logo":"https://preprod-admin.w2o.hindawi.com/themes/custom/hindawi_extended/logo.svg","favicon":"https://preprod-admin.w2o.hindawi.com/themes/custom/hindawi_extended/favicon.ico","headerData":{"status":200,"data":{"header_menu_items":{"header-menu":[{"title":"Journals","external":0,"link":"/journals","expanded":0,"enabled":1},{"title":"Publish with us","external":0,"link":"/publish-research","expanded":0,"enabled":1},{"title":"Publishing partnerships","external":0,"link":"/publishing-partnerships","expanded":0,"enabled":1},{"title":"About us","external":0,"link":"/about","expanded":0,"enabled":1},{"title":"Blog","external":0,"link":"/blog","expanded":0,"enabled":1}]}},"headers":{}},"theme":"HINDAWI","sharingOptions":["facebook","twitter","linkedin","wechat","mail"],"useJournalEtocPages":true,"isUserFromChina":false,"useLazyLoad":false,"hasJournalReportPage":false},"ceased":false,"journalAlias":"/journals/bmri","journalNavigationBarData":{"items":[{"title":"Journal overview","link":"/journals/bmri/jo","key":"jo","children":[{"title":"About this Journal","link":"/journals/bmri/about","key":"about"},{"title":"Editorial Board","link":"/journals/bmri/editors","key":"editors"},{"title":"Peer Review Process","link":"/journals/bmri/prp","key":"prp"},{"title":"Publication Ethics","link":"/publish-research/authors/publication-ethics","key":"pe"},{"title":"Abstracting and Indexing","link":"/journals/bmri/ai","key":"ai"},{"title":"Article Processing Charges","link":"/journals/bmri/apc","key":"apc"}]},{"title":"For authors","link":"/journals/bmri/guidelines","key":"guidelines","children":[]},{"title":"For reviewers","link":"/publish-research/reviewers","key":"fr","children":[]},{"title":"For editors","link":"/publish-research/editors","key":"fe","children":[]},{"title":"Table of Contents","link":"/journals/bmri/contents/year/2022","children":[]},{"title":"Special Issues","link":"/journals/bmri/si","children":[{"title":"Open Special Issues","link":"/journals/bmri/osi","key":"osi"},{"title":"Published Special Issues","link":"/journals/bmri/psi","key":"psi"},{"title":"Propose Special Issue","link":"/publish-research/editors/special-issues/proposing-special-issue","key":"prsi"},{"title":"About Special Issues","link":"/publish-research/editors/special-issues","key":"asi"}]}],"archived":false,"navText":""},"journalUrl":"/journals/bmri","article":{"retracted":false,"related_articles":[{"title":"Research Article","link":"/journals/bmri/2013/582526/","childrens":[]},{"title":"Corrigendum","link":"/journals/bmri/2015/372630","childrens":[{"special_issue":false,"volume":"2015","pdf":"downloads.hindawi.com/journals/bmri/2015/372630.pdf","abstract":"","id":"372630","type":"Corrigendum","title":"Corrigendum to \u0026#x201c;Neurogenesis and Increase in Differentiated Neural Cell Survival via Phosphorylation of Akt1 after Fluoxetine Treatment of Stem Cells\u0026#x201d;","date":"16 Feb 2015","journal":"BioMed Research International","alias":"/journals/bmri/2015/372630","authors":[{"name":"Anahita Rahmani"},{"name":"Danial Kheradmand"},{"name":"Peyman Keyhanvar"},{"name":"Alireza Shoae-Hassani"},{"name":"Amir Darbandi-Azar"}],"reference":"/journals/bmri/2015/372630.ris"}]}],"id":"582526","title":"Neurogenesis and Increase in Differentiated Neural Cell Survival via Phosphorylation of Akt1 after Fluoxetine Treatment of Stem Cells","title_toc":"Neurogenesis and Increase in Differentiated Neural Cell Survival via Phosphorylation of Akt1 after Fluoxetine Treatment of Stem Cells","type":"Research Article","volume":2013,"pub_year":"2013","article_id":"582526","pages":9,"first_page":"","last_page":"","issue_no":"","doi":"https://doi.org/10.1155/2013/582526","doi_simple":"10.1155/2013/582526","shorten_url":"https://doi.org/10.1155/2013/582526","inPress":false,"academic_editors":[{"name":"Paul Higgins"}],"guest_editors":[],"published_date":"18 Aug 2013","received_date":"10 Apr 2013","revised_date":"15 Jul 2013","accepted_date":"15 Jul 2013","authors":[{"name":"Anahita Rahmani","email":"","orcid":"","sup":["1"]},{"name":"Danial Kheradmand","email":"","orcid":"","sup":["2"]},{"name":"Peyman Keyhanvar","email":"","orcid":"","sup":["3","4"]},{"name":"Alireza Shoae-Hassani","email":"","orcid":"http://orcid.org/0000-0002-0655-1343","sup":["1"]},{"name":"Amir Darbandi-Azar","email":"moc.liamy@ygolonhcetoibonan","orcid":"","sup":["4"]}],"affiliations":[{"id":"1","text":"Stem Cell and Tissue Engineering Department, Research Center for Science and Technology in Medicine (RCSTiM), Tehran University of Medical Sciences, Tehran, Iran"},{"id":"2","text":"Faculty of Medicine, Islamic Azad University, Mashhad Branch, Mashhad 19988-96953, Iran"},{"id":"3","text":"Medical Nanotechnology Department, School of Advanced Technologies in Medicine, Tehran University of Medical Sciences, Tehran, Iran"},{"id":"4","text":"Rajaei Cardiovascular, Medical, and Research Centre, Iran University of Medical Sciences, P.O. Box 14185-615, Tehran, Iran"}],"is_special_issue":0,"special_issue_details":{"title":"","url":""},"body":"\u003cdiv class=\"xml-content\"\u003e\u003ch4 class=\"header\" id=\"abstract\"\u003eAbstract\u003c/h4\u003e\u003cp\u003eFluoxetine (FLX) is a selective serotonin reuptake inhibitor (SSRI). Its action is possibly through an increase in neural cell survival. The mechanism of improved survival rate of neurons by FLX may relate to the overexpression of some kinases such as Akt protein. Akt1 (a serine/threonine kinase) plays a key role in the modulation of cell proliferation and survival. Our study evaluated the effects of FLX on mesenchymal stem cell (MSC) fate and Akt1 phosphorylation levels in MSCs. Evaluation tests included reverse transcriptase polymerase chain reaction, western blot, and immunocytochemistry assays. Nestin, MAP-2, and \u003ci\u003e\u003c/i\u003e-tubulin were detected after neurogenesis as neural markers. Ten \u003ci\u003e\u003c/i\u003eM of FLX upregulated phosphorylation of Akt1 protein in induced hEnSC significantly. Also FLX did increase viability of these MSCs. Continuous FLX treatment after neurogenesis elevated the survival rate of differentiated neural cells probably by enhanced induction of Akt1 phosphorylation. This study addresses a novel role of FLX in neurogenesis and differentiated neural cell survival that may contribute to explaining the therapeutic action of fluoxetine in regenerative pharmacology.\u003c/p\u003e\u003cspan class=\"end-abs\"\u003e\u003c/span\u003e\u003ch4 id=\"introduction\"\u003e1. Introduction\u003c/h4\u003e\u003cp\u003e  Recent works in stem cell biology have opened up new ways in therapeutic strategies to replace lost cells with stem cells in injuries. Cell therapy will be an effective strategy for treating neurodegenerative diseases and spinal cord injuries [\u003ca href=\"#B1\"\u003e1\u003c/a\u003e]. However the important part of the successful therapy depends on differentiation and promoting the survival of implanted cells. The survival rate of stem cells after differentiation and transplantation is important for the efficacy of cell therapy [\u003ca href=\"#B2\"\u003e2\u003c/a\u003e]. Some factors are involved in the regulation of neurogenesis and their survival. Corticosteroids were the first hormones found to have a neurogenesis effect [\u003ca href=\"#B3\"\u003e3\u003c/a\u003e]. Neurotransmitters and growth factors also can affect neurogenesis [\u003ca href=\"#B4\"\u003e4\u003c/a\u003e]. Based on the fact that fluoxetine (FLX) improves brain function, researchers have explored the effect of antidepressants on the neurogenesis. FLX was the first selective serotonin reuptake inhibitor (SSRI) approved for the treatment of depression. On the molecular basis of its clinical efficacy, FLX increases serotonin synaptic availability [\u003ca href=\"#B5\"\u003e5\u003c/a\u003e]. Increased neurogenesis started by antidepressants in some manner contributes to their therapeutic effects [\u003ca href=\"#B6\"\u003e6\u003c/a\u003e]. These results provide some initial insights, but more work is needed to fully elucidate the SSRI actions on stem cell neurogenesis. \u003c/p\u003e\u003cp\u003e  To promote extended survival of transplanted stem cells, we must modulate the properties of the cells. This purpose might be accomplished by overexpressing Akt1 protein which is a general mediator of cell survival signal. Akt is a serine/threonine kinase that plays a key role in the modulation of cell proliferation and survival. It is wellknown for its antiapoptotic effects against a variety of situations including oxidative and osmotic stress, irradiation, and ischemic shock [\u003ca href=\"#B7\"\u003e7\u003c/a\u003e\u003ca href=\"#B10\"\u003e10\u003c/a\u003e].\u003c/p\u003e\u003cp\u003e  This study aimed to investigate whether fluoxetine could induce neurogenesis in mesenchymal stem cells and to further examine the putative role of Akt1 and its phosphorylation in FLX-mediated effects.\u003c/p\u003e\u003ch4 id=\"materials-and-methods\"\u003e2. Materials and Methods\u003c/h4\u003e\u003ch5 id=\"sec2.1\"\u003e2.1. Isolation and Culture of Human Endometrial Stem Cells\u003c/h5\u003e\u003cp\u003eThis study was carried out in accordance with the Tehran University of Medical Sciences Ethical Committee Law. There was a consent form for each donor that is included in the supplementary data. Here we were using human endometrial stem cell (hEnSC) as a source of mesenchymal stem cell. Stem cell was obtained from 30 donors between 25 and 35 years old in the gynecology department as described previously [\u003ca href=\"#B11\"\u003e11\u003c/a\u003e]. Briefly, the biopsies from endometrium were dissected and then treated with collagenase (Sigma, USA) for 45min. Isolated cells were suspended in phosphate buffered saline (PBS, Sigma, USA) supplemented with 10% fetal bovine serum (FBS; Gibco, UK), 0.2mM EDTA (Sigma, USA), 100U/mL penicillin, and 0.1mg/mL streptomycin (Gibco, UK). The cells were layered on Ficoll Paque (Sigma, USA) and centrifuged at 400g for 35min at 4C. EnSCs were retrieved from the buffy coat layer, washed in PBS, and then kept in DMEM/F12 medium (Gibco, UK). In the passage two, the CD146\u003csup\u003e+\u003c/sup\u003e, CD105\u003csup\u003e+\u003c/sup\u003e, and CD90\u003csup\u003e+\u003c/sup\u003e cells were isolated from total cells [\u003ca href=\"#B12\"\u003e12\u003c/a\u003e] by the fluorescent analyzer cell sorter (FACS). \u003c/p\u003e\u003ch5 id=\"sec2.2\"\u003e2.2. Mesenchymal Stem Cells Differentiation\u003c/h5\u003e\u003cp\u003eHuman EnSCs were placed on collagen precoated plates with DMEM low-glucose medium. The cultures were kept in a humidified 10% CO\u003csub\u003e2\u003c/sub\u003e atmosphere at 37C for 10 days. The media were replaced with fresh media every 3d. Stem cells that have grown to 70% confluence were pretreated with 1\u003ci\u003e\u003c/i\u003eM dimethyl-sulfoxide (DMSO, Sigma, USA) and then were treated with fluoxetine (1, 2, 5, and 10\u003ci\u003e\u003c/i\u003eM, Sigma, USA). Treatment with 1\u003ci\u003e\u003c/i\u003eM retinoic acid (RA, Sigma, USA) and dH\u003csub\u003e2\u003c/sub\u003eO was done as positive and negative controls in order. Also hEnSCs cultured in FLX treated media containing 10\u003ci\u003e\u003c/i\u003eM phosphatidylinositol-3-kinase (PI3-K) inhibitor (LY294002, Promega, USA) served as control cells to determine the Akt role. After treatment for 10d, cells were subjected to examining the Akt1 phosphorylation by western blot and for specific markers of neural cells via reverse transcriptase PCR and immunocytochemistry assays. In each experiment, a nontreated group was tested.\u003c/p\u003e\u003ch5 id=\"sec2.3\"\u003e2.3. Reverse Transcriptase PCR Analysis for Neural Specific Markers\u003c/h5\u003e\u003cp\u003eFor collection of total RNA from treated hEnSCs, we used an Isogen kit according to the manufacturers instructions (Nippon Gene, Tokyo, Japan). RNA quantity and purity were determined by spectrophotometry (Beckman DU-65). Standard reverse transcription was performed using the AMV kit (Takara Biomedicals, Ohtsu, Japan) with 1\u003ci\u003e\u003c/i\u003eg RNA and 0.5\u003ci\u003e\u003c/i\u003eg oligo-dT per reaction, according to the manufacturers instructions. Reaction mixtures included 2.5\u003ci\u003e\u003c/i\u003eL cDNA, 1x PCR buffer (AMS TM, Cinnagen, Iran), 200\u003ci\u003e\u003c/i\u003eM dNTPs, 0.5\u003ci\u003e\u003c/i\u003eM of each of forward and reverse primers (Table \u003ca href=\"tab1/\" target=\"_blank\"\u003e1\u003c/a\u003e), and 1U Taq DNA polymerase. Polymerase chain reactions were performed at 94C for 1min, 30 cycles 94C for 30s, 5563C for 30s, and 72C for 30s, and 72C for 10min. Amplified DNA fragments were electrophoresed on 1.5% agarose gel. The gels were stained with ethidium bromide (10\u003ci\u003e\u003c/i\u003eg/mL) and photographed on a UV transilluminator (Uvidoc, UK).\u003c/p\u003e\u003cdiv class=\"floats-partial-section partial-other-wrapper\" data-section=\"tab1\"\u003e\u003cdiv class=\"floats-partial-content fig-content-tab1\"\u003e\u003ctable class=\"table-group\" id=\"tab1\"\u003e\u003ctr\u003e\u003ctd\u003e\u003ctable class=\"table\"\u003e\u003ctr\u003e\u003ctd class=\"thead-hr\" colspan=\"3\"\u003e\u003chr /\u003e\u003c/td\u003e\u003c/tr\u003e\u003ctr class=\"thead\"\u003e\u003ctd align=\"left\"\u003eTarget genes\u003c/td\u003e\u003ctd align=\"center\"\u003ePrimer sequences\u003c/td\u003e\u003ctd align=\"center\"\u003eAccession number\u003c/td\u003e\u003c/tr\u003e\u003ctr\u003e\u003ctd class=\"thead-hr\" colspan=\"3\"\u003e\u003chr /\u003e\u003c/td\u003e\u003c/tr\u003e\u003ctr\u003e\u003ctd align=\"left\" rowspan=\"2\"\u003eNestin\u003c/td\u003e\u003ctd align=\"center\"\u003eF: 5-GCCCTGACCACTCCAGTTTA-3\u003c/td\u003e\u003ctd align=\"center\" rowspan=\"2\"\u003eNM:051373\u003c/td\u003e\u003c/tr\u003e\u003ctr\u003e\u003ctd align=\"center\"\u003eR: 5-GGAGTCCTGGATTTCCTTCC-3\u003c/td\u003e\u003c/tr\u003e\u003ctr\u003e\u003ctd align=\"left\" rowspan=\"2\"\u003eMap-2\u003c/td\u003e\u003ctd align=\"center\"\u003eF: 5-CCATTTGCAACAGGAAGACAC-3\u003c/td\u003e\u003ctd align=\"center\" rowspan=\"2\"\u003eNM:002374.3\u003c/td\u003e\u003c/tr\u003e\u003ctr\u003e\u003ctd align=\"center\"\u003eR: 5-CAGCTCAAATGCTTTGCAACTAT-3\u003c/td\u003e\u003c/tr\u003e\u003ctr\u003e\u003ctd align=\"left\" rowspan=\"2\"\u003e\u003ci\u003e\u003c/i\u003e-tubulin\u003c/td\u003e\u003ctd align=\"center\"\u003eF: 5-ATGTACGAAGACGACGAGGAG-3\u003c/td\u003e\u003ctd align=\"center\" rowspan=\"2\"\u003eNM:BC:003021\u003c/td\u003e\u003c/tr\u003e\u003ctr\u003e\u003ctd align=\"center\"\u003eR: 5-GTATCCCCGAAAATATAAACACA-3\u003c/td\u003e\u003c/tr\u003e\u003ctr\u003e\u003ctd align=\"left\" rowspan=\"2\"\u003e\u003ci\u003e\u003c/i\u003e-actin\u003c/td\u003e\u003ctd align=\"center\"\u003eF: 5-AAGAGAGGCATCCTGACCCT-3\u003c/td\u003e\u003c/tr\u003e\u003ctr\u003e\u003ctd align=\"center\"\u003eR: 5-ACATGGCTGGGGTGTTGAAGC-3\u003c/td\u003e\u003c/tr\u003e\u003ctr class=\"table-tr\"\u003e\u003ctd colspan=\"3\"\u003e\u003chr class=\"tbody-hr\" /\u003e\u003c/td\u003e\u003c/tr\u003e\u003c/table\u003e\u003c/td\u003e\u003c/tr\u003e\u003c/table\u003e\u003c/div\u003e\u003cdiv class=\"floats-partial-footer\"\u003e\u003cdiv class=\"floats-partial-caption\"\u003e\u003cspan class=\"caption-text\"\u003eTable 1\u003c/span\u003e\u003ca aria-label=\"full view\" class=\"caption-partial-url\" href=\"tab1/\" title=\"full view\" target=\"_blank\"\u003e\u0026nbsp;\u003c/a\u003e\u003c/div\u003e\u003cdiv class=\"floats-partial-caption-text\"\u003ePrimers used for specific neuronal genes expression.\u003c/div\u003e\u003c/div\u003e\u003c/div\u003e\u003ch5 id=\"sec2.4\"\u003e2.4. Neural Markers Immunostaining\u003c/h5\u003e\u003cp\u003e The hEnSCs treated with FLX and FLX + 10\u003ci\u003e\u003c/i\u003eM PI3-K inhibitor (LY294002, Promega, USA) were fixed by incubation in 9% paraformaldehyde for 20min and permeabilized with 0.5% Triton X-100 for 10min as described previously [\u003ca href=\"#B1\"\u003e1\u003c/a\u003e]. The cells were then reacted with primary antibodies for Nestin (Sigma, USA), MAP-2 (Sigma, USA), \u003ci\u003e\u003c/i\u003e-tubulin-III (Chemicon, USA), and CD11b as a glial marker (Millipore, USA) at 4C for 12h, washed with PBS and reacted with the fluorescent isothiocyanate (FITC) conjugated secondary antibody (Sigma, USA) at room temperature for 2h. Finally, the cells were washed with PBS three times, and DAPI was used for DNA staining. \u003c/p\u003e\u003ch5 id=\"sec2.5\"\u003e2.5. Detection of Akt1 Phosphorylation via Western Blotting\u003c/h5\u003e\u003cp\u003eAfter FLX treatment, the cell lysates were collected and protein concentration was determined by using a protein assay kit (Bio-Rad, USA). Total cell extracts containing equal amounts of protein in sample buffer were subjected to WB analysis as described previously [\u003ca href=\"#B13\"\u003e13\u003c/a\u003e]. Briefly, the samples were boiled for 5min and then separated by 12% sodium dodecyl sulfate polyacrylamide gel electrophoresis (SDS-PAGE). After that, the gel was transferred onto polyvinylidene difluoride (PVDF) membrane for blotting. The membrane was first blocked by incubation in bovine albumin at room temperature for 2h and then incubated with anti-Akt1 antibody (Cell Signaling Technology, USA) and anti-phospho-Akt1 antibody (Cell Signaling Technology, USA) for 2h at room temperature, washed for 3 times with tris buffer containing Tween-20 and incubated at room temperature with HRP conjugated secondary antibody for 2h. The membrane was washed 5 times with tris buffer, and then specific bands were quantified using a ChemiImager System (Alpha Innotech Corporation). Anti-\u003ci\u003e\u003c/i\u003e actin antibody (Abcam, UK) was used as an internal control.\u003c/p\u003e\u003ch5 id=\"sec2.6\"\u003e2.6. Viability Test (MTT) in Neural Differentiated Cells\u003c/h5\u003e\u003cp\u003e MTT (3-[4,5-dimethylthiazol-2-yl]-2,5-diphenyltetrazolium bromide) assay is a useful colorimetric test for detection of cell viability. MTT is for measuring the activity of cellular enzymes that reduce the yellow tetrazolium dye, to its insoluble formazan, giving a purple color. Differentiated mesenchymal stem cells were tested for their survival time in the presence or absence of FLX. The EnSCs were plated into 96 well enzyme linked immunosorbent assay (ELISA) plates, and the differentiation process was repeated as described previously in Section \u003ca href=\"#sec2.2\"\u003e2.2\u003c/a\u003e. After the differentiation for replacing the culture media, FLX was added to three of the wells and PBS was used as a negative control in three other wells. Culture plates were incubated for one week. During incubation (7d), culture media were replaced with medium, containing FLX, FLX + LY294002, and PBS. Cell viability was assessed by MTT assay kit (Biotium, Hayward, USA). The MTT reagent (10\u003ci\u003e\u003c/i\u003eL) was added to the wells and incubated for 3h. At the end of the incubation period, the medium was removed and 100\u003ci\u003e\u003c/i\u003eL DMSO was added into each well. To dissolve the formazan crystals, the supernatant was pipetted several times. Absorbance was measured on an ELISA plate reader at a wavelength of 540nm.\u003c/p\u003e\u003ch5 id=\"sec2.7\"\u003e2.7. Labeling Cell with 5-Bromo-20-deoxyuridine\u003c/h5\u003e\u003cp\u003e One \u003ci\u003e\u003c/i\u003eM BrdU was added to the cultures for 6h on the 8th day of FLX induction. The cells were observed on the 9th day of BrdU labeling and then fixed on the 10th day of development and stained for BrdU and Nestin with anti-BrdU monoclonal antibody (Sigma, St. Louis) overnight at 4C and labeled with secondary antibody conjugated with Rhodamine for 120 minutes at room temperature. BrdU and Nestin positive cells were counted in 10 microscopic fields. The percentage and standard deviation of double stained cells among all Nestin positive cells were calculated.\u003c/p\u003e\u003ch5 id=\"sec2.8\"\u003e2.8. Statistical Analyses\u003c/h5\u003e\u003cp\u003e Data shown were expressed as means  S.D. from data obtained in three independent experiments. MTT and western blot results are obtained from six independent experiments. ANOVA was used to compare the effects of all treatments. Differences of viability within experimental groups were determined by the Mann-Whitney test. Differences were considered statistically significant at \u003csvg height=\"11.85\" id=\"M1\" style=\"vertical-align:-0.546pt;width:58.712502px;\" version=\"1.1\" viewbox=\"0 0 58.712502 11.85\" width=\"58.712502\" xmlns=\"http://www.w3.org/2000/svg\" xmlns:xlink=\"http://www.w3.org/1999/xlink\"\u003e\n\u003cg transform=\"matrix(.017,-0,0,-.017,.062,11.113)\"\u003e\u003cpath d=\"M619 482q0 -69 -40.5 -119t-96 -72.5t-118.5 -26.5h-44l-70 20l-31 -151q-14 -67 0.5 -83t89.5 -22l-5 -28h-287l8 28q65 7 81.5 22t29.5 83l79 398q12 56 0.5 70.5t-78.5 20.5l7 28h255q108 0 164 -43t56 -125zM524 478q0 141 -146 141q-25 0 -47 -8q-16 -6 -20.5 -13.5\u0026#10;t-10.5 -39.5l-43 -241q37 -13 83 -13q67 0 125.5 45t58.5 129z\" id=\"x1D443\"\u003e\u003c/path\u003e\u003c/g\u003e\u003cg transform=\"matrix(.017,-0,0,-.017,15.582,11.113)\"\u003e\u003cpath d=\"M531 71l-474 214v50l474 215v-56l-416 -184l416 -183v-56zM531 -40h-474v50h474v-50z\" id=\"x2264\"\u003e\u003c/path\u003e\u003c/g\u003e\u003cg transform=\"matrix(.017,-0,0,-.017,30.286,11.113)\"\u003e\u003cpath d=\"M241 635q53 0 94 -28.5t63.5 -76t33.5 -102.5t11 -116q0 -58 -11 -112.5t-34 -103.5t-63.5 -78.5t-94.5 -29.5t-95 28t-64.5 75t-34.5 102.5t-11 118.5q0 58 11.5 112.5t34.5 103t64.5 78t95.5 29.5zM238 602q-32 0 -55.5 -25t-35.5 -68t-17.5 -91t-5.5 -105\u0026#10;q0 -76 10 -138.5t37 -107.5t69 -45q32 0 55.5 25t35.5 68.5t17.5 91.5t5.5 105t-5.5 105.5t-18 92t-36 68t-56.5 24.5z\" id=\"x30\"\u003e\u003c/path\u003e\u003c/g\u003e\u003cg transform=\"matrix(.017,-0,0,-.017,38.446,11.113)\"\u003e\u003cpath d=\"M113 -12q-24 0 -39.5 16t-15.5 42q0 24 16 40.5t40 16.5t40 -16.5t16 -40.5q0 -26 -16 -42t-41 -16z\" id=\"x2E\"\u003e\u003c/path\u003e\u003c/g\u003e\u003cg transform=\"matrix(.017,-0,0,-.017,42.321,11.113)\"\u003e\u003cuse xlink:href=\"#x30\"\u003e\u003c/use\u003e\u003c/g\u003e\u003cg transform=\"matrix(.017,-0,0,-.017,50.481,11.113)\"\u003e\u003cpath d=\"M153 550l-26 -186q79 31 111 31q90 0 141.5 -51t51.5 -119q0 -93 -89 -166q-85 -69 -173 -71q-32 0 -61.5 11.5t-41.5 23.5q-18 17 -17 34q2 16 22 33q14 9 26 -1q61 -50 124 -50q60 0 93 43.5t33 104.5q0 69 -41.5 110t-121.5 41q-53 0 -102 -20l38 305h286l6 -8\u0026#10;l-26 -65h-233z\" id=\"x35\"\u003e\u003c/path\u003e\u003c/g\u003e\n\u003c/svg\u003e.\u003c/p\u003e\u003ch4 id=\"results\"\u003e3. Results\u003c/h4\u003e\u003ch5 id=\"sec3.1\"\u003e3.1. Human Endometrial Stem Cell Culture\u003c/h5\u003e\u003cp\u003e Human EnSCs analysis by FACS showed that more than 90% of the cells were CD146+, CD105+, and CD90+ (Figure \u003ca href=\"fig1/\" target=\"_blank\"\u003e1\u003c/a\u003e). This test confirms the true isolation of stem cells from the lining womb. To determine whether the hEnSCs could respond to FLX or not, we treated the stem cells with 110\u003ci\u003e\u003c/i\u003eg serial concentrations of FLX over a period of 10d on collagen precoated and DMSO pretreated plates. In this work, human EnSCs with spindle shaped morphology were cultured (Figure \u003ca href=\"fig2/#a\" target=\"_blank\"\u003e2(a)\u003c/a\u003e). After 10d, fibroblast-like cells with spindle-shape morphology appeared on culture dishes (Figure \u003ca href=\"fig2/#b\" target=\"_blank\"\u003e2(b)\u003c/a\u003e). Considering the role of FLX, we investigated its effect on the stem cell differentiation. Dendrite and axon formation and also neurite outgrowth that are phenotypic changes into neural fate were obvious (Figure \u003ca href=\"fig2/#c\" target=\"_blank\"\u003e2(c)\u003c/a\u003e), and it was comparable with retinoic acid effects as a positive control (Figure \u003ca href=\"fig2/#d\" target=\"_blank\"\u003e2(d)\u003c/a\u003e).\u003c/p\u003e\u003cdiv class=\"floats-partial-section partial-carousel-wrapper\" data-section=\"fig1\"\u003e\u003cdiv class=\"floats-partial-content fig-content-fig1\"\u003e\u003cdiv class=\"partial-carousel--single-image\"\u003e\u003cimg alt=\"(a)\" name=\"582526.fig.001a\" src=\"https://static-01.hindawi.com/articles/bmri/volume-2013/582526/figures/582526.fig.001a.jpg\" /\u003e\u003cbr /\u003e\u003cstrong\u003e(a)\u003c/strong\u003e\u003c/div\u003e\u003cdiv class=\"partial-carousel--single-image\"\u003e\u003cimg alt=\"(b)\" name=\"582526.fig.001b\" src=\"https://static-01.hindawi.com/articles/bmri/volume-2013/582526/figures/582526.fig.001b.jpg\" /\u003e\u003cbr /\u003e\u003cstrong\u003e(b)\u003c/strong\u003e\u003c/div\u003e\u003cdiv class=\"partial-carousel--single-image\"\u003e\u003cimg alt=\"(c)\" name=\"582526.fig.001c\" src=\"https://static-01.hindawi.com/articles/bmri/volume-2013/582526/figures/582526.fig.001c.jpg\" /\u003e\u003cbr /\u003e\u003cstrong\u003e(c)\u003c/strong\u003e\u003c/div\u003e\u003c/div\u003e\u003cdiv class=\"floats-partial-middle\"\u003e\u003cdiv class=\"floats-partial-middle--thumbs fig-thumbs-fig1\"\u003e\u003cbutton class=\"partial-carousel-dot\" aria-label=\"(a)\"\u003e\u003cimg alt=\"(a)\" name=\"582526.fig.001a\" src=\"https://static-01.hindawi.com/articles/bmri/volume-2013/582526/figures/582526.fig.001a.jpg\" /\u003e\u003cbr /\u003e\u003cstrong\u003e(a)\u003c/strong\u003e\u003c/button\u003e\u003cbutton class=\"partial-carousel-dot\" aria-label=\"(b)\"\u003e\u003cimg alt=\"(b)\" name=\"582526.fig.001b\" src=\"https://static-01.hindawi.com/articles/bmri/volume-2013/582526/figures/582526.fig.001b.jpg\" /\u003e\u003cbr /\u003e\u003cstrong\u003e(b)\u003c/strong\u003e\u003c/button\u003e\u003cbutton class=\"partial-carousel-dot\" aria-label=\"(c)\"\u003e\u003cimg alt=\"(c)\" name=\"582526.fig.001c\" src=\"https://static-01.hindawi.com/articles/bmri/volume-2013/582526/figures/582526.fig.001c.jpg\" /\u003e\u003cbr /\u003e\u003cstrong\u003e(c)\u003c/strong\u003e\u003c/button\u003e\u003c/div\u003e\u003cdiv class=\"partial-carousel-next-prev fig-nav-fig1\"\u003e\u003cbutton class=\"carousel-prev\" aria-label=\"Previous\"\u003e\u003c/button\u003e\u003cbutton class=\"carousel-next\" aria-label=\"Next\"\u003e\u003c/button\u003e\u003c/div\u003e\u003c/div\u003e\u003cdiv class=\"floats-partial-footer\"\u003e\u003cdiv class=\"floats-partial-caption\"\u003e\u003cspan class=\"caption-text\"\u003eFigure 1\u003c/span\u003e\u003ca aria-label=\"full view\" class=\"caption-partial-url\" href=\"fig1/\" title=\"full view\" target=\"_blank\"\u003e\u0026nbsp;\u003c/a\u003e\u003c/div\u003e\u003cdiv class=\"floats-partial-caption-text\"\u003e\u003ctable\u003eCharacterization of human endometrial stem cells via fluorescent analyzer cell sorter (FACS). Human EnSCs after the second passage were sorted and analyzed by FACS for CD105\u003csup\u003e+\u003c/sup\u003e, CD146\u003csup\u003e+\u003c/sup\u003e, and CD90\u003csup\u003e+\u003c/sup\u003e markers.\u003c/table\u003e\u003c/div\u003e\u003c/div\u003e\u003c/div\u003e\u003cdiv class=\"floats-partial-section partial-carousel-wrapper\" data-section=\"fig2\"\u003e\u003cdiv class=\"floats-partial-content fig-content-fig2\"\u003e\u003cdiv class=\"partial-carousel--single-image\"\u003e\u003cimg alt=\"(a)\" name=\"582526.fig.002a\" src=\"https://static-01.hindawi.com/articles/bmri/volume-2013/582526/figures/582526.fig.002a.jpg\" /\u003e\u003cbr /\u003e\u003cstrong\u003e(a)\u003c/strong\u003e\u003c/div\u003e\u003cdiv class=\"partial-carousel--single-image\"\u003e\u003cimg alt=\"(b)\" name=\"582526.fig.002b\" src=\"https://static-01.hindawi.com/articles/bmri/volume-2013/582526/figures/582526.fig.002b.jpg\" /\u003e\u003cbr /\u003e\u003cstrong\u003e(b)\u003c/strong\u003e\u003c/div\u003e\u003cdiv class=\"partial-carousel--single-image\"\u003e\u003cimg alt=\"(c)\" name=\"582526.fig.002c\" src=\"https://static-01.hindawi.com/articles/bmri/volume-2013/582526/figures/582526.fig.002c.jpg\" /\u003e\u003cbr /\u003e\u003cstrong\u003e(c)\u003c/strong\u003e\u003c/div\u003e\u003cdiv class=\"partial-carousel--single-image\"\u003e\u003cimg alt=\"(d)\" name=\"582526.fig.002d\" src=\"https://static-01.hindawi.com/articles/bmri/volume-2013/582526/figures/582526.fig.002d.jpg\" /\u003e\u003cbr /\u003e\u003cstrong\u003e(d)\u003c/strong\u003e\u003c/div\u003e\u003c/div\u003e\u003cdiv class=\"floats-partial-middle\"\u003e\u003cdiv class=\"floats-partial-middle--thumbs fig-thumbs-fig2\"\u003e\u003cbutton class=\"partial-carousel-dot\" aria-label=\"(a)\"\u003e\u003cimg alt=\"(a)\" name=\"582526.fig.002a\" src=\"https://static-01.hindawi.com/articles/bmri/volume-2013/582526/figures/582526.fig.002a.jpg\" /\u003e\u003cbr /\u003e\u003cstrong\u003e(a)\u003c/strong\u003e\u003c/button\u003e\u003cbutton class=\"partial-carousel-dot\" aria-label=\"(b)\"\u003e\u003cimg alt=\"(b)\" name=\"582526.fig.002b\" src=\"https://static-01.hindawi.com/articles/bmri/volume-2013/582526/figures/582526.fig.002b.jpg\" /\u003e\u003cbr /\u003e\u003cstrong\u003e(b)\u003c/strong\u003e\u003c/button\u003e\u003cbutton class=\"partial-carousel-dot\" aria-label=\"(c)\"\u003e\u003cimg alt=\"(c)\" name=\"582526.fig.002c\" src=\"https://static-01.hindawi.com/articles/bmri/volume-2013/582526/figures/582526.fig.002c.jpg\" /\u003e\u003cbr /\u003e\u003cstrong\u003e(c)\u003c/strong\u003e\u003c/button\u003e\u003cbutton class=\"partial-carousel-dot\" aria-label=\"(d)\"\u003e\u003cimg alt=\"(d)\" name=\"582526.fig.002d\" src=\"https://static-01.hindawi.com/articles/bmri/volume-2013/582526/figures/582526.fig.002d.jpg\" /\u003e\u003cbr /\u003e\u003cstrong\u003e(d)\u003c/strong\u003e\u003c/button\u003e\u003c/div\u003e\u003cdiv class=\"partial-carousel-next-prev fig-nav-fig2\"\u003e\u003cbutton class=\"carousel-prev\" aria-label=\"Previous\"\u003e\u003c/button\u003e\u003cbutton class=\"carousel-next\" aria-label=\"Next\"\u003e\u003c/button\u003e\u003c/div\u003e\u003c/div\u003e\u003cdiv class=\"floats-partial-footer\"\u003e\u003cdiv class=\"floats-partial-caption\"\u003e\u003cspan class=\"caption-text\"\u003eFigure 2\u003c/span\u003e\u003ca aria-label=\"full view\" class=\"caption-partial-url\" href=\"fig2/\" title=\"full view\" target=\"_blank\"\u003e\u0026nbsp;\u003c/a\u003e\u003c/div\u003e\u003cdiv class=\"floats-partial-caption-text\"\u003e\u003ctable\u003eMorphological characteristics and differentiation of hEnSCs into neural cells. (a) Human EnSC (passage 2) in DMEM low glucose (b), after 10d in DMEM pretreated with DMSO (c), plus 10\u003ci\u003e\u003c/i\u003eM of FLX and (d) 1\u003ci\u003e\u003c/i\u003eg/mL of retinoic acid as a positive control (magnification: 400).\u003c/table\u003e\u003c/div\u003e\u003c/div\u003e\u003c/div\u003e\u003ch5 id=\"sec3.2\"\u003e3.2. Expression of Differential Neural Genes\u003c/h5\u003e\u003cp\u003e The \u003ci\u003ein vitro \u003c/i\u003estudy is conducted to determine that  the neurogenesis regulating effect could be replicated in cell culture system. One week after the treatment of hEnSCs, we examined the neural markers by RT-PCR. RT-PCR analysis was indicative of the expression of \u003ci\u003enestin\u003c/i\u003e, \u003ci\u003emap-2\u003c/i\u003e, and \u003ci\u003e\u003ci\u003e\u003c/i\u003e-tubulin\u003c/i\u003e genes as shown in Figure \u003ca href=\"fig3/\" target=\"_blank\"\u003e3\u003c/a\u003e. \u003c/p\u003e\u003cdiv class=\"floats-partial-section partial-carousel-wrapper\" data-section=\"fig3\"\u003e\u003cdiv class=\"floats-partial-content fig-content-fig3\"\u003e\u003cdiv class=\"partial-carousel--single-image\"\u003e\u003cimg alt=\"\" name=\"582526.fig.003\" src=\"https://static-01.hindawi.com/articles/bmri/volume-2013/582526/figures/582526.fig.003.jpg\" /\u003e\u003cbr /\u003e\u003cstrong\u003e\u003c/strong\u003e\u003c/div\u003e\u003c/div\u003e\u003cdiv class=\"floats-partial-footer\"\u003e\u003cdiv class=\"floats-partial-caption\"\u003e\u003cspan class=\"caption-text\"\u003eFigure 3\u003c/span\u003e\u003ca aria-label=\"full view\" class=\"caption-partial-url\" href=\"fig3/\" title=\"full view\" target=\"_blank\"\u003e\u0026nbsp;\u003c/a\u003e\u003c/div\u003e\u003cdiv class=\"floats-partial-caption-text\"\u003e\u003ctable\u003eExpression of differential genes. Expression of \u003ci\u003eNestin\u003c/i\u003e, \u003ci\u003eMap-2\u003c/i\u003e, and \u003ci\u003e\u003ci\u003e\u003c/i\u003e-tubulin \u003c/i\u003eneuron markers was analyzed in control culture and FLX (10\u003ci\u003e\u003c/i\u003eM) treated and induced differentiation culture after 10d.\u003c/table\u003e\u003c/div\u003e\u003c/div\u003e\u003c/div\u003e\u003ch5 id=\"sec3.3\"\u003e3.3. Immunostaining of Neuronal Induced Specific Markers\u003c/h5\u003e\u003cp\u003eFluoxetine treated and differentiated mesenchymal stem cells were visualized by the staining of some neuronal markers. Immunocytochemistry was used to analyze the Nestin, MAP-2, and \u003ci\u003e\u003c/i\u003e-tubulin proteins. The result showed that these proteins were detected after treatment in 10d (Figure \u003ca href=\"fig4/#a\" target=\"_blank\"\u003e4(a)\u003c/a\u003e). Also a group of cells that were treated with LY294002 as a phosphatidylinositol-3-kinase (PI3-K) inhibitor did not express the neural markers even after 10d treatment by FLX (Figure \u003ca href=\"fig4/#b\" target=\"_blank\"\u003e4(b)\u003c/a\u003e).\u003c/p\u003e\u003cdiv class=\"floats-partial-section partial-carousel-wrapper\" data-section=\"fig4\"\u003e\u003cdiv class=\"floats-partial-content fig-content-fig4\"\u003e\u003cdiv class=\"partial-carousel--single-image\"\u003e\u003cimg alt=\"(a)\" name=\"582526.fig.004a\" src=\"https://static-01.hindawi.com/articles/bmri/volume-2013/582526/figures/582526.fig.004a.jpg\" /\u003e\u003cbr /\u003e\u003cstrong\u003e(a)\u003c/strong\u003e\u003c/div\u003e\u003cdiv class=\"partial-carousel--single-image\"\u003e\u003cimg alt=\"(b)\" name=\"582526.fig.004b\" src=\"https://static-01.hindawi.com/articles/bmri/volume-2013/582526/figures/582526.fig.004b.jpg\" /\u003e\u003cbr /\u003e\u003cstrong\u003e(b)\u003c/strong\u003e\u003c/div\u003e\u003c/div\u003e\u003cdiv class=\"floats-partial-middle\"\u003e\u003cdiv class=\"floats-partial-middle--thumbs fig-thumbs-fig4\"\u003e\u003cbutton class=\"partial-carousel-dot\" aria-label=\"(a)\"\u003e\u003cimg alt=\"(a)\" name=\"582526.fig.004a\" src=\"https://static-01.hindawi.com/articles/bmri/volume-2013/582526/figures/582526.fig.004a.jpg\" /\u003e\u003cbr /\u003e\u003cstrong\u003e(a)\u003c/strong\u003e\u003c/button\u003e\u003cbutton class=\"partial-carousel-dot\" aria-label=\"(b)\"\u003e\u003cimg alt=\"(b)\" name=\"582526.fig.004b\" src=\"https://static-01.hindawi.com/articles/bmri/volume-2013/582526/figures/582526.fig.004b.jpg\" /\u003e\u003cbr /\u003e\u003cstrong\u003e(b)\u003c/strong\u003e\u003c/button\u003e\u003c/div\u003e\u003cdiv class=\"partial-carousel-next-prev fig-nav-fig4\"\u003e\u003cbutton class=\"carousel-prev\" aria-label=\"Previous\"\u003e\u003c/button\u003e\u003cbutton class=\"carousel-next\" aria-label=\"Next\"\u003e\u003c/button\u003e\u003c/div\u003e\u003c/div\u003e\u003cdiv class=\"floats-partial-footer\"\u003e\u003cdiv class=\"floats-partial-caption\"\u003e\u003cspan class=\"caption-text\"\u003eFigure 4\u003c/span\u003e\u003ca aria-label=\"full view\" class=\"caption-partial-url\" href=\"fig4/\" title=\"full view\" target=\"_blank\"\u003e\u0026nbsp;\u003c/a\u003e\u003c/div\u003e\u003cdiv class=\"floats-partial-caption-text\"\u003e\u003ctable\u003eImmunostaining of hEnSCs differential markers. Expression of neuron markers including Nestin, MAP-2 and \u003ci\u003e\u003c/i\u003e-tubulin was analyzed in FLX induced differentiation after 10d. The expression of CD11b as a glial marker was not obvious. The size bar is 10\u003ci\u003e\u003c/i\u003em (a). Immunostaining of LY294002 treated hEnSCs after culture in FLX supplemented medium. There is not an expression of neuron markers in FLX induced differentiation after 10d (b).\u003c/table\u003e\u003c/div\u003e\u003c/div\u003e\u003c/div\u003e\u003cp\u003e\u003c/p\u003e\u003ch5 id=\"sec3.4\"\u003e3.4. Overexpression of Phosphorylated Akt1\u003c/h5\u003e\u003cp\u003e Phosphorylation of Akt1 in FLX-treated mesenchymal stem cells as detected by western blot was higher than non-FLX-treated stem cells. Also LY294002 as a PI3-K inhibitor inhibited the phosphorylation of Akt1 significantly (Figure \u003ca href=\"fig5/\" target=\"_blank\"\u003e5\u003c/a\u003e).\u003c/p\u003e\u003cdiv class=\"floats-partial-section partial-carousel-wrapper\" data-section=\"fig5\"\u003e\u003cdiv class=\"floats-partial-content fig-content-fig5\"\u003e\u003cdiv class=\"partial-carousel--single-image\"\u003e\u003cimg alt=\"\" name=\"582526.fig.005\" src=\"https://static-01.hindawi.com/articles/bmri/volume-2013/582526/figures/582526.fig.005.jpg\" /\u003e\u003cbr /\u003e\u003cstrong\u003e\u003c/strong\u003e\u003c/div\u003e\u003c/div\u003e\u003cdiv class=\"floats-partial-footer\"\u003e\u003cdiv class=\"floats-partial-caption\"\u003e\u003cspan class=\"caption-text\"\u003eFigure 5\u003c/span\u003e\u003ca aria-label=\"full view\" class=\"caption-partial-url\" href=\"fig5/\" title=\"full view\" target=\"_blank\"\u003e\u0026nbsp;\u003c/a\u003e\u003c/div\u003e\u003cdiv class=\"floats-partial-caption-text\"\u003e\u003ctable\u003eWestern blot results after treatment of hEnSC with 10\u003ci\u003e\u003c/i\u003eM fluoxetine after 10d. Protein samples (100\u003ci\u003e\u003c/i\u003eg) were loaded onto SDS PAGE gels and transferred to PVDF membranes. The induced EnSCs produced an increase expression of phosphorylated Akt1 protein. \u003ci\u003e\u003c/i\u003e-Actin was used as an internal control.\u003c/table\u003e\u003c/div\u003e\u003c/div\u003e\u003c/div\u003e\u003ch5 id=\"sec3.5\"\u003e3.5. Viability of FLX Treated Cells\u003c/h5\u003e\u003cp\u003e The effect of FLX on the survival period of the differentiated stem cells was observed directly and investigated by MTT assay. As shown in Figure \u003ca href=\"fig6/\" target=\"_blank\"\u003e6\u003c/a\u003e, FLX treatment affects the cell survival rate significantly (\u003csvg height=\"11.375\" id=\"M2\" style=\"vertical-align:-0.1638pt;width:58.712502px;\" version=\"1.1\" viewbox=\"0 0 58.712502 11.375\" width=\"58.712502\" xmlns=\"http://www.w3.org/2000/svg\" xmlns:xlink=\"http://www.w3.org/1999/xlink\"\u003e\n\u003cg transform=\"matrix(.017,-0,0,-.017,.062,11.112)\"\u003e\u003cuse xlink:href=\"#x1D443\"\u003e\u003c/use\u003e\u003c/g\u003e\u003cg transform=\"matrix(.017,-0,0,-.017,15.582,11.112)\"\u003e\u003cpath d=\"M512 -3l-437 233v51l437 233v-58l-378 -200v-2l378 -199v-58z\" id=\"x3C\"\u003e\u003c/path\u003e\u003c/g\u003e\u003cg transform=\"matrix(.017,-0,0,-.017,30.286,11.112)\"\u003e\u003cuse xlink:href=\"#x30\"\u003e\u003c/use\u003e\u003c/g\u003e\u003cg transform=\"matrix(.017,-0,0,-.017,38.446,11.112)\"\u003e\u003cuse xlink:href=\"#x2E\"\u003e\u003c/use\u003e\u003c/g\u003e\u003cg transform=\"matrix(.017,-0,0,-.017,42.321,11.112)\"\u003e\u003cuse xlink:href=\"#x30\"\u003e\u003c/use\u003e\u003c/g\u003e\u003cg transform=\"matrix(.017,-0,0,-.017,50.481,11.112)\"\u003e\u003cuse xlink:href=\"#x35\"\u003e\u003c/use\u003e\u003c/g\u003e\n\u003c/svg\u003e) higher than all other groups. While the retinoic acid strongly suppressed cell survival in this assay, the suppressive effect of FLX on differentiated stem cells was very low. The continuance of FLX treatment extended the time and percentage of cell viability (Figure \u003ca href=\"fig6/\" target=\"_blank\"\u003e6\u003c/a\u003e). The BrdU labeled cells were observed 24h after labeling that showed over 90% of hEnSCs were BrdU positive (Figure \u003ca href=\"fig7/#a\" target=\"_blank\"\u003e7(a)\u003c/a\u003e). The amounts of Nestin-BrdU positive cells were determined on the 10th day in cultures. The percentage of double stained cells among all Nestin positive cells and standard deviation were calculated from data of 10 microscopic fields. Cultures treated with BrdU and fixed on the 10th day contained about 60% double stained positive cells (Figure \u003ca href=\"fig7/#b\" target=\"_blank\"\u003e7(b)\u003c/a\u003e).\u003c/p\u003e\u003cdiv class=\"floats-partial-section partial-carousel-wrapper\" data-section=\"fig6\"\u003e\u003cdiv class=\"floats-partial-content fig-content-fig6\"\u003e\u003cdiv class=\"partial-carousel--single-image\"\u003e\u003cimg alt=\"\" name=\"582526.fig.006\" src=\"https://static-01.hindawi.com/articles/bmri/volume-2013/582526/figures/582526.fig.006.jpg\" /\u003e\u003cbr /\u003e\u003cstrong\u003e\u003c/strong\u003e\u003c/div\u003e\u003c/div\u003e\u003cdiv class=\"floats-partial-footer\"\u003e\u003cdiv class=\"floats-partial-caption\"\u003e\u003cspan class=\"caption-text\"\u003eFigure 6\u003c/span\u003e\u003ca aria-label=\"full view\" class=\"caption-partial-url\" href=\"fig6/\" title=\"full view\" target=\"_blank\"\u003e\u0026nbsp;\u003c/a\u003e\u003c/div\u003e\u003cdiv class=\"floats-partial-caption-text\"\u003e\u003ctable\u003eMTT shows EnSCs differentiated neural cell viability rate in the presence of FLX, FLX + LY294002, LY294002, and retinoic acid after one week (\u003csvg height=\"11.85\" id=\"M3\" style=\"vertical-align:-0.546pt\" version=\"1.1\" viewbox=\"0 0 58.712502 11.85\" width=\"58.712502\" xmlns=\"http://www.w3.org/2000/svg\" xmlns:xlink=\"http://www.w3.org/1999/xlink\"\u003e\n\u003cg transform=\"matrix(.017,-0,0,-.017,.062,11.113)\"\u003e\u003cpath d=\"M619 482q0 -69 -40.5 -119t-96 -72.5t-118.5 -26.5h-44l-70 20l-31 -151q-14 -67 0.5 -83t89.5 -22l-5 -28h-287l8 28q65 7 81.5 22t29.5 83l79 398q12 56 0.5 70.5t-78.5 20.5l7 28h255q108 0 164 -43t56 -125zM524 478q0 141 -146 141q-25 0 -47 -8q-16 -6 -20.5 -13.5\u0026#10;t-10.5 -39.5l-43 -241q37 -13 83 -13q67 0 125.5 45t58.5 129z\" id=\"x1D443\"\u003e\u003c/path\u003e\u003c/g\u003e\u003cg transform=\"matrix(.017,-0,0,-.017,15.582,11.113)\"\u003e\u003cpath d=\"M531 71l-474 214v50l474 215v-56l-416 -184l416 -183v-56zM531 -40h-474v50h474v-50z\" id=\"x2264\"\u003e\u003c/path\u003e\u003c/g\u003e\u003cg transform=\"matrix(.017,-0,0,-.017,30.286,11.113)\"\u003e\u003cpath d=\"M241 635q53 0 94 -28.5t63.5 -76t33.5 -102.5t11 -116q0 -58 -11 -112.5t-34 -103.5t-63.5 -78.5t-94.5 -29.5t-95 28t-64.5 75t-34.5 102.5t-11 118.5q0 58 11.5 112.5t34.5 103t64.5 78t95.5 29.5zM238 602q-32 0 -55.5 -25t-35.5 -68t-17.5 -91t-5.5 -105\u0026#10;q0 -76 10 -138.5t37 -107.5t69 -45q32 0 55.5 25t35.5 68.5t17.5 91.5t5.5 105t-5.5 105.5t-18 92t-36 68t-56.5 24.5z\" id=\"x30\"\u003e\u003c/path\u003e\u003c/g\u003e\u003cg transform=\"matrix(.017,-0,0,-.017,38.446,11.113)\"\u003e\u003cpath d=\"M113 -12q-24 0 -39.5 16t-15.5 42q0 24 16 40.5t40 16.5t40 -16.5t16 -40.5q0 -26 -16 -42t-41 -16z\" id=\"x2E\"\u003e\u003c/path\u003e\u003c/g\u003e\u003cg transform=\"matrix(.017,-0,0,-.017,42.321,11.113)\"\u003e\u003cpath d=\"M241 635q53 0 94 -28.5t63.5 -76t33.5 -102.5t11 -116q0 -58 -11 -112.5t-34 -103.5t-63.5 -78.5t-94.5 -29.5t-95 28t-64.5 75t-34.5 102.5t-11 118.5q0 58 11.5 112.5t34.5 103t64.5 78t95.5 29.5zM238 602q-32 0 -55.5 -25t-35.5 -68t-17.5 -91t-5.5 -105\u0026#10;q0 -76 10 -138.5t37 -107.5t69 -45q32 0 55.5 25t35.5 68.5t17.5 91.5t5.5 105t-5.5 105.5t-18 92t-36 68t-56.5 24.5z\" id=\"x30\"\u003e\u003c/path\u003e\u003c/g\u003e\u003cg transform=\"matrix(.017,-0,0,-.017,50.481,11.113)\"\u003e\u003cpath d=\"M153 550l-26 -186q79 31 111 31q90 0 141.5 -51t51.5 -119q0 -93 -89 -166q-85 -69 -173 -71q-32 0 -61.5 11.5t-41.5 23.5q-18 17 -17 34q2 16 22 33q14 9 26 -1q61 -50 124 -50q60 0 93 43.5t33 104.5q0 69 -41.5 110t-121.5 41q-53 0 -102 -20l38 305h286l6 -8\u0026#10;l-26 -65h-233z\" id=\"x35\"\u003e\u003c/path\u003e\u003c/g\u003e\n\u003c/svg\u003e). The numbers from the left side are as follows: (1) 1\u003ci\u003e\u003c/i\u003eM FLX, (2) 5\u003ci\u003e\u003c/i\u003eM FLX, (3) 10\u003ci\u003e\u003c/i\u003eM FLX, (4) 10\u003ci\u003e\u003c/i\u003eM FLX + 10\u003ci\u003e\u003c/i\u003eM LY294002, (5) 10\u003ci\u003e\u003c/i\u003eM LY294002, (6) 1\u003ci\u003e\u003c/i\u003eM retinoic acid, (7) neural differentiated cells without FLX supplement, and (8) undifferentiated mesenchymal stem cells.\u003c/table\u003e\u003c/div\u003e\u003c/div\u003e\u003c/div\u003e\u003cdiv class=\"floats-partial-section partial-carousel-wrapper\" data-section=\"fig7\"\u003e\u003cdiv class=\"floats-partial-content fig-content-fig7\"\u003e\u003cdiv class=\"partial-carousel--single-image\"\u003e\u003cimg alt=\"(a)\" name=\"582526.fig.007a\" src=\"https://static-01.hindawi.com/articles/bmri/volume-2013/582526/figures/582526.fig.007a.jpg\" /\u003e\u003cbr /\u003e\u003cstrong\u003e(a)\u003c/strong\u003e\u003c/div\u003e\u003cdiv class=\"partial-carousel--single-image\"\u003e\u003cimg alt=\"(b)\" name=\"582526.fig.007b\" src=\"https://static-01.hindawi.com/articles/bmri/volume-2013/582526/figures/582526.fig.007b.jpg\" /\u003e\u003cbr /\u003e\u003cstrong\u003e(b)\u003c/strong\u003e\u003c/div\u003e\u003c/div\u003e\u003cdiv class=\"floats-partial-middle\"\u003e\u003cdiv class=\"floats-partial-middle--thumbs fig-thumbs-fig7\"\u003e\u003cbutton class=\"partial-carousel-dot\" aria-label=\"(a)\"\u003e\u003cimg alt=\"(a)\" name=\"582526.fig.007a\" src=\"https://static-01.hindawi.com/articles/bmri/volume-2013/582526/figures/582526.fig.007a.jpg\" /\u003e\u003cbr /\u003e\u003cstrong\u003e(a)\u003c/strong\u003e\u003c/button\u003e\u003cbutton class=\"partial-carousel-dot\" aria-label=\"(b)\"\u003e\u003cimg alt=\"(b)\" name=\"582526.fig.007b\" src=\"https://static-01.hindawi.com/articles/bmri/volume-2013/582526/figures/582526.fig.007b.jpg\" /\u003e\u003cbr /\u003e\u003cstrong\u003e(b)\u003c/strong\u003e\u003c/button\u003e\u003c/div\u003e\u003cdiv class=\"partial-carousel-next-prev fig-nav-fig7\"\u003e\u003cbutton class=\"carousel-prev\" aria-label=\"Previous\"\u003e\u003c/button\u003e\u003cbutton class=\"carousel-next\" aria-label=\"Next\"\u003e\u003c/button\u003e\u003c/div\u003e\u003c/div\u003e\u003cdiv class=\"floats-partial-footer\"\u003e\u003cdiv class=\"floats-partial-caption\"\u003e\u003cspan class=\"caption-text\"\u003eFigure 7\u003c/span\u003e\u003ca aria-label=\"full view\" class=\"caption-partial-url\" href=\"fig7/\" title=\"full view\" target=\"_blank\"\u003e\u0026nbsp;\u003c/a\u003e\u003c/div\u003e\u003cdiv class=\"floats-partial-caption-text\"\u003e\u003ctable\u003eEndometrial stem cells labeled by BrdU (a). Cultures were treated with FLX and labeled with BrdU. They were then stained with antibodies against BrdU and nestin, followed by either rhodamine- (for BrdU, red) or FITC- (nestin, green) labeled secondary antibodies (b). Data are representative of 3 independent experiments.\u003c/table\u003e\u003c/div\u003e\u003c/div\u003e\u003c/div\u003e\u003ch4 id=\"discussion\"\u003e4. Discussion\u003c/h4\u003e\u003cp\u003e  Differentiation of mesenchymal stem cells into a specific lineage, their survival, and functionality are related to molecular regulation. The main finding of this research is that the fluoxetine antidepressant could induce neurogenesis in mesenchymal stem cells and upregulate the phosphorylation of serine/threonine kinase Akt1, and therefore it could be a differentiation and proliferation signaling mediator in cell therapy. \u003c/p\u003e\u003cp\u003e  Selective serotonin reuptake inhibitors like FLX facilitate signaling of serotonin by inhibiting its reuptake. At the molecular levels, FLX increases synaptic availability of serotonin [\u003ca href=\"#B14\"\u003e14\u003c/a\u003e]. It has been shown that FLX could inhibit or activate PI3k/Akt or ERK1/2 pathways depending on the cell types and their function [\u003ca href=\"#B15\"\u003e15\u003c/a\u003e\u003ca href=\"#B17\"\u003e17\u003c/a\u003e]. So it could have a dual role in the cancer therapy and cell therapy in regenerative medicine. For this purpose, we selected the Akt signaling to determine its role in mesenchymal stem cell proliferation, differentiation, and survival. \u003c/p\u003e\u003cp\u003e  First, our \u003ci\u003ein vitro \u003c/i\u003estudy was conducted to determine the possibility of neurogenesis by FLX in the mesenchymal stem cell system (Figures \u003ca href=\"fig2/#a\" target=\"_blank\"\u003e2(a)\u003c/a\u003e and \u003ca href=\"fig2/#b\" target=\"_blank\"\u003e2(b)\u003c/a\u003e). Our results demonstrated that hEnSCs could be induced to differentiate into neurons in the presence of FLX (Figure \u003ca href=\"fig2/#c\" target=\"_blank\"\u003e2(c)\u003c/a\u003e) as was seen in cells treated with retinoic acid (Figure \u003ca href=\"fig2/#d\" target=\"_blank\"\u003e2(d)\u003c/a\u003e). High concentrations of FLX have nonserotoninergic effects on cells [\u003ca href=\"#B5\"\u003e5\u003c/a\u003e]. Nonserotoninergic targets of fluoxetine that mediate its other effects are likely to have a lower binding affinity or lower availability for FLX. Inhibition of cytochrome P450 is known to be due to a nonserotoninergic effect of FLX [\u003ca href=\"#B18\"\u003e18\u003c/a\u003e]. Lee et al. (2008) showed that liver cytochrome P450-dependent ROS formation is responsible for cyclin-A downregulation and inhibition of neural progenitor cell proliferation [\u003ca href=\"#B19\"\u003e19\u003c/a\u003e] so inhibition of cytochrome P450 may inhibit cyclin-A downregulation and restoring cyclin-A reverse inhibition of neural progenitor cell proliferation. However, this induction did not occur in the brain and suggested a tissue-specific response [\u003ca href=\"#B20\"\u003e20\u003c/a\u003e]. It has been demonstrated that the SSRIs interact with the \u003ci\u003eeag \u003c/i\u003evoltage-gated K\u003csub\u003e1\u003c/sub\u003e channel [\u003ca href=\"#B21\"\u003e21\u003c/a\u003e], and  voltage-gated potassium channels play a functional role in the development of human neural progenitor cells and differentiation of neurons [\u003ca href=\"#B22\"\u003e22\u003c/a\u003e]. Also studies by de Oliveira and colleagues in 2012 showed that \u003ci\u003eeag\u003c/i\u003e potassium channel expression in the rat hippocampus has been associated with neural cell survival and transient brain ischemia [\u003ca href=\"#B23\"\u003e23\u003c/a\u003e]. \u003c/p\u003e\u003cp\u003e  In our experiment, fluoxetine-induced hEnSCs displayed neuronal morphology with axon formation and neurite outgrowth and expressed Nestin and other neuronal specific molecular markers by the reverse transcriptase polymerase chain reaction (Figure \u003ca href=\"fig3/\" target=\"_blank\"\u003e3\u003c/a\u003e) and immunocytochemistry (Figure \u003ca href=\"fig4/#a\" target=\"_blank\"\u003e4(a)\u003c/a\u003e) assays. EnSCs cultured in serum-free DMEM/F12 medium could not differentiate or even proliferated constantly. These findings indicate FLX-induced EnSCs may provide a stem-cell-based way to generate neuronal cells for the treatment of neurodegenerative diseases. This finding could determine that the endometrial stem cells express serotonin receptors. In neuropharmacology, it may be beneficial to study the effect of the different antidepressants on the neurogenesis since this provides insights into the regulation of stem cell proliferation. \u003c/p\u003e\u003cp\u003e  Regeneration of neurons that undergo cell death soon after injury is the main goal of all cell-based therapies. From the point that neurogenesis has the capacity to enhance brain repair and/or spinal cord repair after ischemia and/or trauma by replacement of dead cells or seriously injured cells FLX neurogenesis could lead to recovery of these cells. FLX would appear to be a candidate as a neurogenesis factor. Our experiment showed that the hEnSCs expressed neural cell markers after FLX treatment, but there was no expression of CD11b marker that is a specific glial marker (Figure \u003ca href=\"fig4/#a\" target=\"_blank\"\u003e4(a)\u003c/a\u003e). This is an important point because glial scar formation that occurs following CNS injuries is an important obstacle of neuroregeneration. FLX could introduce a regenerative product in neuronal injuries and find its position in regenerative pharmacology.\u003c/p\u003e\u003cp\u003e  Many groups have examined the potential of neuron replacement from embryonic stem cells [\u003ca href=\"#B24\"\u003e24\u003c/a\u003e], induced pluripotent stem cells (iPS) [\u003ca href=\"#B25\"\u003e25\u003c/a\u003e, \u003ca href=\"#B26\"\u003e26\u003c/a\u003e], and cord blood derived stem cells. Endometrial stem cells have demonstrated superior potential. They expand rapidly and they have fewer technical and ethical problems so they have great potential as therapeutic agents and autologous grafts [\u003ca href=\"#B2\"\u003e2\u003c/a\u003e]. Our team has previously shown that the endometrial stem cells could be differentiated successfully into other lineages of cells especially neural cells [\u003ca href=\"#B1\"\u003e1\u003c/a\u003e, \u003ca href=\"#B11\"\u003e11\u003c/a\u003e]. It represents a progress in the development of a new source of neurons. \u003c/p\u003e\u003cp\u003e  We further confirmed the protective mechanisms of Akt1 phosphorylation as a survival signaling that introduces this pathway as a potential target for stem cell survival after differentiation of mesenchymal stem cells (Figure \u003ca href=\"fig6/\" target=\"_blank\"\u003e6\u003c/a\u003e). PI3k/Akt is the important cell survival pathways and phosphorylation of Akt mediates anti-apoptosis in many kinds of cells [\u003ca href=\"#B27\"\u003e27\u003c/a\u003e]. In 2003, Kim et al. have shown that the Akt activation results in phosphorylation and then inactivation of the pro-apoptotic protein glycogen synthase kinase 3 (GSK3b), thus extending the cell survival period [\u003ca href=\"#B28\"\u003e28\u003c/a\u003e]. In support of the role of Akt1 phosphorylation, we found that the PI3K inhibitor LY294002 in the concentration of 10\u003ci\u003e\u003c/i\u003eM decreased the FLX mediated Akt phosphorylation (Figure \u003ca href=\"fig5/\" target=\"_blank\"\u003e5\u003c/a\u003e), differentiation (Figure \u003ca href=\"fig4/#b\" target=\"_blank\"\u003e4(b)\u003c/a\u003e), and the viability of neuronal differentiated cells (Figure \u003ca href=\"fig6/\" target=\"_blank\"\u003e6\u003c/a\u003e). This suggests a key role for activating Akt1 in the protection of mesenchymal stem cell from the precocious death. Also we have labeled the hEnSCs with BrdU to obtain more exact cell proliferation rate (Figure \u003ca href=\"fig7/#a\" target=\"_blank\"\u003e7(a)\u003c/a\u003e). The FLX treated stem cells that were labeled with BrdU showed double-staining for both BrdU and Nestin on the 10th day. Cells acquiring Nestin positive phenotype seemed to go through cell cycles enough to dilute the BrdU label to the non-detectable levels. In our experiment, BrdU was added on the 8th day of induction, and about half of nestin positive cells carried BrdU-label on the 10th day (Figure \u003ca href=\"fig7/#b\" target=\"_blank\"\u003e7(b)\u003c/a\u003e). In cultures that FLX was absent about 70% of Nestin positive cells carried BrdU-label.\u003c/p\u003e\u003cp\u003e  In 2006, Frebel and Wiese confirmed the neuronal survival and differentiation implicated PI3-K/AKT in synaptic plasticity, learning, and memory in the mammalian brain [\u003ca href=\"#B29\"\u003e29\u003c/a\u003e].\u003c/p\u003e\u003cp\u003e  Although this finding supports the neurogenesis role of SSRIs, it has been suggested that excessive neurogenesis is not beneficial and could result in inappropriate migration into existing neural networks. Scharfman and Hen believe that this manner could cause some pathological conditions as epilepsy [\u003ca href=\"#B30\"\u003e30\u003c/a\u003e], but previously Rush et al. reporting that SSRIs could lose their effect after long-term use [\u003ca href=\"#B31\"\u003e31\u003c/a\u003e]. This has been called relapse during maintenance treatment. A possible mechanism underlying this effect is the weakness of neurogenesis because of excessive stimulation. So it is possible that long-term SSRI therapy might affect PI3/Akt pathway and its activation that leads to cognitive functions by disrupting the normal regulation of neurogenesis.\u003c/p\u003e\u003ch4 id=\"conclusion\"\u003e5. Conclusion\u003c/h4\u003e\u003cp\u003e   In conclusion our data argue with fluoxetine effect on mesenchymal stem cell neurogenesis and its role in the phosphorylation of Akt1 in the differentiated cells to increase the survival rate of differentiated cells.\u003c/p\u003e\u003ch4 id=\"conflict-of-interests\"\u003eConflict of Interests\u003c/h4\u003e\u003cp\u003e The authors have no conflict of interests.\u003c/p\u003e\u003c/div\u003e\u003cdiv class=\"xml-content\"\u003e\u003ch4 class=\"references\" id=\"references\"\u003eReferences\u003c/h4\u003e\u003col\u003e\u003cli id=\"B1\"\u003eM. Noureddini, J. Verdi, S. A. Mortazavi Tabatabaei, S. Sharif, and A. Shoae Hassani, Human endometrial stem cell neurogenesis in response to NGF and bFGF, \u003ci\u003eCell Biology International\u003c/i\u003e, vol. 36, no. 1, pp. 961966, 2012. \u003cspan class=\"reflinks\"\u003eView at: \u003ca href=\"https://scholar.google.com/scholar_lookup?title=Human%20endometrial%20stem%20cell%20neurogenesis%20in%20response%20to%20NGF%20and%20bFGF\u0026author=M. Noureddini\u0026author=J. Verdi\u0026author=S. A. Mortazavi Tabatabaei\u0026author=S. Sharif\u0026author=\u0026author=A. Shoae Hassani\u0026publication_year=2012\" target=\"_blank\"\u003eGoogle Scholar\u003c/a\u003e\u003c/span\u003e\u003cli id=\"B2\"\u003eA. Shoae-Hassani, S. A. Mortazavi-Tabatabaei, S. Sharif, H. Rezaei-Khaligh, and J. Verdi, DHEA provides a microenvironment for endometrial stem cells neurogenesis, \u003ci\u003eMedical Hypotheses\u003c/i\u003e, vol. 76, no. 6, pp. 843846, 2011. \u003cspan class=\"reflinks\"\u003eView at: \u003ca href=\"https://doi.org/10.1016/j.mehy.2011.02.033\"\u003ePublisher Site\u003c/a\u003e\u003cspan class =\"sep\"\u003e | \u003c/span\u003e\u003ca href=\"https://scholar.google.com/scholar_lookup?title=DHEA%20provides%20a%20microenvironment%20for%20endometrial%20stem%20cells%20neurogenesis\u0026author=A. Shoae-Hassani\u0026author=S. A. Mortazavi-Tabatabaei\u0026author=S. Sharif\u0026author=H. Rezaei-Khaligh\u0026author=\u0026author=J. Verdi\u0026publication_year=2011\" target=\"_blank\"\u003eGoogle Scholar\u003c/a\u003e\u003c/span\u003e\u003cli id=\"B3\"\u003eH. A. Cameron, Adult neurogenesis is regulated by adrenal steroids in the dentate gyrus, \u003ci\u003eNeuroscience\u003c/i\u003e, vol. 61, no. 2, pp. 203209, 1994. \u003cspan class=\"reflinks\"\u003eView at: \u003ca href=\"https://doi.org/10.1016/0306-4522(94)90224-0\"\u003ePublisher Site\u003c/a\u003e\u003cspan class =\"sep\"\u003e | \u003c/span\u003e\u003ca href=\"https://scholar.google.com/scholar_lookup?title=Adult%20neurogenesis%20is%20regulated%20by%20adrenal%20steroids%20in%20the%20dentate%20gyrus\u0026author=H. A. Cameron\u0026publication_year=1994\" target=\"_blank\"\u003eGoogle Scholar\u003c/a\u003e\u003c/span\u003e\u003cli id=\"B4\"\u003eP.-M. Lledo, M. Alonso, and M. S. Grubb, Adult neurogenesis and functional plasticity in neuronal circuits, \u003ci\u003eNature Reviews Neuroscience\u003c/i\u003e, vol. 7, no. 3, pp. 179193, 2006. \u003cspan class=\"reflinks\"\u003eView at: \u003ca href=\"https://doi.org/10.1038/nrn1867\"\u003ePublisher Site\u003c/a\u003e\u003cspan class =\"sep\"\u003e | \u003c/span\u003e\u003ca href=\"https://scholar.google.com/scholar_lookup?title=Adult%20neurogenesis%20and%20functional%20plasticity%20in%20neuronal%20circuits\u0026author=P.-M. Lledo\u0026author=M. Alonso\u0026author=\u0026author=M. S. Grubb\u0026publication_year=2006\" target=\"_blank\"\u003eGoogle Scholar\u003c/a\u003e\u003c/span\u003e\u003cli id=\"B5\"\u003eR. Ranganathan, E. R. Sawin, C. Trent, and H. R. Horvitz, Mutations in the \u003ci\u003eCaenorhabditis elegans\u003c/i\u003eserotonin reuptake transporter MOD-5 reveal serotonin-dependent and -independent activities of fluoxetine, \u003ci\u003eJournal of Neuroscience\u003c/i\u003e, vol. 21, no. 16, pp. 58715884, 2001. \u003cspan class=\"reflinks\"\u003eView at: \u003ca href=\"https://scholar.google.com/scholar_lookup?title=Mutations%20in%20the%20Caenorhabditis%20elegansserotonin%20reuptake%20transporter%20MOD-5%20reveal%20serotonin-dependent%20and%20-independent%20activities%20of%20fluoxetine\u0026author=R. Ranganathan\u0026author=E. R. Sawin\u0026author=C. Trent\u0026author=\u0026author=H. R. Horvitz\u0026publication_year=2001\" target=\"_blank\"\u003eGoogle Scholar\u003c/a\u003e\u003c/span\u003e\u003cli id=\"B6\"\u003eA. Abdipranoto, S. Wu, S. Stayte, and B. Vissel, The role of neurogenesis in neurodegenerative diseases and its implications for therapeutic development, \u003ci\u003eCNS and Neurological Disorders-Drug Targets\u003c/i\u003e, vol. 7, no. 2, pp. 187210, 2008. \u003cspan class=\"reflinks\"\u003eView at: \u003ca href=\"https://doi.org/10.2174/187152708784083858\"\u003ePublisher Site\u003c/a\u003e\u003cspan class =\"sep\"\u003e | \u003c/span\u003e\u003ca href=\"https://scholar.google.com/scholar_lookup?title=The%20role%20of%20neurogenesis%20in%20neurodegenerative%20diseases%20and%20its%20implications%20for%20therapeutic%20development\u0026author=A. Abdipranoto\u0026author=S. Wu\u0026author=S. Stayte\u0026author=\u0026author=B. Vissel\u0026publication_year=2008\" target=\"_blank\"\u003eGoogle Scholar\u003c/a\u003e\u003c/span\u003e\u003cli id=\"B7\"\u003eH. Dudek, S. R. Datta, T. F. Franke et al., Regulation of neuronal survival by the serine-threonine protein kinase Akt, \u003ci\u003eScience\u003c/i\u003e, vol. 275, no. 5300, pp. 661665, 1997. \u003cspan class=\"reflinks\"\u003eView at: \u003ca href=\"https://doi.org/10.1126/science.275.5300.661\"\u003ePublisher Site\u003c/a\u003e\u003cspan class =\"sep\"\u003e | \u003c/span\u003e\u003ca href=\"https://scholar.google.com/scholar_lookup?title=Regulation%20of%20neuronal%20survival%20by%20the%20serine-threonine%20protein%20kinase%20Akt\u0026author=H. Dudek\u0026author=S. R. Datta\u0026author=T. F. Franke et al.\u0026publication_year=1997\" target=\"_blank\"\u003eGoogle Scholar\u003c/a\u003e\u003c/span\u003e\u003cli id=\"B8\"\u003eS. G. Kennedy, E. S. Kandel, T. K. Cross, and N. Hay, Akt/protein kinase B inhibits cell death by preventing the release of cytochrome C from mitochondria, \u003ci\u003eMolecular and Cellular Biology\u003c/i\u003e, vol. 19, no. 8, pp. 58005810, 1999. \u003cspan class=\"reflinks\"\u003eView at: \u003ca href=\"https://scholar.google.com/scholar_lookup?title=Akt/protein%20kinase%20B%20inhibits%20cell%20death%20by%20preventing%20the%20release%20of%20cytochrome%20C%20from%20mitochondria\u0026author=S. G. Kennedy\u0026author=E. S. Kandel\u0026author=T. K. Cross\u0026author=\u0026author=N. Hay\u0026publication_year=1999\" target=\"_blank\"\u003eGoogle Scholar\u003c/a\u003e\u003c/span\u003e\u003cli id=\"B9\"\u003eA. Brunet, S. R. Datta, and M. E. Greenberg, Transcription-dependent and\u0026#x2014;independent control of neuronal survival by the PI3K-Akt signaling pathway, \u003ci\u003eCurrent Opinion in Neurobiology\u003c/i\u003e, vol. 11, no. 3, pp. 297305, 2001. \u003cspan class=\"reflinks\"\u003eView at: \u003ca href=\"https://doi.org/10.1016/S0959-4388(00)00211-7\"\u003ePublisher Site\u003c/a\u003e\u003cspan class =\"sep\"\u003e | \u003c/span\u003e\u003ca href=\"https://scholar.google.com/scholar_lookup?title=Transcription-dependent%20andindependent%20control%20of%20neuronal%20survival%20by%20the%20PI3K-Akt%20signaling%20pathway\u0026author=A. Brunet\u0026author=S. R. Datta\u0026author=\u0026author=M. E. Greenberg\u0026publication_year=2001\" target=\"_blank\"\u003eGoogle Scholar\u003c/a\u003e\u003c/span\u003e\u003cli id=\"B10\"\u003eT. F. Franke, C. P. Hornik, L. Segev, G. A. Shostak, and C. Sugimoto, PI3K/Akt and apoptosis: size matters, \u003ci\u003eOncogene\u003c/i\u003e, vol. 22, no. 56, pp. 89838998, 2003. \u003cspan class=\"reflinks\"\u003eView at: \u003ca href=\"https://doi.org/10.1038/sj.onc.1207115\"\u003ePublisher Site\u003c/a\u003e\u003cspan class =\"sep\"\u003e | \u003c/span\u003e\u003ca href=\"https://scholar.google.com/scholar_lookup?title=PI3K/Akt%20and%20apoptosis:%20size%20matters\u0026author=T. F. Franke\u0026author=C. P. Hornik\u0026author=L. Segev\u0026author=G. A. Shostak\u0026author=\u0026author=C. Sugimoto\u0026publication_year=2003\" target=\"_blank\"\u003eGoogle Scholar\u003c/a\u003e\u003c/span\u003e\u003cli id=\"B11\"\u003eA. Shoae-Hassani, A. M. Seifalian, S. A. Mortazavi-Tabatabaei, S. Sharif, A. Azimi, and J. Verdi, Differentiation of human endometrial stem cells into urothelial cells on a three-dimensional nanofibrous silk-collagen scaffold: an autologous cell resource for reconstruction of the urinary bladder wall, \u003ci\u003eJournal of Tissue Engineering and Regenerative Medicine\u003c/i\u003e, 2013. \u003cspan class=\"reflinks\"\u003eView at: \u003ca href=\"https://doi.org/10.1002/term.1632\"\u003ePublisher Site\u003c/a\u003e\u003cspan class =\"sep\"\u003e | \u003c/span\u003e\u003ca href=\"https://scholar.google.com/scholar_lookup?title=Differentiation%20of%20human%20endometrial%20stem%20cells%20into%20urothelial%20cells%20on%20a%20three-dimensional%20nanofibrous%20silk-collagen%20scaffold:%20an%20autologous%20cell%20resource%20for%20reconstruction%20of%20the%20urinary%20bladder%20wall\u0026author=A. Shoae-Hassani\u0026author=A. M. Seifalian\u0026author=S. A. Mortazavi-Tabatabaei\u0026author=S. Sharif\u0026author=A. Azimi\u0026author=\u0026author=J. Verdi\u0026publication_year=2013\" target=\"_blank\"\u003eGoogle Scholar\u003c/a\u003e\u003c/span\u003e\u003cli id=\"B12\"\u003eC. E. Gargett, Uterine stem cells: what is the evidence? \u003ci\u003eHuman Reproduction Update\u003c/i\u003e, vol. 13, no. 1, pp. 87101, 2007. \u003cspan class=\"reflinks\"\u003eView at: \u003ca href=\"https://doi.org/10.1093/humupd/dml045\"\u003ePublisher Site\u003c/a\u003e\u003cspan class =\"sep\"\u003e | \u003c/span\u003e\u003ca href=\"https://scholar.google.com/scholar_lookup?title=Uterine%20stem%20cells:%20what%20is%20the%20evidence?\u0026author=C. E. Gargett\u0026publication_year=2007\" target=\"_blank\"\u003eGoogle Scholar\u003c/a\u003e\u003c/span\u003e\u003cli id=\"B13\"\u003eA. Shoae-Hassani, S. A. Mortazavi-Tabatabaei, S. Sharif, S. Madadi, H. Rezaei-Khaligh, and J. Verdi, Recombinant lambda bacteriophage displaying nanobody towards third domain of Her-II epitope inhibits proliferation of breast carcinoma SKBR-3 cell line, \u003ci\u003eArchivum Immunologiae et Therapiae Experimentalis\u003c/i\u003e, vol. 61, no. 1, pp. 7583, 2013. \u003cspan class=\"reflinks\"\u003eView at: \u003ca href=\"https://doi.org/10.1007/s00005-012-0206-x\"\u003ePublisher Site\u003c/a\u003e\u003cspan class =\"sep\"\u003e | \u003c/span\u003e\u003ca href=\"https://scholar.google.com/scholar_lookup?title=Recombinant%20lambda%20bacteriophage%20displaying%20nanobody%20towards%20third%20domain%20of%20Her-II%20epitope%20inhibits%20proliferation%20of%20breast%20carcinoma%20SKBR-3%20cell%20line\u0026author=A. Shoae-Hassani\u0026author=S. A. Mortazavi-Tabatabaei\u0026author=S. Sharif\u0026author=S. Madadi\u0026author=H. Rezaei-Khaligh\u0026author=\u0026author=J. Verdi\u0026publication_year=2013\" target=\"_blank\"\u003eGoogle Scholar\u003c/a\u003e\u003c/span\u003e\u003cli id=\"B14\"\u003eF. Karege, M. Schwald, and M. Cisse, Postnatal developmental profile of brain-derived neurotrophic factor in rat brain and platelets, \u003ci\u003eNeuroscience Letters\u003c/i\u003e, vol. 328, no. 3, pp. 261264, 2002. \u003cspan class=\"reflinks\"\u003eView at: \u003ca href=\"https://doi.org/10.1016/S0304-3940(02)00529-3\"\u003ePublisher Site\u003c/a\u003e\u003cspan class =\"sep\"\u003e | \u003c/span\u003e\u003ca href=\"https://scholar.google.com/scholar_lookup?title=Postnatal%20developmental%20profile%20of%20brain-derived%20neurotrophic%20factor%20in%20rat%20brain%20and%20platelets\u0026author=F. Karege\u0026author=M. Schwald\u0026author=\u0026author=M. Cisse\u0026publication_year=2002\" target=\"_blank\"\u003eGoogle Scholar\u003c/a\u003e\u003c/span\u003e\u003cli id=\"B15\"\u003eG. Mercier, A. M. Lennon, B. Renouf et al., MAP kinase activation by fluoxetine and its relation to gene expression in cultured rat astrocytes, \u003ci\u003eJournal of Molecular Neuroscience\u003c/i\u003e, vol. 24, no. 2, pp. 207216, 2004. \u003cspan class=\"reflinks\"\u003eView at: \u003ca href=\"https://doi.org/10.1385/JMN:24:2:207\"\u003ePublisher Site\u003c/a\u003e\u003cspan class =\"sep\"\u003e | \u003c/span\u003e\u003ca href=\"https://scholar.google.com/scholar_lookup?title=MAP%20kinase%20activation%20by%20fluoxetine%20and%20its%20relation%20to%20gene%20expression%20in%20cultured%20rat%20astrocytes\u0026author=G. Mercier\u0026author=A. M. Lennon\u0026author=B. Renouf et al.\u0026publication_year=2004\" target=\"_blank\"\u003eGoogle Scholar\u003c/a\u003e\u003c/span\u003e\u003cli id=\"B16\"\u003eF. Fumagalli, R. Molteni, F. Calabrese, A. Frasca, G. Racagni, and M. A. Riva, Chronic fluoxetine administration inhibits extracellular signal-regulated kinase 1/2 phosphorylation in rat brain, \u003ci\u003eJournal of Neurochemistry\u003c/i\u003e, vol. 93, no. 6, pp. 15511560, 2005. \u003cspan class=\"reflinks\"\u003eView at: \u003ca href=\"https://doi.org/10.1111/j.1471-4159.2005.03149.x\"\u003ePublisher Site\u003c/a\u003e\u003cspan class =\"sep\"\u003e | \u003c/span\u003e\u003ca href=\"https://scholar.google.com/scholar_lookup?title=Chronic%20fluoxetine%20administration%20inhibits%20extracellular%20signal-regulated%20kinase%201/2%20phosphorylation%20in%20rat%20brain\u0026author=F. Fumagalli\u0026author=R. Molteni\u0026author=F. Calabrese\u0026author=A. Frasca\u0026author=G. Racagni\u0026author=\u0026author=M. A. Riva\u0026publication_year=2005\" target=\"_blank\"\u003eGoogle Scholar\u003c/a\u003e\u003c/span\u003e\u003cli id=\"B17\"\u003eE. Ha, K. H. Jung, B.-K. Choe et al., Fluoxetine increases the nitric oxide production via nuclear factor kappa B-mediated pathway in BV2 murine microglial cells, \u003ci\u003eNeuroscience Letters\u003c/i\u003e, vol. 397, no. 3, pp. 185189, 2006. \u003cspan class=\"reflinks\"\u003eView at: \u003ca href=\"https://doi.org/10.1016/j.neulet.2005.12.022\"\u003ePublisher Site\u003c/a\u003e\u003cspan class =\"sep\"\u003e | \u003c/span\u003e\u003ca href=\"https://scholar.google.com/scholar_lookup?title=Fluoxetine%20increases%20the%20nitric%20oxide%20production%20via%20nuclear%20factor%20kappa%20B-mediated%20pathway%20in%20BV2%20murine%20microglial%20cells\u0026author=E. Ha\u0026author=K. H. Jung\u0026author=B.-K. Choe et al.\u0026publication_year=2006\" target=\"_blank\"\u003eGoogle Scholar\u003c/a\u003e\u003c/span\u003e\u003cli id=\"B18\"\u003eR. K. Choy and J. H. Thomas, Fluoxetine-resistant mutants in \u003ci\u003eC. elegans\u003c/i\u003e define a novel family of transmembrane proteins, \u003ci\u003eMolecular Cell\u003c/i\u003e, vol. 4, no. 2, pp. 143152, 1999. \u003cspan class=\"reflinks\"\u003eView at: \u003ca href=\"https://doi.org/10.1016/S1097-2765(00)80362-7\"\u003ePublisher Site\u003c/a\u003e\u003cspan class =\"sep\"\u003e | \u003c/span\u003e\u003ca href=\"https://scholar.google.com/scholar_lookup?title=Fluoxetine-resistant%20mutants%20in%20C.%20elegans%20define%20a%20novel%20family%20of%20transmembrane%20proteins\u0026author=R. K. Choy \u0026author=J. H. Thomas\u0026publication_year=1999\" target=\"_blank\"\u003eGoogle Scholar\u003c/a\u003e\u003c/span\u003e\u003cli id=\"B19\"\u003eC.-T. Lee, J. Chen, T. Hayashi et al., A mechanism for the inhibition of neural progenitor cell proliferation by cocaine, \u003ci\u003ePLoS Medicine\u003c/i\u003e, vol. 5, no. 6, article e117, 2008. \u003cspan class=\"reflinks\"\u003eView at: \u003ca href=\"https://doi.org/10.1371/journal.pmed.0050117\"\u003ePublisher Site\u003c/a\u003e\u003cspan class =\"sep\"\u003e | \u003c/span\u003e\u003ca href=\"https://scholar.google.com/scholar_lookup?title=A%20mechanism%20for%20the%20inhibition%20of%20neural%20progenitor%20cell%20proliferation%20by%20cocaine\u0026author=C.-T. Lee\u0026author=J. Chen\u0026author=T. Hayashi et al.\u0026publication_year=2008\" target=\"_blank\"\u003eGoogle Scholar\u003c/a\u003e\u003c/span\u003e\u003cli id=\"B20\"\u003eW. J. Ray, G. Bain, M. Yao, and D. I. Gottlieb, CYP26, a novel mammalian cytochrome P450, is induced by retinoic acid and defines a new family, \u003ci\u003eJournal of Biological Chemistry\u003c/i\u003e, vol. 272, no. 30, pp. 1870218708, 1997. \u003cspan class=\"reflinks\"\u003eView at: \u003ca href=\"https://doi.org/10.1074/jbc.272.30.18702\"\u003ePublisher Site\u003c/a\u003e\u003cspan class =\"sep\"\u003e | \u003c/span\u003e\u003ca href=\"https://scholar.google.com/scholar_lookup?title=CYP26,%20a%20novel%20mammalian%20cytochrome%20P450,%20is%20induced%20by%20retinoic%20acid%20and%20defines%20a%20new%20family\u0026author=W. J. Ray\u0026author=G. Bain\u0026author=M. Yao\u0026author=\u0026author=D. I. Gottlieb\u0026publication_year=1997\" target=\"_blank\"\u003eGoogle Scholar\u003c/a\u003e\u003c/span\u003e\u003cli id=\"B21\"\u003eD. Weinshenker, G. Garriga, and J. H. Thomas, Genetic and pharmacological analysis of neurotransmitters controlling egg laying in \u003ci\u003eC. elegans\u003c/i\u003e, \u003ci\u003eJournal of Neuroscience\u003c/i\u003e, vol. 15, no. 10, pp. 69756985, 1995. \u003cspan class=\"reflinks\"\u003eView at: \u003ca href=\"https://scholar.google.com/scholar_lookup?title=Genetic%20and%20pharmacological%20analysis%20of%20neurotransmitters%20controlling%20egg%20laying%20in%20C.%20elegans\u0026author=D. Weinshenker\u0026author=G. Garriga\u0026author=\u0026author=J. H. Thomas\u0026publication_year=1995\" target=\"_blank\"\u003eGoogle Scholar\u003c/a\u003e\u003c/span\u003e\u003cli id=\"B22\"\u003eG. Schaarschmidt, F. Wegner, S. C. Schwarz, H. Schmidt, and J. Schwarz, Characterization of voltage-gated potassium channels in human neural progenitor cells, \u003ci\u003ePLoS ONE\u003c/i\u003e, vol. 4, no. 7, Article ID e6168, 2009. \u003cspan class=\"reflinks\"\u003eView at: \u003ca href=\"https://doi.org/10.1371/journal.pone.0006168\"\u003ePublisher Site\u003c/a\u003e\u003cspan class =\"sep\"\u003e | \u003c/span\u003e\u003ca href=\"https://scholar.google.com/scholar_lookup?title=Characterization%20of%20voltage-gated%20potassium%20channels%20in%20human%20neural%20progenitor%20cells\u0026author=G. Schaarschmidt\u0026author=F. Wegner\u0026author=S. C. Schwarz\u0026author=H. Schmidt\u0026author=\u0026author=J. Schwarz\u0026publication_year=2009\" target=\"_blank\"\u003eGoogle Scholar\u003c/a\u003e\u003c/span\u003e\u003cli id=\"B23\"\u003eR. M. W. de Oliveira, S. Martin, C. L. de Oliveira et al., Eag1, Eag2, and SK3 potassium channel expression in the rat hippocampus after global transient brain ischemia, \u003ci\u003eJournal of Neuroscience Research\u003c/i\u003e, vol. 90, no. 3, pp. 632640, 2012. \u003cspan class=\"reflinks\"\u003eView at: \u003ca href=\"https://doi.org/10.1002/jnr.22772\"\u003ePublisher Site\u003c/a\u003e\u003cspan class =\"sep\"\u003e | \u003c/span\u003e\u003ca href=\"https://scholar.google.com/scholar_lookup?title=Eag1,%20Eag2,%20and%20SK3%20potassium%20channel%20expression%20in%20the%20rat%20hippocampus%20after%20global%20transient%20brain%20ischemia\u0026author=R. M. W. de Oliveira\u0026author=S. Martin\u0026author=C. L. de Oliveira et al.\u0026publication_year=2012\" target=\"_blank\"\u003eGoogle Scholar\u003c/a\u003e\u003c/span\u003e\u003cli id=\"B24\"\u003eM. S. Cho, Y.-E. Lee, J. Y. Kim et al., Highly efficient and large-scale generation of functional dopamine neurons from human embryonic stem cells, \u003ci\u003eProceedings of the National Academy of Sciences of the United States of America\u003c/i\u003e, vol. 105, no. 9, pp. 33923397, 2008. \u003cspan class=\"reflinks\"\u003eView at: \u003ca href=\"https://doi.org/10.1073/pnas.0712359105\"\u003ePublisher Site\u003c/a\u003e\u003cspan class =\"sep\"\u003e | \u003c/span\u003e\u003ca href=\"https://scholar.google.com/scholar_lookup?title=Highly%20efficient%20and%20large-scale%20generation%20of%20functional%20dopamine%20neurons%20from%20human%20embryonic%20stem%20cells\u0026author=M. S. Cho\u0026author=Y.-E. Lee\u0026author=J. Y. Kim et al.\u0026publication_year=2008\" target=\"_blank\"\u003eGoogle Scholar\u003c/a\u003e\u003c/span\u003e\u003cli id=\"B25\"\u003eY.-H. Rhee, J.-Y. Ko, M.-Y. Chang et al., Protein-based human iPS cells efficiently generate functional dopamine neurons and can treat a rat model of Parkinson disease, \u003ci\u003eJournal of Clinical Investigation\u003c/i\u003e, vol. 121, no. 6, pp. 23262335, 2011. \u003cspan class=\"reflinks\"\u003eView at: \u003ca href=\"https://doi.org/10.1172/JCI45794\"\u003ePublisher Site\u003c/a\u003e\u003cspan class =\"sep\"\u003e | \u003c/span\u003e\u003ca href=\"https://scholar.google.com/scholar_lookup?title=Protein-based%20human%20iPS%20cells%20efficiently%20generate%20functional%20dopamine%20neurons%20and%20can%20treat%20a%20rat%20model%20of%20Parkinson%20disease\u0026author=Y.-H. Rhee\u0026author=J.-Y. Ko\u0026author=M.-Y. Chang et al.\u0026publication_year=2011\" target=\"_blank\"\u003eGoogle Scholar\u003c/a\u003e\u003c/span\u003e\u003cli id=\"B26\"\u003eA. Shoae-Hassani, S. Sharif, and J. Verdi, The neurosteroid dehydroepiandrosterone could improve somatic cell reprogramming, \u003ci\u003eCell Biology International\u003c/i\u003e, vol. 35, no. 1, pp. 10371041, 2011. \u003cspan class=\"reflinks\"\u003eView at: \u003ca href=\"https://doi.org/10.1042/CBI20100927\"\u003ePublisher Site\u003c/a\u003e\u003cspan class =\"sep\"\u003e | \u003c/span\u003e\u003ca href=\"https://scholar.google.com/scholar_lookup?title=The%20neurosteroid%20dehydroepiandrosterone%20could%20improve%20somatic%20cell%20reprogramming\u0026author=A. Shoae-Hassani\u0026author=S. Sharif\u0026author=\u0026author=J. Verdi\u0026publication_year=2011\" target=\"_blank\"\u003eGoogle Scholar\u003c/a\u003e\u003c/span\u003e\u003cli id=\"B27\"\u003eD. S. Kwon, C. H. Kwon, J. H. Kim, J. S. Woo, J. S. Jung, and Y. K. Kim, Signal transduction of MEK/ERK and PI3K/Akt activation by hypoxia/reoxygenation in renal epithelial cells, \u003ci\u003eEuropean Journal of Cell Biology\u003c/i\u003e, vol. 85, no. 11, pp. 11891199, 2006. \u003cspan class=\"reflinks\"\u003eView at: \u003ca href=\"https://doi.org/10.1016/j.ejcb.2006.06.001\"\u003ePublisher Site\u003c/a\u003e\u003cspan class =\"sep\"\u003e | \u003c/span\u003e\u003ca href=\"https://scholar.google.com/scholar_lookup?title=Signal%20transduction%20of%20MEK/ERK%20and%20PI3K/Akt%20activation%20by%20hypoxia/reoxygenation%20in%20renal%20epithelial%20cells\u0026author=D. S. Kwon\u0026author=C. H. Kwon\u0026author=J. H. Kim\u0026author=J. S. Woo\u0026author=J. S. Jung\u0026author=\u0026author=Y. K. Kim\u0026publication_year=2006\" target=\"_blank\"\u003eGoogle Scholar\u003c/a\u003e\u003c/span\u003e\u003cli id=\"B28\"\u003eJ. W. Kim, J. E. Lee, M. J. Kim, E.-G. Cho, S.-G. Cho, and E.-J. Choi, Glycogen synthase kinase 3\u003ci\u003e\u0026#x3b2;\u003c/i\u003e is a natural activator of mitogen-activated protein kinase/extracellular signal-regulated kinase kinase kinase 1 (MEKK1), \u003ci\u003eJournal of Biological Chemistry\u003c/i\u003e, vol. 278, no. 16, pp. 1399514001, 2003. \u003cspan class=\"reflinks\"\u003eView at: \u003ca href=\"https://doi.org/10.1074/jbc.M300253200\"\u003ePublisher Site\u003c/a\u003e\u003cspan class =\"sep\"\u003e | \u003c/span\u003e\u003ca href=\"https://scholar.google.com/scholar_lookup?title=Glycogen%20synthase%20kinase%203%20is%20a%20natural%20activator%20of%20mitogen-activated%20protein%20kinase/extracellular%20signal-regulated%20kinase%20kinase%20kinase%201%20(MEKK1)\u0026author=J. W. Kim\u0026author=J. E. Lee\u0026author=M. J. Kim\u0026author=E.-G. Cho\u0026author=S.-G. Cho\u0026author=\u0026author=E.-J. Choi\u0026publication_year=2003\" target=\"_blank\"\u003eGoogle Scholar\u003c/a\u003e\u003c/span\u003e\u003cli id=\"B29\"\u003eK. Frebel and S. Wiese, Signalling molecules essential for neuronal survival and differentiation, \u003ci\u003eBiochemical Society Transactions\u003c/i\u003e, vol. 34, no. 6, pp. 12871290, 2006. \u003cspan class=\"reflinks\"\u003eView at: \u003ca href=\"https://doi.org/10.1042/BST0341287\"\u003ePublisher Site\u003c/a\u003e\u003cspan class =\"sep\"\u003e | \u003c/span\u003e\u003ca href=\"https://scholar.google.com/scholar_lookup?title=Signalling%20molecules%20essential%20for%20neuronal%20survival%20and%20differentiation\u0026author=K. Frebel \u0026author=S. Wiese\u0026publication_year=2006\" target=\"_blank\"\u003eGoogle Scholar\u003c/a\u003e\u003c/span\u003e\u003cli id=\"B30\"\u003eH. E. Scharfman and R. Hen, Is more neurogenesis always better? \u003ci\u003eScience\u003c/i\u003e, vol. 315, no. 5810, pp. 336338, 2007. \u003cspan class=\"reflinks\"\u003eView at: \u003ca href=\"https://doi.org/10.1126/science.1138711\"\u003ePublisher Site\u003c/a\u003e\u003cspan class =\"sep\"\u003e | \u003c/span\u003e\u003ca href=\"https://scholar.google.com/scholar_lookup?title=Is%20more%20neurogenesis%20always%20better?\u0026author=H. E. Scharfman \u0026author=R. Hen\u0026publication_year=2007\" target=\"_blank\"\u003eGoogle Scholar\u003c/a\u003e\u003c/span\u003e\u003cli id=\"B31\"\u003eA. J. Rush, M. H. Trivedi, S. R. Wisniewski et al., Acute and longer-term outcomes in depressed outpatients requiring one or several treatment steps: a STAR\u0026#x2a;D report, \u003ci\u003eAmerican Journal of Psychiatry\u003c/i\u003e, vol. 163, no. 11, pp. 19051917, 2006. \u003cspan class=\"reflinks\"\u003eView at: \u003ca href=\"https://doi.org/10.1176/appi.ajp.163.11.1905\"\u003ePublisher Site\u003c/a\u003e\u003cspan class =\"sep\"\u003e | \u003c/span\u003e\u003ca href=\"https://scholar.google.com/scholar_lookup?title=Acute%20and%20longer-term%20outcomes%20in%20depressed%20outpatients%20requiring%20one%20or%20several%20treatment%20steps:%20a%20STAR*D%20report\u0026author=A. J. Rush\u0026author=M. H. Trivedi\u0026author=S. R. Wisniewski et al.\u0026publication_year=2006\" target=\"_blank\"\u003eGoogle Scholar\u003c/a\u003e\u003c/span\u003e\u003c/li\u003e\u003c/ol\u003e\u003c/div\u003e\u003cdiv class=\"xml-content\"\u003e\u003ch4 class=\"copyright\" id=\"copyright\"\u003eCopyright\u003c/h4\u003e\u003cp\u003eCopyright \u0026#xa9; 2013 Anahita Rahmani et al. This is an open access article distributed under the \u003ca rel=\"license\" href=\"http://creativecommons.org/licenses/by/3.0/\"\u003e  Creative Commons Attribution License\u003c/a\u003e, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.\u003c/p\u003e\u003c/div\u003e","section_links":[{"hash":"abstract","title":"Abstract"},{"hash":"introduction","title":"Introduction"},{"hash":"materials-and-methods","title":"Materials and Methods"},{"hash":"results","title":"Results"},{"hash":"discussion","title":"Discussion"},{"hash":"conclusion","title":"Conclusion"},{"hash":"conflict-of-interests","title":"Conflict of Interests"},{"hash":"references","title":"References"},{"hash":"copyright","title":"Copyright"}],"style":"","block_links":[{"title":"PDF","type":"PDF","url":"downloads.hindawi.com/journals/bmri/2013/582526.pdf","childrens":[]},{"title":"Download Reference","type":"RIS","url":"/journals/bmri/2013/582526.ris","childrens":[]},{"title":"Download other formats","type":"","url":"","childrens":[{"title":"ePub","type":"ePUB","url":"downloads.hindawi.com/journals/bmri/2013/582526.epub"},{"title":"XML","type":"XML","url":"downloads.hindawi.com/journals/bmri/2013/582526.xml"}]}],"articleStats":{"no_of_views":2763,"no_of_downloads":1049,"no_of_citations":17},"relatedArticleChildren":{"articles":[]},"alertMessage":{"HIGH":[],"MODERATE":[],"LOW":["A \u003cb\u003eCorrigendum\u003c/b\u003e for this article has been published.\n  To view the article details, please click the Corrigendum tab above."]}},"year":"2013","statusCode":false},"currentUrl":"https://www.hindawi.com/journals/bmri/2013/582526/","siteUrl":"https://www.hindawi.com","currentPath":"/journals/bmri/2013/582526/","host":"www.hindawi.com"},"page":"/journal_article","query":{},"buildId":"cpr9K8AjZYaP4CWVbtn5c","dynamicBuildId":false,"assetPrefix":"https://static-01.hindawi.com/next_assets/cpr9K8AjZYaP4CWVbtn5c"}</script><script async="" id="__NEXT_PAGE__/journal_article" src="https://static-01.hindawi.com/next_assets/cpr9K8AjZYaP4CWVbtn5c/_next/static/cpr9K8AjZYaP4CWVbtn5c/pages/journal_article.js"></script><script async="" id="__NEXT_PAGE__/_app" src="https://static-01.hindawi.com/next_assets/cpr9K8AjZYaP4CWVbtn5c/_next/static/cpr9K8AjZYaP4CWVbtn5c/pages/_app.js"></script><script src="https://static-01.hindawi.com/next_assets/cpr9K8AjZYaP4CWVbtn5c/_next/static/runtime/webpack-8ed9452df514b4d17d80.js" async=""></script><script src="https://static-01.hindawi.com/next_assets/cpr9K8AjZYaP4CWVbtn5c/_next/static/chunks/common.833c76e043bbff9f1f05.js" async=""></script><script src="https://static-01.hindawi.com/next_assets/cpr9K8AjZYaP4CWVbtn5c/_next/static/chunks/vendors~static/cpr9K8AjZYaP4CWVbtn5c/pages/_error.js~static/cpr9K8AjZYaP4CWVbtn5c/pages/basic_page.j~be281a1b.25833a967f60c50378e5.js" async=""></script><script src="https://static-01.hindawi.com/next_assets/cpr9K8AjZYaP4CWVbtn5c/_next/static/runtime/main-87fc3e527b54e364ead2.js" async=""></script><script src="https://static-01.hindawi.com/next_assets/cpr9K8AjZYaP4CWVbtn5c/_next/static/chunks/vendors~static/cpr9K8AjZYaP4CWVbtn5c/pages/_app.js~static/cpr9K8AjZYaP4CWVbtn5c/pages/login.js~stati~9d879864.8fb864f66b07cdcdf10f.js" async=""></script><script src="https://static-01.hindawi.com/next_assets/cpr9K8AjZYaP4CWVbtn5c/_next/static/chunks/vendors~static/cpr9K8AjZYaP4CWVbtn5c/pages/_app.js~static/cpr9K8AjZYaP4CWVbtn5c/pages/content_alerts~fb8dc725.93e0b4fc708693fdbfaa.js" async=""></script><script src="https://www.hindawi.com/static/themes/hindawi/base.js"></script></body></html>